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Evaluating Acupuncture and Standard carE for pregnant
women with Back pain (EASE Back): a feasibility study and
pilot randomised trial
Nadine E Foster,1* Annette Bishop,1 Bernadette Bartlam,1
Reuben Ogollah,1 Panos Barlas,1 Melanie Holden,1 Khaled Ismail,2
Sue Jowett,3 Christine Kettle,4 Jesse Kigozi,3 Martyn Lewis,1
Alison Lloyd,1 Jackie Waterfield1 and Julie Young1
1Research Institute of Primary Care and Health Sciences, Faculty of Health, Keele University,
Keele, Staffordshire, UK
2Reproduction, Genes and Development Department, School of Clinical and Experimental
Medicine, University of Birmingham, Birmingham, West Midlands, UK
3Health Economics Unit, School of Health and Population Sciences, University of Birmingham,
Birmingham, West Midlands, UK
4Faculty of Health Sciences, Staffordshire University, Stoke-on-Trent, Staffordshire, UK
*Corresponding author n.foster@keele.ac.uk
Background: Many pregnant women experience low back pain. Acupuncture appears to be a safe,
promising intervention but evidence is needed about its clinical effectiveness and cost-effectiveness.
Objectives: To assess the feasibility of a future large randomised controlled trial (RCT) testing the
additional benefit of adding acupuncture to standard care (SC) for pregnancy-related back pain.
Design: Phase 1: a questionnaire survey described current care for pregnancy-related back pain.
Focus groups and interviews with midwives, physiotherapists and pregnant women explored acceptability
and feasibility of acupuncture and the proposed RCT. Phase 2: a single-centre pilot RCT. Participants
were identified using six methods and randomised to SC, SC plus true acupuncture or SC plus
non-penetrating acupuncture.
Participants: Phase 1: 1093 physiotherapists were surveyed and 15 midwives, 21 physiotherapists and
17 pregnant women participated in five focus groups and 20 individual interviews. Phase 2: 125 women
with pregnancy-related back pain participated.
Interventions: SC: a self-management booklet and onward referral for one-to-one physiotherapy (two to
four sessions) for those who needed it. SC plus true acupuncture: the self-management booklet and six
to eight treatments with a physiotherapist comprising true (penetrating) acupuncture, advice and exercise.
SC plus non-penetrating acupuncture: the self-management booklet and six to eight treatments with a
physiotherapist comprising non-penetrating acupuncture, advice and exercise.
Main outcome measures: Pilot RCT outcomes included recruitment rates, treatment fidelity, follow-up
rate, patient-reported pain and function, quality of life and health-care resource use. Birth and neonatal
outcomes were also assessed. Staff overseeing outcome data collection were blind to treatment allocation.
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v
Results: Phase 1: 629 (57.5%) physiotherapists responded to the survey, 499 were experienced in treating
pregnancy-related back pain and reported 16 advice and 18 treatment options. Typical treatment comprised
two to four individual sessions of advice and exercise over 6 weeks. Acupuncture was reported by 24%.
Interviews highlighted the impact of back pain and paucity of effective interventions. Women and midwives
strongly supported a RCT and expressed few concerns. Physiotherapists’ concerns about acupuncture in
pregnancy informed a training programme prior to the pilot RCT. Phase 2: We recruited 125 of 280 potentially
eligible women (45%) in 6 months and randomised 41 to SC and 42 each to the SC plus true acupuncture
and SC plus non-penetrating acupuncture arms. Analysis was conducted with 124 participants (41, 42 and 41,
respectively) as one participant was randomised in error. Three of six recruitment methods were the most
successful. In total, 10% of women (n= 4) randomised to SC alone accessed one-to-one physiotherapy and
received an average of two treatments. The average number of treatments was six for both SC plus true
acupuncture and SC plus non-penetrating acupuncture. Treatments were in line with protocols. Eight-week
follow-up was 74%. Patient-reported outcomes (pain, function and quality of life) favoured the addition of
acupuncture. There was no evidence of serious adverse events on mothers or birth and neonatal outcomes.
The Pelvic Girdle Questionnaire was found to be an appropriate outcome measure for a future trial.
Conclusions: A future main RCT is feasible and would be welcomed by women and clinicians. Longer-term
follow-up and further follow-up efforts are recommended for a main trial.
Trial registration: Current Controlled Trials ISRCTN49955124.
Funding: This project was funded by the National Institute of Health Research Health Technology Assessment
programme and will be published in full in Health Technology Assessment; Vol. 20, No. 33. See the NIHR
Journals Library website for further project information.
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Plain English summary
Many pregnant women have back pain that impacts on their activities, work and sleep. Acupuncture isa promising intervention already used by physiotherapists in the NHS, but we do not know if it is
better than standard care (SC).
Based on information from a survey of almost 500 physiotherapists across the UK and from interviews with
17 pregnant women, 15 midwives and 21 physiotherapists, we found that SC varies a lot and more needs to
be done to help these women. We discovered that pregnant women are keen to take part in a study to
find out if acupuncture is better than SC. Pregnant women and their midwives had few concerns about
acupuncture although physiotherapists expressed some concerns and training needs that helped us design a
brief training programme for them.
We performed a small study with 125 women to test whether or not acupuncture offers additional benefit over
SC. We found that almost half of pregnant women with back pain agreed to join the study and three-quarters
gave us information 8 weeks later. The results show that a much larger study in the NHS is possible and
desirable but we need to make some minor changes to the ways we recruit and follow up women
after treatment.
This prepares the way for a larger study involving three hospitals and linked physiotherapy services over
several years. When it is finished we will know whether or not women with low back pain during
pregnancy should be offered acupuncture in addition to SC.
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Scientific summary
Background
More than two-thirds of pregnant women experience low back pain that interferes with everyday activities,
work and sleep. Most women do not receive much in the way of treatment but are advised to self-manage
and only those with the most severe problems are referred to NHS physiotherapists. Acupuncture appears
to be a safe, promising intervention used by some NHS physiotherapists, but there are no high-quality trial
data regarding its clinical effectiveness or cost-effectiveness, in comparison with standard care (SC).
We wish to investigate the short- and long-term clinical effectiveness and cost-effectiveness of acupuncture in
a future randomised controlled trial (RCT). Before this can be done, a feasibility and pilot trial was needed.
Our main concerns were whether or not pregnant women would find the offer of acupuncture acceptable
and if they could be recruited and retained in a RCT, whether or not physiotherapists would be willing
to provide acupuncture for this indication, and whether or not we could design a credible SC intervention;
we also wanted to determine the most suitable primary outcome measure and to estimate the sample size
needed for a future full RCT.
Aim and objectives
The overall aim was to assess the feasibility of a future RCT testing the additional benefit of acupuncture
to SC in women with pregnancy-related low back pain [with and without pelvic girdle pain (PGP)]. The
Evaluating Acupuncture and Standard carE for pregnant women with Back pain (EASE Back) feasibility and
pilot trial, funded over 24 months by the National Institute of Health Research (NIHR) Health Technology
Assessment, was conducted in two phases.
Phase 1: pre-pilot work
The objectives were to:
l provide data on current UK SC and acupuncture treatment for low back pain in pregnant women
l explore the views of pregnant women with back pain on the acceptability of the proposed
interventions, the content and delivery of participant information, the outcomes most important to
them and the most appropriate timing of outcome measurement
l optimise trial information, recruitment and consent procedures by learning what works best from the
perspectives of pregnant women with low back pain, midwives and physiotherapists
l investigate the views of NHS health professionals regarding (1) the acceptability and feasibility of
referring women with back pain in pregnancy to physiotherapists for acupuncture, (2) the proposed
trial design and interventions and (3) ways in which to maximise recruitment and retention to a trial.
Phase 2: pilot randomised controlled trial
The objectives were to:
l test the trial procedures, training programme for health professionals, interventions and short-term
outcomes with pregnant women with back pain; provide data on recruitment and follow-up rates,
treatment fidelity, outcome completion rates; and estimate the between-group difference on
key outcomes
l bring the above findings together, with experts in SC, acupuncture and trial design, in a consensus
conference to finalise the design, interventions, primary outcome measure, sample size and operational
aspects of a future main trial.
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Methods
Phase 1: pre-pilot work
Phase 1 consisted of exploratory mixed methods, using survey research and qualitative interviews
conducted between June and November 2012.
Current UK standard care and acupuncture practice
A cross-sectional postal survey of 1093 chartered physiotherapists described current SC and acupuncture
treatment for women with pregnancy-related low back pain.
Experiences and views of pregnant women with low back pain, midwives
and physiotherapists
Qualitative semistructured focus groups and individual interviews were conducted with midwives,
physiotherapists and pregnant women to explore current care and attitudes towards acupuncture in
pregnancy, and to inform the recruitment methods, patient information materials and interventions
for the pilot RCT. Results also informed the development of a training programme for physiotherapists
participating in the pilot RCT.
Optimise the information, recruitment and consent procedures for the
pilot trial
Findings from the focus groups and interviews were used to develop the patient information leaflet,
recruitment methods, screening and consent procedures and finalise the timing and content of outcome
assessments in the pilot RCT. Findings from the survey and interviews informed the development of the
self-management booklet Managing Your Back and Pelvic Girdle Pain in Pregnancy used in the pilot RCT.
Phase 2: pilot randomised controlled trial
A single-centre, three-arm parallel pilot RCT was performed in one NHS hospital trust and surrounding
NHS community trust between May 2013 and April 2014. Potentially eligible participants were identified
using six methods. If women appeared eligible during a brief screening telephone call, they were invited
for a face-to-face full eligibility screen with a research midwife or nurse. We audio-recorded and analysed
a sample of 30 of these face-to-face screening and consent meetings.
Women were included if they had pregnancy-related low back pain (with or without PGP), were under the
care of participating NHS sites and general practitioner practices, were 18 years and over, were at 13 to
31 weeks’ gestation, were naive to acupuncture treatment, were able to read and communicate in English
and were willing to participate. Women were excluded if they had ever had any form of acupuncture
previously, were at high risk of miscarriage or pre-term labour, had pre-eclampsia, had previous history
of surgery to the spine or pelvis, had contraindications to the treatments or had a particularly high fear of
needles, pain in the anterior pelvic region only or a current urinary tract infection.
Eligible women who gave written informed consent to participate were randomised in a 1 : 1 : 1 ratio,
stratified by gestational weeks, to receive SC alone, SC plus a course of true acupuncture or SC plus a
course of non-penetrating acupuncture, delivered by physiotherapists.
Standard care: SC comprised a posted copy of the EASE Back study self-management booklet and onward
referral for one-to-one physiotherapy for those women who needed it, in negotiation with their community
midwife. The treatment protocol for physiotherapy was between two and four sessions of advice, education
and exercise.
Standard care plus true acupuncture: participants received the same EASE Back study self-management
booklet and were offered a course of between six and eight treatment sessions with a physiotherapist
comprising true (penetrating) acupuncture at between 12 and 20 agreed acupuncture points, as well as
advice, education and exercise.
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Standard care plus non-penetrating acupuncture: participants received the same EASE Back study self-management
booklet and were offered a course of between six and eight treatment sessions with a physiotherapist comprising
non-penetrating acupuncture at eight agreed acupuncture points, as well as advice, education and exercise.
Patients were followed up at 8 weeks after randomisation using patient-reported outcome measures
for pain and function [Oswestry Disability Index (ODI), Pelvic Girdle Questionnaire (PGQ) and Pain
Numeric Rating Scale (NRS)] and quality of life (Short Form questionnaire-12 items and European Quality
of Life-5 Dimensions). Patients were also asked to report pain before going to bed at night and ability to
sleep through the night.
Consideration of outcome measures and sample size for a full randomised
controlled trial
We reviewed the data from the pilot RCT on three potential primary outcome measures for a full RCT
(ODI, PGQ and Pain NRS), and considered missing data, floor and ceiling effects and responsiveness to
change. We used information on minimum clinically important difference, effect size and standard
deviation (SD) to estimate the sample size needed for a future full RCT.
Results
Phase 1: pre-pilot work
There was a 57.5% (n= 629) response to the survey, with 499 physiotherapists experienced in treating
pregnancy-related back pain included in the analysis. A total of 16 advice and 18 treatment options were
reported, most frequently advice on posture (98%) and work (88%), home exercise (94%), postural
exercise (93%), support belts (48%) and manual therapy (48%). A typical course of treatment was two
to four one-to-one treatment sessions over 6 weeks. Acupuncture was reported by 24%.
A total of 53 individuals (17 pregnant women, 15 midwives and 21 physiotherapists) were interviewed
in five focus groups and 20 individual interviews. Results highlighted the extensive impact of moderate
to severe back pain and the paucity of effective interventions. Despite many physiotherapists using
acupuncture for musculoskeletal pain, they articulated a reluctance to use acupuncture in pregnant
women. They expressed a lack of confidence about the use of acupuncture in pregnancy, particularly
relating to fears of inducing early labour and the threat of litigation.
Agreeing a standard care treatment package
We developed an intervention protocol with the following components: (1) a high-quality posted
self-management booklet and (2) an onward pathway to one-to-one physiotherapy for those who both
the pregnant women and their midwives felt needed it. One-to-one physiotherapy involved (1) a detailed
patient assessment; (2) education and advice about pregnancy-related low back pain and PGP; (3) an
individualised exercise programme; and (4) help with pain relief. Between two and four one-to-one sessions
were agreed for those accessing physiotherapy in the SC alone arm over 6 weeks, with the episode of care left
open until the end of the pregnancy.
Women’s attitudes towards acupuncture and design of patient information
material for a randomised controlled trial
Our sample included 17 women with current, or experience of, pregnancy-related low back pain. Few
concerns were expressed about acupuncture; these focused on positioning, requirements for treatment
and whether or not the needling would be painful. These concerns were addressed within the patient
information material for the pilot RCT.
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Phase 2: pilot randomised controlled trial
Of 388 women assessed for eligibility in 6 months, 280 were screened as eligible and 125 women (45% of
those eligible) were recruited and randomised (41 to SC, 42 to SC plus true acupuncture and 42 to SC plus
non-penetrating acupuncture). Baseline characteristics were similar among the three treatment arms; mean age
was 28 (SD 5.3) years, 54 (44%) were married, 87 (70%) were in full/part-time employment and 53 (42%)
were 24 or more weeks pregnant. More than half had back pain for more than 6 weeks and mean pain
severity was 4.6 (SD 1.7) out of 10. About one-third had low back pain with anterior PGP and pain in other
parts of the body.
Of the 108 women who did not participate, 67 did not attend the face-to-face eligibility screening visit,
50 declined to participate and 38 were unable to be contacted in order to conduct a full eligibility screen.
The most frequent reasons for ineligibility were previous acupuncture (25%) and previously giving birth
before 37 weeks (12%). Audio-recordings showed that women had few concerns, mostly related to the
bodily sites of needling and length of time needed for treatment. Recruitment challenges were getting in
contact with women by telephone and the time constraints of the target population (e.g. their work and
childcare commitments).
In total, 10% of women randomised to SC alone accessed one-to-one physiotherapy. The average number
of physiotherapy-led treatment sessions per arm was two for SC alone, six for SC plus true acupuncture
and six for SC plus non-penetrating acupuncture and the content of treatment was in line with the
specified protocols.
The 8-week follow-up rate was 74%: 80% in the SC group, 76% in the SC plus true acupuncture group
and 66% in the SC plus non-penetrating acupuncture group. Those lost to follow-up were on average
younger, were more likely to come from the most deprived neighbourhoods and had more severe disability
and pain at baseline. Only 14% of participants had given birth by the time they returned the 8-week
follow-up questionnaire.
Exploratory analyses of clinical outcomes showed reductions in pain and disability at 8-week follow-up.
There was an indication of between-group differences in symptoms and activity (PGQ) and pain severity (NRS)
between the SC plus true acupuncture arm and the SC alone group and between the SC plus non-penetrating
acupuncture arm and the SC alone arm, but not between the two acupuncture arms. Half of the participants
(45 out of 91) reported complete recovery or much improvement. This proportion was much lower in those
randomised to SC alone (19%) than SC plus true acupuncture (66%) or SC plus non-penetrating acupuncture
(67%). There was substantial reduction in pain intensity before going to bed and the proportion of women
woken up every night or most nights at 8 weeks compared with baseline in both acupuncture arms but not in
the SC alone arm.
No serious adverse events attributable to the trial interventions or trial processes were reported (there
were four cases of brief hospitalisation for other reasons and all resumed EASE Back study treatment).
The most common minor and expected adverse event was a slight bleed at the needle site (in 35 of
164 true acupuncture treatment sessions and 1 of 197 non-penetrating acupuncture treatment sessions).
Overall, 10 women (five in the SC plus true acupuncture group and five in the SC plus non-penetrating
acupuncture group) reported side effects from treatment in their follow-up questionnaire (mostly
drowsiness/light-headedness).
Fourteen physiotherapists (13 female) participated in a 3-day training programme, completed three
questionnaires (before and immediately after the training programme and at the end of the pilot RCT) and
offered all three treatment arms in the pilot RCT. They were experienced [median (interquartile range) of
9 (5–18) years in clinical practice] and all had prior experience of treating pregnancy-related low back pain.
Physiotherapists’ self-confidence in the diagnosis and management of pregnancy-related low back pain
increased after the EASE Back study training and remained high at the end of the pilot RCT.
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We identified the PGQ at 8 weeks post randomisation as an appropriate outcome measure for a future
main trial and observed favourable additional benefits with acupuncture over SC alone in the pilot RCT.
We used these data to estimate the required sample size for a future multicentre trial.
In May 2014, we hosted a consensus conference with 35 participants (physiotherapists, service and
research managers, midwives and nurses, members of the Trial Steering Committee and two Swedish
researchers who had led previous RCTs in this field). The findings were presented and discussed. All felt
that a future main trial was desirable and feasible and that an adaptive main trial design was favoured,
alongside minor changes to recruitment (to ensure that all women attending a 20-week ultrasound scan
were given a back pain screening questionnaire) and follow-up procedures (to add further follow-up
reminders and consider financial incentives in the form of shopping vouchers to enhance follow-up rates).
Conclusion
A future large RCT testing the additional benefit of acupuncture to SC is desirable and feasible and
would be welcomed by pregnant women and clinicians. A combination of recruitment methods including
awareness raising through local media is needed, as are further efforts to increase follow-up rates. We
propose a full RCT of an adaptive design (based on a pre-specified interim analysis) with three treatment
arms and a primary outcome combining symptoms and impact on activities (the PGQ) at 8 weeks after
randomisation, with longer-term follow-up at 3 and 6 postnatal months. The trial would need three
maternity centres with linked community services, 15 months of recruitment and 600 participants.
Trial registration
This trial is registered as ISRCTN49955124.
Funding
This project was funded by the NIHR Health Technology Assessment programme and will be published in
full in Health Technology Assessment; Vol. 20, No. 33. See the NIHR Journals Library website for further
project information.
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Chapter 1 Introduction
Pregnancy-related low back pain (with and without pelvic
girdle pain)
Low back pain in pregnancy is defined as pain in the lower back, located above the lumbosacral junction,
with or without radiation in the legs,1 although this is a narrower definition than that used in the general
population,2 in which low back pain is usually defined as pain and discomfort localised below the
costal margin and above the inferior gluteal folds, with or without leg pain. Pelvic girdle pain (PGP) is
musculoskeletal pain located within the pelvic area between the posterior iliac crest and the gluteal folds,
particularly in the vicinity of the sacroiliac joints, that develops in relation to pregnancy.3,4 The pain may
radiate in the posterior thigh and can also occur in conjunction with or separately from pain in the
pubic symphysis.
Low back pain and PGP during pregnancy are common and, although they can occur separately, many
women experience both. Although prevalence estimates vary between studies owing to different definitions
and diagnostic criteria, low back pain is reported to affect between 45% and 75% of women at some stage
during their pregnancy,5,6 with a point prevalence of approximately 34%.6 Prevalence estimates for PGP range
widely and include 20% overall,3 35% to 50% in early pregnancy and 60% to 70% in late pregnancy.3,7,8 The
pain increases with advancing pregnancy, is usually worse at night and interferes with sleep, daily activities
and work.7 It is a common reason for sick leave, with reports suggesting that 20–23% of women take sick
leave because of their pain.6,9 Studies have shown that pregnant women with back pain have lower quality of
life than pregnant women without back pain.10 Hence, low back pain and PGP in pregnancy negatively affect
activities of daily life and quality of life during pregnancy and are an important health problem. Some have
reported an increasing number of affected women requesting induction of labour or elective caesarean
section before the recommended 39th week of gestation in order to achieve symptomatic relief.11 Although
longitudinal data are limited, it has been estimated that in 1 in 10 women the pain becomes long-lasting and
disability persists after childbirth.12,13 Pregnancy-related low back pain has been found to reduce soon after
delivery but it improves in few women later than 6 months post partum.14 By 2 years after giving birth, the
prevalence of back pain has been reported to fall to the same level found pre pregnancy (18%).
A range of biomedical, psychological and social factors may be important predictors of non-recovery from low
back pain in pregnancy, but in general these have not been well studied. Cohort studies15,16 suggest that
predictors of poor recovery from symptoms post partum include older age, work dissatisfaction and the
presence of combined low back pain and PGP in comparison with pain in either location alone. There is some
evidence that women with combined pubic symphysis pain and bilateral posterior PGP in pregnancy have a
slower recovery than those women with fewer pain locations12,16 and that women with a high number of
other bodily pain sites are more likely to have high pain intensity scores and postpartum non-recovery.17
Guidelines3 suggest risk factors for PGP include a previous history of low back pain and previous trauma to the
pelvis. Studies of low back pain in general have shown the important role of psychosocial obstacles to
recovery18,19 and there is some evidence that psychological factors such as a lack of belief in improvement,20
exaggerated negative thoughts or catastrophising about the pain, fear avoidance beliefs21 and distress (anxiety
and depression) are also important predictors of poor outcome in women with pregnancy-related back pain.8
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Current clinical management
Women experiencing these problems most often report them to their midwives; for example, in an Australian
study 71% reported their pain to their maternity carer,6 but it appears that few receive much in the way of
treatment. Pierce et al.6 found that only 25% of women received any treatment. There are no high-quality UK
data that describe current treatment for pregnancy-related low back pain or PGP. It is most often accepted as a
‘normal’ discomfort of pregnancy6,11 with some suggesting this may be related to health professionals’ lack of
knowledge about available treatments and fear of possible harmful effects of treatment on the developing
fetus.11 Women are encouraged to believe that their pain is temporary and self-limiting (which may not always
be the case), a part of the normal aches and pains of pregnancy,11 and those involved in their care tend to give
women information on how to self-manage7 through postural changes, adaptations in lifting techniques,
simple exercises to try at home, rest, heat and cold therapy, supportive belts and pillows, massage and relaxation.
Some women, however, do proceed to use a range of treatments, such as physiotherapy-led exercise, manual
therapy, acupuncture, massage, transcutaneous electrical nerve stimulation (TENS) and mobility aids as well
as safe pharmacological options (mostly paracetamol) and, much less commonly, epidural injections.6,7,11
None of these treatment options has been well researched in women with pregnancy-related back pain.
Current NHS practice varies across services and geographical regions. Most women are not referred from
their midwives or general practitioners (GPs) to other health professionals for treatment, but are advised to
self-manage. The self-management advice tends to follow the guidance from national associations such as
the National Childbirth Trust (www.nct.org.uk) or the Association of Chartered Physiotherapists in Women’s
Health (ACPWH; http://pogp.csp.org.uk/) and only the most severely affected women are referred to
physiotherapists and receive individual assessment, advice or treatment. We estimate that approximately
10–20% of women are likely to be referred to see a NHS physiotherapist for help with severe back pain and/
or PGP. In North Staffordshire, for example, 10% of women with back pain in pregnancy are referred by their
midwife (and some cases by their GP), to women’s health physiotherapists, who invite them to a group
advice and education session, and are offered individual care following the group session only if needed. The
referral is left open for the duration of the pregnancy so that the woman can access further physiotherapy
support if needed. In other services, physiotherapists offer individual assessment and individualised advice
and treatment.
Acupuncture
Acupuncture is based on needle stimulation of points on the surface of the body (acupuncture points) and
originates from traditional Chinese medicine (TCM). It encompasses a variety of different procedures and
techniques but most often is based on penetrating the skin at anatomical points on the body with thin, solid,
metallic needles that are manipulated manually or by electrical stimulation. Since its introduction to the West
several hundred years ago, many different styles of acupuncture have developed, including Japanese meridian
therapy, French energetic acupuncture, Korean constitutional acupuncture and Lemington five-element
acupuncture.22 Although similar to traditional acupuncture, these various styles have their own distinct
characteristics. In the past several decades, new forms and styles of acupuncture have evolved, including
ear (auricular), hand, foot and scalp acupuncture. As a result of advances in the understanding of the
neurophysiology of pain and acupuncture, the boundary between acupuncture and conventional medicine is
changing. For example, a simplified and more empirical Western approach to acupuncture of local dry needling
at the site of pain or at points in the vicinity of pain, called trigger points, is popular among conventional health
professionals (medical doctors and physiotherapists). Modern acupuncturists typically use a combination of
both TCMmeridian acupuncture points and non-meridial (or extrameridial) points. Once appropriate points are
selected, the therapist inserts a needle into each point by gently tapping it into place and rotating it until the
patient experiences a needle sensation or de-qi, usually described as a tingling, numbness or dull ache
sensation. A typical session with acupuncture includes treatment with a varying number of needles (1–30)
inserted and kept in place for 20–30 minutes, during which period the therapist may stimulate the needles by
rotating or tapping them. Some therapists may also use electrical stimulation (in which an electrical stimulator is
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connected to the acupuncture needles), injection acupuncture (herbal extracts are injected into acupuncture
points), heat lamps or moxibustion. Although the neurophysiological mechanisms of acupuncture are well
established in research for experimental pain, the exact mechanisms underlying the action of acupuncture in
clinical practice are still unclear.23 In terms of Western scientific principles, it is uncertain how acupuncture may
help musculoskeletal pain such as back pain in pregnancy. Current theories suggest that acupuncture may
produce its effects through the nervous system by stimulating the production of biochemicals such as
endorphins and other neurotransmitters that influence pain sensation; that acupuncture works through the
gate control theory of pain, in which the sensory input is inhibited in the central nervous system by another
type of input (the needle); or that the presence of a foreign substance (the needle) within the tissue of the body
stimulates vascular and immunomodulatory factors such as mediators of inflammation.22
The use of acupuncture for musculoskeletal problems appears to be increasing and acupuncture has been
recommended within recent UK national guidelines for the management of persistent non-specific low back
pain.24 One of the few randomised trials conducted within the UK25 concluded that there was weak evidence
of an effect of a short course of acupuncture on persistent non-specific low back pain (rather than back pain in
pregnancy) at 12 months, but that at 24 months there was stronger evidence of a small benefit compared with
usual GP care. The health economic analysis conducted alongside that trial26 concluded that acupuncture
confers a modest health benefit for minor extra cost to the NHS. The most recent Cochrane Review of
acupuncture for low back pain27 included 35 trials, but only three of these were of acute low back pain. Overall,
no firm conclusions could be drawn but there was some evidence of short-term pain relief and functional
improvement from acupuncture compared with no treatment or sham treatment. There was also some
evidence that acupuncture, added to other conventional therapies, relieves pain and improves function better
than conventional therapies alone.
A small number of trials have evaluated acupuncture for low back pain and PGP during pregnancy.28–33 To date,
two rigorously conducted systematic reviews have been published.7,34 The first of these was a Cochrane Review
of eight studies (1305 participants) testing the effects of adding various pregnancy-specific exercises,
physiotherapy, acupuncture and pillows to standard pre-natal care.7 That review found positive results for the
additional benefit of strengthening exercises, pelvic tilt exercises and exercise in water for women with low back
pain. Both acupuncture and stabilising exercises relieved PGP more than usual pre-natal care, and acupuncture
provided more relief from evening pain than exercise. One study found that acupuncture was more effective
than physiotherapy for pain reduction,28 although it was unclear if this was a result of the type of treatment
delivery (acupuncture was individually delivered while the physiotherapy was delivered in groups). A further
study showed that 60% of those who received acupuncture reported less intense pain, compared with 14%
who had standard pre-natal care.31 The second systematic review34 focused on randomised trials of needle
acupuncture for back pain and PGP in pregnancy and included only three trials (448 women), all from
Sweden.28,31,32 The conclusions were similar to the Cochrane Review by Pennick and Young.7 Overall, there was
limited, though promising, evidence for the effectiveness of acupuncture. Both systematic reviews highlighted
the need for further high-quality trials given the weaknesses in the available evidence. Most previous trials have
a moderate to high risk of bias, with unclear randomisation and allocation concealment and lack of full
intention-to-treat analyses, and only one trial reported work outcomes, despite these clearly being an important
outcome for both pregnant women and society more generally. The one trial with low risk of bias32 focused
on Swedish women with PGP at 12–31 weeks’ gestation, and randomised them to standard treatment
(information, advice about activities, a pelvic belt and a home exercise programme), standard treatment plus
acupuncture (twice per week over 6 weeks using 10 local acupuncture points and seven extrasegmental points
with the needles manipulated to evoke a de-qi sensation and left in situ for 30 minutes and stimulated every
10 minutes) or standard treatment plus stabilising exercise (individual stabilising exercises modified for
pregnancy for a total of 6 hours over 6 weeks). Since the publication of the two systematic reviews in 2008,
a small number of further studies were published. One small pilot study35 found auricular acupuncture to be
more effective than either sham acupuncture or a waiting list control. Another further high-quality trial by
Elden et al.33 from Sweden compared standard treatment plus acupuncture with standard treatment plus sham
(non-penetrating) acupuncture for women with PGP. In that trial, 12 acupuncture treatments were provided
over 8 weeks and results showed no differences between groups on pain or sick leave, questioning the
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importance of needle penetration in the reported beneficial effects of acupuncture. The existing research clearly
highlights the need for a high-quality randomised trial in the UK NHS setting, testing the clinical effectiveness
and cost-effectiveness of the addition of acupuncture to standard care (SC) for pregnant women with low
back pain (with or without PGP). It also highlights the importance of including a sham or non-penetrating
acupuncture intervention.
Key methodological issues for the EASE Back study
Given the known limitations of previous trials of acupuncture, we followed published recommendations
about methods and reporting trials of acupuncture,36 non-pharmacological interventions37 and sham
interventions in trials of physical medicine and rehabilitation23 for our pilot trial. This was informed by the
results of our pre-pilot work in phase 1 of the Evaluating Acupuncture and Standard carE for pregnant
women with Back pain (EASE Back; a national survey and interviews) study and includes the rationale for
acupuncture type, the details of the needling, the intervention protocol, other components of the treatment,
practitioner background and experience, full details of the treatments, similar protocols for the true and sham
acupuncture treatments and data on participants’ treatment preferences and expectations before they are
randomised. There are several key methodological issues relevant to conducting trials of acupuncture
(and, more broadly, non-pharmacological interventions for pain); these include sham treatment considerations,
issues of blinding, safety, protocolising or standardising what is usually a highly individualised acupuncture
treatment for the purposes of a trial and choosing the most appropriate package of SC for comparison. Each of
these is discussed along with the implications for the EASE Back study.
Sham acupuncture
A key discussion in the existing research on acupuncture focuses on the challenge of adequate sham or
placebo acupuncture treatments.23 In fact, some believe that it is virtually impossible to construct a
completely inert placebo that sufficiently mimics the insertion and manipulation of acupuncture needles;
hence we use the term ‘sham’. The use of sham intervention helps to ensure participant blinding and
reduces the risk of potential bias that can interfere with the observed outcomes.23 We believe that any future
large trial should include a treatment group that receives sham acupuncture to enable us to better
understand the possible basis of acupuncture effects. Previous trials have used different methods of sham
and there is little agreement on the best sham, given that some methods appear to induce physiological
effects (e.g. inserting needles at non-acupuncture points or superficial needling at acupuncture points).23
A perfect sham for acupuncture would induce the needle or de-qi sensation,23 but it is increasingly clear
that inducing this needling sensation regardless of the stimulation point is associated with the physiological
effects of acupuncture. A recent review38 concluded that the effect of acupuncture seems to be unrelated to
the type of sham acupuncture used as control and that non-penetrating acupuncture shams are thought
to be least likely to have physiological effects. We believe that using non-penetrating needles on a small
number of the same acupuncture points that would be used for true acupuncture alongside the inclusion of
acupuncture-naive participants are the best solutions to this challenge. Similar approaches have been used
successfully in previous trials of acupuncture for musculoskeletal problems39 and pregnant women with PGP.33
Thus, we included three treatment arms in the pilot EASE Back trial: SC, SC plus true acupuncture and SC plus
sham acupuncture using non-penetrating needles. The use of sham in trials of acupuncture remains a matter
of debate, and some may consider it an ethical dilemma. However, by ensuring that all our pilot trial
participants received a package of SC, and that the acupuncture treatment (either true or non-penetrating)
was in addition to this SC, we are confident that all participants received appropriate treatment for their pain.
Blinding
A further methodological challenge is the need to ensure adequate blinding: ideally, patients, therapists,
outcome assessors and data analysts should be adequately blinded. In a trial of SC and acupuncture, clearly,
the therapist cannot be blinded to treatment, but it is possible to blind acupuncture-naive patients to the
type of acupuncture (true or non-penetrating), as well as those involved in collecting data and data analysis.
Successful blinding has been achieved in a previous trial of acupuncture within the NHS39 and we incorporated
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this level of blinding into the EASE Back pilot trial. In particular, by gaining ethics approval to explain to
potential participants that they would all receive SC and some would receive one of two forms of acupuncture,
we were able to ensure that all participants expected to receive good treatment, thus maximising expectation
and treatment credibility effects. We included measures of treatment preference and expectation in our pilot
trial data set and captured information on treatment credibility at follow-up.
Safety/risks of acupuncture
Despite promising evidence for the effectiveness of acupuncture for relief of back pain and PGP in pregnant
women, some clinicians express concerns about safety. One concern is that acupuncture might induce
pre-term labour, but available data show this not to be the case. The normal risk of pre-term labour (before
37 weeks’ gestation) is 7–10%. In one of the Swedish trials, Elden et al.40 assessed the adverse effects of
acupuncture on the pregnancy, mother, delivery and fetus/neonate. Acupuncture that may be considered
strong was used and treatment was started in the second trimester of pregnancy. Adverse effects were
recorded during treatment and throughout the pregnancy. The results showed that there were no serious
adverse events (SAEs) after any of the treatments, in either babies or mothers. Minor adverse events were
common in the acupuncture group, but women rated acupuncture favourably despite this. Therefore,
acupuncture administered with a stimulation that may be considered strong led to minor adverse complaints
from the mothers and had no observable severe adverse influences on the pregnancy, mother, delivery or
fetus/neonate. In addition, acupuncture in early pregnancy (for nausea and vomiting) has been shown to
be safe, with no adverse effects on perinatal outcome, congenital abnormalities, pregnancy complications
and other infant outcomes.41 In the wider literature, most side effects associated with acupuncture are
minor and transient, such as dizziness/light-headedness and slight bleeding after the needles are removed.42
Although there have been reports of fatal events following acupuncture (14 cases in a review of literature
over the last 50 years),43 these appear to have been related to cases of clear malpractice and negligence
(e.g. as described by Halvorsen et al.44). In the UK, acupuncture training for health professionals, including
physiotherapists, is set at a high level, and in trained hands acupuncture is a safe intervention. In our pilot
trial in phase 2 of the EASE Back study, the participant information leaflet and consent procedures made
the known risks clear and explained the frequency of these risks where these data were available while
reassuring pregnant women that even strong acupuncture stimulation has been shown to have no adverse
effects on the pregnancy, mother, delivery or developing baby. In addition, the trial design ensured that all
women received SC and that acupuncture was in addition to this SC. Therefore, we did not withhold
SC from any woman in the EASE Back trial.
Standardising acupuncture treatment for a randomised controlled trial
Since the location and manipulation of the needles in acupuncture are thought to be important in achieving
successful outcomes, the therapist usually individualises the treatment for each patient in clinical practice.
For the purposes of a trial, however, some degree of standardisation is needed in order to be able to describe
the treatment that participants were expected to receive (the intervention protocol) and then to be able to
judge whether or not patients received the treatment as expected (protocol adherence). Previous trials of
acupuncture have been criticised for lack of clarity about the acupuncture intervention provided as well as for
being overly prescriptive with the selection of acupuncture points and needle manipulation to the point that
those using acupuncture in clinical practice do not feel that the acupuncture provided in the trial reflects their
practice. We believe the best solution to this challenge, for the purposes of a randomised controlled trial (RCT),
is to agree a semiflexible acupuncture protocol, in which therapists assess the individual patient’s pain type
and location, they palpate for tender points and then they select points from a large number of points that
have been agreed to be suitable for inclusion in the protocol (including acupuncture and tender points).
This approach has been used successfully in previous trials33,39 ensuring that the acupuncture treatment is
individualised, reflecting clinical practice, and that it can be amended over a course of treatment sessions but
can also be clearly described in publications.
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Copy of the Health Technology Assessment commissioning brief
(Health Technology Assessment number 10/69/05)
Question: what is the clinical effectiveness and cost-effectiveness of acupuncture in pregnant women with
back pain, in comparison to SC?
Technology: a 6-week acupuncture package, as may plausibly be delivered in the NHS.
Patient group: pregnant women with back pain (including women attending antenatal clinics and
outpatients clinics because of back pain).
Control or comparator treatment: sham acupuncture.
Design: a feasibility study to assess the acceptability and design of a trial in the NHS. Methods are likely
to include a survey of current practice and qualitative work with clinicians, patients and commissioners.
Researchers should identify an appropriate acupuncture intervention and control. They should explore the
merits of a sham acupuncture arm.
Important outcomes of main study: pain.
Other outcomes: adverse events, consumption of analgesics, obstetric outcomes, absence from work,
functional status, health-related quality of life and cost-effectiveness.
Outcome of the feasibility study: outline plan for a randomised controlled study with evidence supporting
its design and delivery.
Minimum duration of follow-up of main study: 6 months after delivery.
Appropriate standard care comparison
The choice of the comparison treatment in acupuncture trials is critically important. Previous trials that
compare acupuncture with waiting list controls, ongoing stable medication or minimal care packages tend
to show that acupuncture is superior, whereas those that compare acupuncture with more intensive or
active interventions have tended to conclude that there are no differences between acupuncture and
comparisons.39 We wanted to include a SC comparison that accurately reflected what currently happens in
the UK for pregnant women with low back pain. Thus, we followed the recommendations of Ee et al.34
that some form of consensus about treatments for these women is essential to inform clinical trials.
Although usual care differs in different services and geographical regions, our interview and survey results
from the phase 1 pre-pilot work in the EASE Back study provide the most useful information on which to
base a trial protocol for SC. These data ensured that the pilot trial protocol for SC reflected current care in
the UK and thus is a fair comparison in the trial.
Rationale for the EASE Back study
A high-quality randomised trial in the NHS is needed to test the clinical effectiveness and cost-effectiveness of
adding acupuncture to SC for pregnant women with low back pain (with and without PGP). Before such a
large trial can be conducted, however, a feasibility and pilot study was commissioned by the National Institute
of Health Research (NIHR) Health Technology Assessment (HTA) programme to inform the design, recruitment,
interventions and outcomes. A feasibility study is a research study carried out prior to a main study in order
to answer the question ‘Can this study be done?’, and it is used to estimate important parameters needed to
design the main study.45 In the EASE Back study we wanted to find out whether or not pregnant women with
low back pain would be willing to try acupuncture as a treatment and whether or not they had concerns about
acupuncture or being involved in a trial. We also wanted to find out the likely proportions of eligible women
from all of the pregnancies overseen by a large maternity centre and whether or not clinicians (community
INTRODUCTION
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midwives and physiotherapists in particular) would be willing to recruit to, and treat, this patient population in
a trial of acupuncture. We needed to test out all the processes of a future main trial and, therefore, the EASE
Back study also involved a pilot RCT. A pilot study is a version of the main study run in miniature to test
whether or not all the components of the main study can work together.45 The EASE Back pilot RCT therefore
tested the inclusion and exclusion criteria, the processes of identification of potentially eligible women,
screening and recruitment, randomisation, training of participating research staff and physiotherapists, delivery
of treatment, treatment fidelity and credibility of treatment. It allowed us to test whether or not pregnant
women with back pain would be willing to be randomised, to test out the outcome measures that might be
used in a future main trial, to explore the short-term effects of treatment on these outcomes, to determine
short-term follow-up rate, to select a primary outcome measure for a future main trial and to estimate the
sample size for a future main trial.
The EASE Back study was a mixed-methods feasibility and pilot study, designed in two phases over 24 months
(June 2012 to May 2014), combining survey research (of current practice), qualitative research (focus groups
and individual interviews) and a pilot randomised trial with pregnant women with back pain (with and without
PGP) with short-term follow-up and audio-recordings of screening and consent meetings with a subsample of
women. The results were shared at a dissemination event with stakeholders in May 2014 and consensus
achieved about the feasibility and desirability of a main trial. Figure 1 provides a summary of the EASE Back
study design.
Overall aim of the EASE Back study
The overall aim of the EASE Back study was to assess the feasibility of a future RCT to test the addition of
acupuncture to SC in women with pregnancy-related low back pain.
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FIGURE 1 Summary of the EASE Back study design. AACP, Acupuncture Association of Chartered Physiotherapists;
MIMDTP, McKenzie Institute of Mechanical Diagnosis and Therapy Practitioners; NP, non-penetrating.
INTRODUCTION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
8
Chapter 2 Phase 1 pre-pilot work
Objectives of phase 1 pre-pilot work
The specific objectives of phase 1 were to:
l provide data on current UK SC and acupuncture treatment for low back pain in pregnant women
l explore the views of pregnant women with back pain about the acceptability of the proposed
interventions, the content and delivery of participant information, the outcomes most important to
them and the most appropriate timing of outcome measurement
l optimise trial information, recruitment and consent procedures by learning what works best from the
perspectives of pregnant women with low back pain, midwives and physiotherapists
l investigate the views of NHS health professionals regarding (1) the acceptability and feasibility of
referring women with back pain in pregnancy to physiotherapists for acupuncture, (2) the proposed
trial design and interventions and (3) ways in which to maximise recruitment and retention to a trial.
In order to address the above objectives, we used mixed research methods of a descriptive survey and
qualitative interviews. Findings from the survey informed the semistructured interview schedule, and findings
from both methods were integrated at the analysis stage to give additional validation.46 The pre-pilot work in
phase 1 was reviewed and approved by National Research Ethics Service Committee North West – Greater
Manchester North (ref. 12/NW/0227).
National survey of chartered physiotherapists
Methods
Design and setting
This was a national cross-sectional survey of national samples of physiotherapists working in the UK from
June to July 2012. Consent of respondents was assumed if they completed and returned the questionnaire;
therefore, written consent was not sought from each participant.
Survey sample and mailing
The inclusion criteria were physiotherapists who:
l were members of the Chartered Society of Physiotherapy
l had experience of treating women with pregnancy-related low back pain.
We randomly sampled from three professional networks of the Chartered Society of Physiotherapy. Although
the optimal approach to generate representative survey findings is to use a simple random sample, there is no
comprehensive sampling frame for all UK-based physiotherapists available at the current time. The professional
networks selected were those with interests relevant to low back pain, acupuncture and pregnancy/women’s
health, with a total combined membership of around 7000 physiotherapists. This large sampling frame was
required to access physiotherapists with a range of experience and clinical interests, to result in as generalisable
a data set as possible about physiotherapy care for pregnancy-related back pain across the UK. The Chartered
Society of Physiotherapy is the predominant professional trade union and educational body for physiotherapists
in the UK and has 30 affiliated professional networks, usually with a specific clinical or occupational interest,
which members have the option of joining. It was not possible to target only those physiotherapists working in
the NHS. Random samples of members of the three professional networks (total n= 1093) were mailed by
the administrators of each network and two reminder mailings were subsequently sent to non-responders.
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The professional networks were chosen to include physiotherapists with a special interest in (1) women’s health
(ACPWH), (2) acupuncture (the Acupuncture Association of Chartered Physiotherapists) and (3) musculoskeletal
pain conditions (McKenzie Institute of Mechanical Diagnosis and Therapy Practitioners). An initial filter question
identified those respondents who had never treated a pregnant woman with low back pain in pregnancy, and
only respondents with experience of treating this patient group were included in the analysis.
As the aim of this survey was primarily descriptive, a formal sample size calculation was not carried out.
Previous surveys of physiotherapists in the UK indicated a likely response rate of 55–60%47–49 and so we
expected approximately 600–650 overall responses from the mailing of 1093. This sample size is sufficient
to estimate the proportions of the key survey variables within less than a 5% margin of error with
95% confidence.
Survey questionnaire
A previous national survey questionnaire of physiotherapy practice for non-specific low back pain (not related
to pregnancy) was adapted for use in this study.48 The questionnaire captured information about respondents’
demographics and clinical practice including years in practice, practice setting, postgraduate training in
musculoskeletal pain, women’s health and acupuncture as well as experience of managing women with
pregnancy-related back pain. The questionnaire investigated current clinical care using a patient vignette of a
specific, typical case developed from a real patient example following recommendations from other studies50–52
and was pilot tested with 18 physiotherapists. The patient vignette is reproduced below, whereas the full
questionnaire is provided in Appendix 1. Respondents were asked how they would manage this woman,
including likely treatment approaches, advice offered and number of treatment sessions provided. Specific
questions on their use of acupuncture were also included.
We additionally asked the physiotherapists whether or not they routinely used specific advice or
self-management leaflets in the management of pregnancy-related low back pain and PGP and, if so, to
enclose a copy of the leaflet in their response to the survey. This resulted in the research team receiving
examples of 37 different advice and self-management leaflets currently used by physiotherapists. These were
used to help develop the self-management booklet used in the pilot RCT in phase 2 of the EASE Back study
(see The development of a standard care protocol).
The patient vignette of a typical patient
A 34-year-old woman was referred from her GP with symptoms of intermittent sharp pain at her lower thoracic
and lumbar regions and reports that the symptoms began a few weeks ago. She is 24 weeks pregnant with
her first child. She is in good general health and of normal weight for her height and has never had back
pain before.
Her back pain presents as occasional sharp sensations at the lumbar/lower thoracic regions of her spine and
seems to be unrelated to posture or activity. She also has some dull pain in the lower back region, which is
more persistent but of lesser intensity than the sharp pain she occasionally experiences. Her symptoms are
worse if she maintains a sitting posture for prolonged periods. She is reluctant to use any analgesic medication
because of her pregnancy.
Upon examination there is no exacerbation with movement or any directional preference. She has normal
range of movement and is moderately tender on the paraspinal muscles of her lower back. Straight-leg raise
and slump tests are negative.
PHASE 1 PRE-PILOT WORK
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Statistical analysis
Analysis was primarily descriptive, using summary statistics to describe physiotherapists’ characteristics
and provide data on current practice, including SC and their use of acupuncture. As treatment has been
shown to differ across practice settings,53 treatment approaches used by respondents working in NHS and
non-NHS settings were compared using Pearson’s chi-squared tests. This survey was not designed to test
for differences between members of different professional networks. However, as the survey sample was
not a simple random sample of physiotherapists in the UK, some exploratory comparisons between the
professional networks were undertaken to explore any internetwork differences. All analyses were performed
using Stata version 13 (StataCorp LP, College Station, TX, USA).
Results
Response rate and characteristics of responders
Responses were received from 629 (58%) of thosemailed. Of these, 499 had treated at least one womanwith
pregnancy-related low back pain andwere included in the analysis. The demographic and practice characteristics
of the respondents are presented in Table 1. The respondents were very experienced (mean of 22 years in
TABLE 1 Demographic and practice characteristics of physiotherapists. Values are frequencies and percentages
unless specified as mean and SD
Characteristic (denominator)a n %
Years of experience (456) 21.5 (mean) 10.4 (SD)
Female (499) 459 92.0
Work setting (498)
Exclusively NHS 201 40.4
Exclusively non-NHS 159 31.9
Combination of NHS and non-NHS 138 27.7
Frequency of treating pregnant women with back pain (499)
Infrequent – at most one in last 6 months 173 34.7
Somewhat frequent – between two and five in last 6 months 148 29.7
Frequent – at least one per month 70 14.0
Very frequent – at least one per week 108 21.6
Referral sourceb (499)
Referral from GP 347 69.5
Referral from midwife 241 48.3
Self-referral 240 48.1
Referral from a physiotherapy colleague 147 29.5
Referral from obstetrician 137 27.5
Other 38 7.6
Trainingb
Specific postgraduate training in low back pain in general (491) 444 89.0
Specific postgraduate training in acupuncture (497) 370 74.5
Specific postgraduate training in women’s health (492) 327 65.5
Specific postgraduate training in low back pain in pregnancy (496) 264 52.9
Use of acupuncture in management of musculoskeletal pain (496) 338 68.2
SD, standard deviation.
a Denominator varies according to number of valid responses because of varying missing data or not applicable cases.
b Respondents were able to indicate multiple responses.
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practice) andmost were female. Respondents worked in a variety of settings: NHS only, non-NHS only or a
combination of practice settings. Referrals of women with pregnancy-related back pain were received by
respondents from a variety of other health-care practitioners and self-referral to physiotherapy by women
themselves was also commonly reported. Approximately one-third of respondents reported seeing a pregnant
womanwith back pain at least once a month.
Standard care management
Standard care was explored by asking respondents to indicate the management options they would use
for the typical patient described in the vignette. Most respondents (88%, n= 430) reported that they
would be responsible for the care of such a patient, but 12% (n= 58) reported it was not their role and
that this type of patient would be specifically referred to a women’s health specialist physiotherapist.
A large majority of respondents (85%, n= 364) reported that they would manage this patient in one-to-one
treatment sessions. The remainder reported that they would manage this patient as part of a group or class
and that they would use one-to-one sessions for initial patient assessment only or only if required. This
typical patient would be seen three or four times over a period of 3–6 weeks, although the episode would
be left open for the duration of the pregnancy so that a woman could reconsult the physiotherapist if
needed until after the birth of her baby. Table 2 summarises the episode of SC by physiotherapists.
Many advice and treatment options were reported for the management of the typical patient described in
the vignette, and combinations of advice and treatments were commonly reported. Advice on aspects of
pregnancy, low back pain and activities of daily living was reported by the respondents and, although
combinations of treatments were described in packages of care, most physiotherapists reported using
exercise approaches to manage women with pregnancy-related low back pain (Figures 2 and 3).
TABLE 2 Episode of care details for the vignette patient
Characteristics of care (denominator)a n %
Number of times patient typically seen (425)
Once 51 12
Twice 103 24.2
Three or four times 205 48.2
Five or more times 66 15.5
Time period over which patient would typically be treated (415)
1–2 weeks 79 19
3–6 weeks 221 53.3
7–10 weeks 70 16.9
> 10 weeks 45 10.8
Typical episode of care (428)
Finished after treatment, re-referral required for further treatment 27 6.3
Left open for duration of the pregnancy 258 60.3
Left open for a defined period after end of treatment 66 15.4
Other 77 18.0
a Denominator varies according to number of valid responses because of varying missing data or not applicable cases.
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Advice for the vignette patient
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FIGURE 2 Survey findings: advice for the vignette patient.
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FIGURE 3 Survey findings: treatment for the vignette patient.
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Acupuncture management
Regarding use of acupuncture, of the 469 individuals who responded to this item, 68% (n= 338) reported
that they used it in the management of patients with musculoskeletal conditions, including low back pain
not related to pregnancy, whereas 37% (n= 126 of 337 responses to this question) reported that they
used it to treat women with pregnancy-related low back pain. However, when asked about the treatment
they would provide to the specific patient described in the vignette (430 responses), 24% (n= 101)
reported that acupuncture would be part of their treatment. Respondents had a mean of 11 [standard
deviation (SD) 6.2] years’ experience of using acupuncture in clinical practice. The majority of respondents
(298 responses) used Western/medical acupuncture (71%, n= 212), 16% (n= 48) used TCM/traditional
acupuncture and 11% (n= 32) used trigger point/myofascial acupuncture. Of 336 respondents completing
details about acupuncture training, 37.5% had completed up to 80 hours of acupuncture training (the
national minimum requirement for physiotherapists), 53% had completed more than 80 hours but less
than 200 hours and 9.5% had completed a degree/diploma in acupuncture or equivalent.
If acupuncture was a treatment option selected by respondents for the vignette patient, further details about
acupuncture management were requested in the questionnaire. The mean number of acupuncture points
used in a treatment session was 7 (SD 2.6), with the needles being left in situ for a mean of 20 (SD 6.0)
minutes, and 84% of respondents would elicit a de-qi needle sensation. The selection of acupuncture
points varied considerably for the vignette patient, and the 10 most commonly reported local and distal
acupuncture points are summarised in Table 3. Only two acupuncture points (BL25 and BL23) were reported
by more than one-third of respondents. Of those using acupuncture in the treatment of pregnant women,
22 respondents (4%) reported they had observed some minor adverse effects during treatment. These
included the patient feeling lightheaded/dizzy (n= 8) or fainting (n= 5), mild bruising at needle site (n= 3),
worsening of symptoms (n= 3), vomiting (n= 2) and significant pain at a needle site (n= 1). One respondent
reported that a patient she had treated with acupuncture miscarried the day after acupuncture treatment,
but reported that the treatment was not thought to contribute to this.
Differences between respondents working in different practice settings (exclusively NHS or exclusively
non-NHS) were few. However, those working exclusively in the NHS were more likely than those in non-NHS
settings to report that they saw the patient only once or twice (52% compared with 17%). Conversely,
physiotherapists reporting the most patient treatment visits (more than five) were more likely to be working
in non-NHS settings (24%, compared with 7% in exclusively NHS settings). In addition, physiotherapists
working in non-NHS settings more commonly than those working exclusively in NHS settings reported using
treatment approaches that were classified as ‘hands-on’. Overall, the proportion of respondents who would
offer the patient any hands-on treatment approaches was significantly higher among those who worked
exclusively in non-NHS settings than among those working exclusively in NHS settings (Table 4). For example,
of the 33% (101 out of 304) of respondents who would offer massage, 71 (70%) worked exclusively in
non-NHS settings, compared with 30 (30%) who worked exclusively in the NHS.
Differences between professional networks
Exercise was the most common treatment reported by respondents from all three professional networks.
Data about the typical episode of care (number of treatment sessions, length of sessions, length of episode
of care) were also similar across all networks. The one area in which reported practice differed between
professional networks was in the use of acupuncture for the typical patient described in the vignette,
with respondents from the acupuncture professional network (the Acupuncture Association of Chartered
Physiotherapists) being more likely to report using acupuncture (43.9%) than those from either a general
musculoskeletal (the McKenzie Institute of Mechanical Diagnosis and Therapy Practitioners; 9.0%) or a
women’s health professional network (ACPWH; 6.2%).
These survey findings, particularly those from NHS-based clinicians, were used to help develop the
treatment content and intervention protocols for the pilot EASE Back trial in phase 2 of the EASE Back
study (see The development of a standard care protocol).
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TABLE 4 Use of hands-on treatment approaches for pregnancy-related low back pain
Treatment offered (total responses, n= 304) Overall, n (%) NHS, n (%) Non-NHS, n (%) Significancea
Manual therapy 134 (44.1) 53 (32.9) 81 (56.6) p< 0.001
Acupuncture 69 (22.7) 23 (14.3) 46 (32.2) p< 0.001
Massage 101 (33.2) 30 (18.6) 71 (49.7) p< 0.001
a p-value based on chi-squared test for the differences in treatment offered between the physiotherapists working
exclusively in the NHS and non-NHS.
TABLE 3 Most commonly reported acupuncture points for the vignette patient
Acupuncture points n %
Local acupuncture points (n = 93)
BL25 33 35.5
BL23 31 33.3
GB30 24 25.8
BL26 22 23.7
BL24 18 19.4
BL28 13 14.0
BL27 12 12.9
HJJ 10 10.8
BL54 7 7.5
BL22 7 7.5
Distal acupuncture points (n = 81)
GB34 25 30.9
LI4 20 24.7
BL60 16 19.8
LR3 16 19.8
BL62 14 17.3
ST36 13 16.0
BL40 11 13.6
GB41 7 8.6
BL57 6 7.4
SI3 5 6.2
BL, bladder; GB, gall bladder; HJJ, Huato Jia Ji; LI, large intestine; LR, liver; SI, small intestine; ST, stomach.
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Qualitative focus groups and individual interviews
Methods
The qualitative research was guided by our initial research objectives but retained the flexibility to explore
previously unforeseen avenues of enquiry.54,55 Methods consisted of focus groups or individual interviews
(in person or by telephone) with pregnant women, midwives and physiotherapists. Given that both
health-care professionals56 and women57 can be difficult to engage in research, the offer of choice
over interview format was pragmatic rather than methodological and intended to meet the needs of
participants in terms of convenience. All participants were given full information about the study ahead
of deciding to participate, with the option of focus groups or individual face-to-face or telephone
interviews. The health-care practitioners were invited to complete a brief questionnaire to describe their
qualifications and experience (see Appendix 2). Semistructured interview guides were developed from
the research objectives and from the findings of the national survey. They focused on exploring the
acceptability of acupuncture, the sort of information that might be required to reach a decision around
participation in a trial, the most important outcomes and the most appropriate timing of outcome
measures for the pilot trial. In addition, participants were also invited to talk about the care and support
they considered available for this population (see Appendix 3 for copies of the topic guides). All interviews
were audio-recorded with consent and the focus groups were facilitated by two members of the research
team. Data collection was concurrent with all three sets of participants and ceased when data saturation
was reached.
Interviews with pregnant women
For pregnant women, the original intention had been to hold a series of focus groups, offering individual
interviews if these were more convenient. In the planned recruitment period for phase 1 of the study
(June to September 2012) it was estimated that there might be as many as 600 pregnant women with
low back pain under the care of the participating maternity hospital who could be invited to participate;
however, owing to poor response to the invitation to participate in the interviews, we extended the
recruitment phase by a further 2 months to November 2012. A convenience sampling strategy58 was
adopted and any pregnant woman with back pain could either self-refer or agree for the health-care
practitioner caring for her to pass on her contact details to the research team. A flyer and poster were
designed outlining the study and providing contact details of the research team. In total, 3000 flyers
and 100 posters were distributed through a variety of means: general maternity information packs when
the woman first booked in with her community midwife; local antenatal clinics; community midwives
giving the flyers directly to pregnant women under their care; and the women’s health physiotherapy
service back class for pregnant women at the local hospital. In addition, an invitation to participate
was also posted on internet sites [Mumsnet (www.mumsnet.com) and the Pelvic Pain Support Network
(www.pelvicpain.org.uk)]. Contact was also made with the National Childbirth Trust (www.nct.org.uk) and
the Pelvic Partnership (www.pelvicpartnership.org.uk), but administrative difficulties on the part of these
organisations meant it was not possible for them to collaborate with the research team within the time
frame of phase 1.
In total, 43 women gave consent to contact, which was attempted through telephone calls at differing
times of the day, including in the evening, and a total of 18 women agreed to telephone interviews.
On contact, if they were still willing to be interviewed, a convenient interview time was arranged. At that
point, a letter confirming the interview arrangements, detailed information about the study and two copies
of the consent form together with a stamped addressed envelope for the return of a signed copy of
the consent form, were posted out. The information and consent form were discussed at the time of the
interview and audio consent was also recorded then.
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Interviews with midwives and physiotherapists
For the health professionals, a purposive sampling strategy was adopted to ensure a range of experience
and perspectives.59 Two teams of community midwives were approached, together with the group of
research midwives working in the local maternity hospital who would be involved in recruiting women into
the EASE Back pilot RCT. Physiotherapists from the local community musculoskeletal outpatient services
and from the local hospital’s women’s health physiotherapy service were also invited to participate. In
addition, a sample of those physiotherapists (n= 30) who consented to further contact on returned
questionnaires from the national survey were also invited to take part. Owing to geographical spread and
participant convenience, these individuals were also interviewed by telephone. The individual interviews
took place after the focus groups with physiotherapists and, because of data saturation, were limited to
three individuals. In total, 15 midwives and 21 physiotherapists took part, giving a total of 53 individuals
interviewed in phase 1 (Table 5).
Analysis
An exploratory thematic analysis was adopted, within a constructivist grounded theory framework.
Emergent findings were checked out in subsequent interviews across all three groups of participants in an
iterative cycle.60,61 All interviews were digitally recorded, lasted between 20 and 60 minutes and were
transcribed in full. To preserve participants’ anonymity, all were given unique identification numbers.
To maximise the benefits of the interdisciplinary research team, the interview coders brought differing
disciplinary perspectives to bear on the qualitative data (BB, social science; PB, acupuncture; and JW,
physiotherapy). To ensure intercoder reliability, each independently coded a random selection of
interviews as part of agreeing the initial coding frame, which was then applied across the whole data set,
checking for consistencies and confounding cases and for further refinements of the coding frame.
The findings were then compared with those from the national survey to identify areas of corroboration
and contradiction.
TABLE 5 Summary of participants in individual and focus group interviews (n= 53)
Participants
Individual interviews
(telephone) Focus group interviews (face to face)
Pregnant women 17 participants 0 focus groups
Midwives 0 participants 3 focus groups (2 with community midwives, 1 with research midwives),
15 participants in total (2 were maternity assistants)
Physiotherapists 3 participants 3 focus groups (2 with community physiotherapists, 1 with women’s
health physiotherapists), 18 participants in total (1 was a
physiotherapy technician)
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Results
Engagement in the interviews
Despite the many flyers, posters and efforts on the part of clinical staff to discuss the study with potentially
eligible women, and extending the recruitment period by 2 months, only 43 women agreed to contact by
(or contacted) the research team. Of these, two self-referred, two were referred by physiotherapists, three
were referred by obstetricians and 20 were referred to the research team by community midwives. The
remaining 16 were identified through members of the research team attending the back education class
within the women’s health physiotherapy service in the local hospital. We received no responses to the
online invitations to participate that had been posted on Mumsnet or the Pelvic Pain Support Network.
There were also challenges in making contact with the 43 women and in setting up focus groups. On
average, it took five telephone calls spread over different times of day, including the evenings, to make
initial contact. Two women declined to be interviewed during their first telephone contact (one no longer
had low back pain and the husband of the other was ill) and 22 women were not contactable despite the
five contact attempts. The difficulties in contacting these women were discussed at the focus groups with
midwives and physiotherapists. They expressed little surprise, which they attributed to a patient population
struggling to cope with everyday life and, moreover, discussions suggested that travelling to a focus group
meeting would be an additional and unacceptable burden for pregnant women. The decision to offer
individual telephone interviews instead of focus groups was made. Eighteen women agreed to interview,
one was unavailable at the agreed time, and so a total of 17 women were interviewed over the 6-month
period from June to November 2012, representing 39% of those who consented to further contact.
Characteristics of participants
Despite the initial difficulties in contacting women, the interview sample of 17 women was diverse and
sufficient for data saturation. The average age was 26 years, with a range from 22 to 34 years; gestation
ranged from 15 to 39 weeks, with a mean of 32 weeks; and for eight women it was their first pregnancy.
In terms of ethnicity, eight described themselves as English, five were ‘other British’, three were ‘other
white’ and one was ‘African’. All were either married or living with a partner and employment included
health professional and clerical worker.
Analysis of the midwives’ profiles questionnaires indicated that the average length of practice was 18 years,
with the majority (n= 9) qualified for over 12 years. The least experienced person had been qualified for
3 years, and there were also two maternity assistants included in the focus groups. None reported any
specific postgraduate training around the area of back pain in pregnancy. Six midwives reported that
they saw pregnant women with back pain either very frequently (at least one per week) or frequently
(at least one per month). Just one midwife reported seeing such patients infrequently (at most one in the
last 6 months).
As with the midwives, the physiotherapists were experienced practitioners. Their average length of practice
was 12 years, nine had been qualified for 12 years or more (one for 36 years) and the least experienced
person had been qualified for over 3 years. Fourteen individuals had a Bachelor of Science in Physiotherapy,
of whom one also had a Master of Science in Musculoskeletal Healthcare, one a Master of Science in
Acupuncture, one an Advanced Critical Care Practitioner (ACCP) foundation qualification in acupuncture
and one Higher National Diploma in Sports Science. Another person had a Diploma in Physiotherapy,
two individuals reported themselves simply as members of the Chartered Society of Physiotherapists (MCSP),
and the final person was a physiotherapy technician with National Vocational Training Qualifications at
Levels 1, 2 and 3. In terms of their contact with pregnant women, seven reported seeing such patients
infrequently. All seven were community physiotherapists, and all apart from one reported that they had no
specific postgraduate training in the topic of back pain in pregnancy. Unsurprisingly, the women’s health
physiotherapists leading the hospital-based back class for pregnant women reported seeing such patients
frequently. They identified that their education around treating pregnant women came from either in-house
training or short (1-day) courses (the exact nature of these was not specified).
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Key themes
We identified three main themes from the qualitative data in phase 1: the high burden of back pain in
pregnancy and outcomes most important to women; the paucity of treatment options; and acupuncture as
an acceptable intervention for women and midwives but generating concerns for many physiotherapists.
Each of these main themes is presented briefly below with example quotations from the transcripts.
Theme 1: high burden of back pain in pregnancy and outcomes most important
to women
During the interviews with these women a picture of the burden of low back pain in pregnancy and
its often wide-ranging impact on daily life emerged strongly, corroborating the views of the midwives
and physiotherapists, and highlighting the importance of flexibility in appointment times and treatment
locations for the pilot RCT. The interview data highlighted the severely disabling effects of back pain
during pregnancy, which can affect all aspects of life, ranging from sleep through to being unable to carry
out basic activities of daily living. Many of the women reported considerable support from partners and
family. However, there were also reports of serious misunderstandings in the workplace, arising from
managers and/or colleagues seeing back pain as a normal part of pregnancy and expecting women to ‘just
get on with it’, with resulting lack of support. For some, even attending routine antenatal appointments
was difficult to negotiate with their workplace and, consequently, anything that might incur further time
away from work was seen as challenging. This is particularly significant because many women reported
needing to work as long as possible up to their due date, because of their maternity leave entitlement
and for financial reasons. It was clear others in severe pain were unable to work or participate in social
activities, with consequences for their mental well-being and relationships, as the following quote illustrates:
W8: My mood at the moment is all over the place anyway [laughs], but it [the pain] affects you,
because it does limit me, especially first thing in the morning when I’ve been in one position for a
long period of time, it kind of freezes up. So in the morning when I get up, I kind of crawl out of bed
rather than spring out of bed.
Individual interview: 56
The women interviewed did not expect to experience immediate pain relief with acupuncture but believed
that it would take several treatments to make a difference. The severity of the pain and its impact on
activities of daily life meant that they felt that it was unlikely the pain could be completely resolved but
rather alleviation was seen as an acceptable outcome:
W10: I know nothing can sort of get rid of my pain completely but perhaps just alleviate, you know,
something to alleviate it for a little bit and enable me to sort of get around and move around a little
bit more [yeah] you know? I think that would be a pretty good outcome really.
Individual interview: 156
Theme 2: the paucity of treatment options
The responses to the survey indicated that SC varied widely for this patient group. This variation in care and
lack of effective treatment options were also reflected in the narratives from women and professionals. It
was clear that the emphasis is on self-management strategies, with only the most severely affected women
being referred to physiotherapists for individualised advice about posture, movement and gentle exercise.
Both midwives and physiotherapists tended to view these women as ‘heart-sink’ patients for whom they
could offer very little in the way of effective interventions, as this illustrates:
P4: I think it’s one of the few types of patients that we won’t see more than once because you know
that, physio-wise, there’s very little to offer. So it’s a case of give them what they need and leave them
on hold for further appointments.
Community physiotherapists: group A, 48
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Midwives and physiotherapists reported explaining the causes of back pain during pregnancy as a way of
reassuring the women and, although they described offering advice, they felt that this amounted to ‘fobbing
off’ their patients, expressing a lack of faith in the effectiveness of their suggestions. Moreover, the advice
provided was clearly highly variable, indicating uncertainty among midwives and physiotherapists regarding
the most appropriate forms of advice, and there clearly were no consistently used sources of advice in terms
of either written leaflets or website resources. Examples of patient information leaflets (PILs) and websites
recommended to women were collected from respondents to the national survey, and the 37 different
leaflets returned underline the variation in current advice provided to these women. This reflects the
uncertainty voiced by the professionals about what constitutes ‘the right advice’ for this group of patients.
Most women were advised to try self-management techniques around posture, gentle exercise and pain relief
medication. Women’s health physiotherapists reported favouring a ‘hands-off’ approach, with advice on
posture, preparation for labour and delivery and feeding positions after delivery. They identified an important
part of their role as providing reassurance. The uncertainty about what constituted ‘the right advice’ for this
group of patients was reflected in the accounts of the women, who conveyed a sense of being left to ‘get on
with it’, as this severely affected individual reported:
W6: No, I refused to take that [co-codamol]. They did prescribe it in the end and I did take it home
with me but I haven’t took any because I just don’t agree with that in pregnancy. And after that I was
discharged because really there’s nothing you can do. They referred me to the physio back class that
I went to, and every time I’ve seen my midwife, she gave me a little tip of how to get in and out of
cars, and things like that. But I don’t really think it can be helped. I just think it’s one of them things
you’ve got to deal with.
Individual interview: 75
Theme 3: acupuncture as an acceptable intervention for women and midwives,
but generating concerns for many physiotherapists
Although some women did express the need for information and reassurance over safety of acupuncture
and whether or not the positioning for acupuncture would require them to lie in positions that could
exacerbate their pain, in the main women expressed little concern expressed about its use in pregnancy.
W17: I think if people were telling me that it could help my back pain then I would pretty much
do anything.
Individual interview: 149
W2: I don’t know where they put the needles in pregnancy. If they were in my tummy I think I’d be a
bit like, ‘mmm, not quite sure about that’.
Individual interview: 98
Midwives were generally in favour of the idea that acupuncture could be offered to women with
pregnancy-related back pain and that it could offer a useful additional treatment option. They felt that
many women would be interested in knowing more about acupuncture for their back pain, particularly
those women who are severely affected, and who, they felt, would be willing to try it within the context of
a trial. The midwives felt that pregnant women with back pain under their care would have few concerns
about acupuncture and these would be most likely linked to the location of and sensations from the
needles, as this focus group excerpt indicates:
M1: [They’ll] want to know where you’re going to put the needles.
M2: That’s the first thing I’d ask.
M3: Yeah, and they’d want to know if it hurts.
Community midwives: group B, 373
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Physiotherapists were also generally in favour of testing the additional benefit of acupuncture for this
patient group in a trial because of the difficulties in treating the pain through other treatment methods.
P4: I mean, it’s [acupuncture] very interesting because drugs do not seem to work for these women.
You know, talking about sort of real heavy painkillers . . . We had a lady admitted last week and was
immediately put on morphine, it didn’t touch her pain at all. And all that does then is make the baby
sleepy, and the mum sleepy. So for some women it is very difficult pain to manage.
Women’s health physiotherapist group
However, the physiotherapists raised concerns about safety of acupuncture in pregnancy, given their
previous acupuncture training during which they recalled they had been advised that acupuncture was
contraindicated in pregnancy.
P3: And again like the previous two people, I thought acupuncture was contraindicated, that was part
of my training. And I wouldn’t have done it to a pregnant lower back pain patient.
Community physiotherapists: group B, 57
Such concerns included the general safety of acupuncture in pregnancy and the specific acupuncture points
and techniques to be used, and these concerns were rooted in their lack of confidence and/or experience
in caring for pregnant women, as this excerpt indicates:
P2: With them being pregnant, you’re just so aware that they’re pregnant and you feel limited to
what you can do because you don’t want to . . .
P3: I think we’re just scared to hurt them, aren’t we?
Community physiotherapists: group A, 81
This fear was related to concerns over a perceived lack of adequate training, specifically in the application
of acupuncture in pregnancy:
P6: I don’t think I’ve got the training to do it. There might be other stuff out there, but I don’t feel
that I’m well enough equipped to deliver other things.
Interviewer: Is that the same for everybody?
P1: Yeah. I think because we don’t see them often enough, we don’t – there isn’t the training out
there. We don’t know exactly . . .
Community physiotherapists: group A, 95
Such fears around possible harm to the mother and/or baby generated a culture of caution, underpinned
by a fear of litigation. Although most physiotherapists shared these fears, the three who participated in
individual interviews and who practised acupuncture with pregnant women held starkly contrasting views.
They worked in NHS musculoskeletal outpatient departments in which acupuncture was available. One
had been qualified for 11 years, one for 18 years and one for 28 years. They were confident about the
safety and efficacy of acupuncture for this population and indeed considered it safer, in fact, than
medication, as illustrated by this quotation:
SP1: I would use acupuncture as a first choice of treatment with pregnant ladies over medication
because of the safety risks with medication. In fact, I find my pregnant patients respond better
[to acupuncture] than perhaps my standard lower back pains.
Physiotherapists’ survey
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These interview findings were pivotal in developing the content of the training and support programme
offered to physiotherapists participating in the EASE Back pilot trial in phase 2.
In addition, both the midwife and physiotherapist interviews highlighted a number of issues around
recruitment, including the importance of detailed patient information and reassurance (about the acupuncture
needling, any known side effects on the baby, information about positioning during treatment), flexibility
around time and location of treatments and generally minimising the research burden on participants.
The fact that the issues emerging through the interviews and focus groups were consistent with some of
the survey responses acted as a further form of validation. The qualitative results specifically about
physiotherapists’ concerns in using acupuncture during pregnancy also help explain the practice patterns
seen in the survey responses. The findings from the qualitative interviews were incorporated into the
participant information leaflet, the recruitment methods, the selection of treatment sites, the treatment
protocols and the outcomes for the EASE Back pilot trial in phase 2.
Implications for recruitment to the pilot randomised
controlled trial
The challenges in recruiting pregnant women to participate in the phase 1 interviews made it clear that we
needed to develop and test a range of approaches to identify and recruit eligible women for the pilot trial
in phase 2. Originally the plan had been to raise awareness about the pilot trial by inserting a flyer within
the booking information pack given when seen by their community midwives and for women with back
pain in pregnancy to be given an information pack about the trial by their usual midwife. We tested these
approaches in phase 1, and overall these approaches alone were not particularly successful in identifying
suitable women who were willing to be involved in the interviews. Recruitment of this population to
research in phase 1 was clearly challenging, and therefore we used the results of the interviews with
pregnant women, midwives and physiotherapists as well as suggestions for additional recruitment methods
from research midwives who had worked on other research studies with pregnant women in order to
agree six methods with which to identify and recruit women to the pilot RCT in phase 2. While using
six methods was complex for a pilot trial and we had not originally included these costs of some of these
methods in the grant application, we were keen to test out the methods in order to identify a smaller set
of methods that might work best for a future large trial. The details of the six methods are provided in
the next chapter (see Chapter 3, Recruitment methods and procedures), but they included a brief
questionnaire that screened for the presence of back pain and willingness to be contacted further among
women attending their antenatal 20-week ultrasound scan appointment and a local awareness-raising
campaign that included use of a study website, newspaper, radio and other local media in order to take
the message about the study directly to local pregnant women who could then opt to self-refer to the
research team for eligibility screening.
In addition, we had planned that research midwives would screen all women for eligibility in face-to-face
information and consent meetings. Through discussions with the research midwives it was agreed that a
much more efficient use of their time would be to conduct brief telephone screening first and invite only
those who appeared potentially eligible to face-to-face meetings for full eligibility screening, informed
consent and baseline data collection.
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Specification of information and interventions for the pilot
randomised controlled trial
The development of the participant information leaflet
In order for potential participants to be fully informed about what taking part in the pilot trial in phase 2
would involve, a detailed PIL was developed. The format and content of the PIL was both based on a best
practice example provided within the good clinical practice and regulatory requirements for clinical trials and
taken from the findings of the qualitative research in phase 1. Information was provided not only on the
rationale of the study, why women were being invited to take part, what taking part would involve, issues
around anonymity and confidentiality, payment and the funders of the study, but also on the acupuncture
treatment. This specific information included the required positioning for treatment, the difference between
acupuncture needles and other types of needles (e.g. those used to take blood), whether or not children
were able to attend appointments, the ability to drive after treatment and the known risk of specific adverse
events from acupuncture during pregnancy. The PIL was reviewed by patient representatives on the Trial
Steering Committee (TSC) and amended following feedback. A copy of the PIL is in Appendix 4.
The development of a standard care protocol
Given the variation in SC for pregnancy-related back pain, we sought to use the results of the national
survey and the qualitative interviews, along with available research evidence, to specify a SC intervention
protocol for the pilot RCT. The protocol included a high-quality and comprehensive self-management
booklet and, for those who needed it, an onward pathway to individualised assessment and treatment
with an EASE Back study physiotherapist.
Self-management booklet
The national survey resulted in the research team receiving examples of 37 different advice and
self-management leaflets currently used by physiotherapists across the UK. These were used to help develop
the specific self-management booklet used in the pilot RCT. Other than the professionally produced leaflet
Pregnancy-Related Pelvic Girdle Pain, published by the ACPWH, all others were examples of brief and
inexpensive leaflets produced by individual NHS trusts or individual clinicians. It was clear that none was
clearly fit for purpose for use in the EASE Back pilot RCT and, therefore, we developed the EASE Back:
Managing Your Back and Pelvic Girdle Pain in Pregnancy booklet specifically for use in phase 2. The available
leaflets were reviewed for common themes and good examples of both content and layout, taking into
account the issues raised by pregnant women, midwives and physiotherapists during the phase 1 pre-pilot
work. We sought to develop a booklet that would be seen as more comprehensive than those available
to date, that was produced in colour, of high quality, with clear photographs of real pregnant women
(rather than diagrams only, as was the case in most of the available examples), divided into sections and
with clear page numbers and handy hints boxes throughout. We also wanted the booklet to be of a size
that women could fit into their handbag so that they could, if they wished, carry it around with them
and thus refer to it during the day (most of the available examples were photocopied A4 sheets of paper).
Working with the women’s health specialist physiotherapist at the participating hospital [University Hospital
of North Staffordshire (UHNS)], who was also a member of the ACPWH, we developed sections for the
booklet about the good prognosis of back pain in pregnancy, advice about appropriate self-management of
back pain in pregnancy, including pacing between activities and rest, simple exercises to try at home, advice
on adaptation in lifting techniques, tips about relieving postures for sitting, standing and sleeping, advice
about work and continuing with everyday activities, the use of pelvic supports/belts and supportive pillows,
and the use of simple and safe analgesics. We also included some self-management hints and tips, advice
for labour and after the birth, a summary and useful websites.
The booklet was reviewed by patient representatives (women with experience of pregnancy-related
back pain) on the TSC, physiotherapists and an antenatal and postnatal exercise specialist before
we finalised the content, photographs and layout. A copy of the booklet is included in Appendix 5.
In the pilot trial, the booklet was posted to all trial participants, who were advised to follow the advice
and exercises in the booklet and that, if they felt they needed to see a physiotherapist, they should
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discuss this with their community midwife (as in usual care) and then book an appointment with an
EASE Back study physiotherapist.
One-to-one standard care physiotherapy
We protocolised the number and content of physiotherapy sessions for the pilot RCT using the data from
the national survey and qualitative interviews. We knew that women who were severely affected would
need help with pain and function, and that onward referral to physiotherapists for assessment, advice and
treatment needed to be available within the SC protocol. Therefore, we provided information in the SC
information pack on how to access EASE Back study physiotherapy care should both the woman and her
midwife feel this was needed and we developed an EASE Back study SC protocol for those women, based on
the results of our surveys and interviews from phase 1. This involved an individualised assessment of the
problem, individualised advice particularly about posture and a home exercise programme (focusing mainly
on stabilising trunk exercise and pelvic floor muscle exercise but which could include stretching, pelvic tilt
exercises and gluteal muscle strengthening), with treatment options that included supportive Tubigrip™
(Mölnlycke Health Care Limited, Dunstable, UK), pelvic supports/belts, manual therapy including massage,
supervised exercise therapy and use of walking aids for those that might need them. Hydrotherapy, group
treatments and acupuncture were not permitted within the protocol for SC alone. If women enquired about
or engaged in antenatal aqua classes this was fine, as long as the treatment from the physiotherapist did not
involve exercise in water. The episode of care consisted of between two and four treatment sessions over
6 weeks, with the episode of care left open until the end of the pregnancy, in line with our survey findings.
The development of the acupuncture treatment protocol
The results from the national survey and the interviews with physiotherapists who used acupuncture in the
management of pregnancy-related low back pain and PGP were used, alongside evidence from previous
trials, to specify the content and delivery of the acupuncture treatments in the pilot RCT. We attended to
the need for an individualised approach to acupuncture (in terms of selection of initial points to be needled
and the flexibility to change the selection of points over the series of treatment sessions) while also needing to
be able to describe the range of points that therapists could select from. Thus, following individual patient
assessment including examination of tender points, physiotherapists could choose the most appropriate true
acupuncture points for the individual patient from a long list of potential points. The agreed list of points
was based on our survey findings and previous trials in similar patient populations. We ensured that formal
service-level agreements with participating physiotherapy services stipulated between six and eight treatment
sessions should be delivered within 6 weeks (based on the survey results and balancing the need to offer
sufficient acupuncture sessions to be effective while also providing a treatment course that might be suitable
for the NHS in future). Full details of both the true and non-penetrating acupuncture protocols are provided in
Chapter 3, Interventions.
Development of training programmes for participating
clinicians
Training programme for research midwives and nurses
The research midwives and nurses involved in the EASE Back pilot trial (n= 8) attended a half-day training
programme prior to recruitment commencing, which included lectures, practical sessions, role play, group
discussion, problem-solving and case studies. During the training programme, the research midwives
and nurses were informed about (1) the rationale and design of the EASE Back study, including how the
findings from phase 1 had informed the design of the pilot trial and (2) the planned procedures involved
in identification of potentially eligible women, screening, gaining written informed consent, audio-recording
a sample of the face-to-face screening and consent meeting, baseline data collection and the randomisation
and completion of maternity record reviews after trial participants had given birth. Audit procedures were
also finalised; these included clinic activities such as informed consent, guiding women in the performance
of the two objective tests for PGP, the telephone calls to the randomisation service at the Clinical Trials Unit
(CTU) as well as the collection of minimum data over the telephone at follow-up. A summary of the
half-day training programme is provided in Appendix 6.
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In order to consolidate learning, the initial half-day training programme was followed by a 2-hour refresher
session that took place immediately prior to commencing recruitment in the pilot RCT. This included role
play of a number of different scenarios from the point of initially identifying potentially eligible women,
completing screening and eligibility checking over the telephone and completing the face-to-face screening
and consent meeting. Example scenarios included women who were ineligible for various reasons, women
who were eligible but who declined participation and women who were eligible and provided informed
consent. Throughout all scenarios, study documentation was completed to enable the research midwives
and nurses to become familiar with it before starting recruitment, and all research midwives and nurses
were observed by a member of the study team to ensure that they were competent in completing all study
eligibility screening and recruitment procedures as planned.
Training programme for physiotherapists
All the physiotherapists providing care in the pilot trial were trained in the use of acupuncture for pain
conditions, in training programmes that met national standards. The EASE Back pilot trial training programme
for participating physiotherapists took place over 3 full days and a copy of the programme content is available
in Appendix 7. Day 1 summarised relevant literature, including the changes during pregnancy to women’s
bodies, the potential explanations for back pain during pregnancy, assessment of pregnant women with back
pain (with or without PGP), and SC for pregnancy-related back pain, including key findings from phase 1.
Day 2 focused on acupuncture for pregnancy-related back pain, available data on safety of acupuncture for
this patient population and the details of the EASE Back study protocols for both the true and non-penetrating
acupuncture treatments. Day 3 combined SC and acupuncture protocols together using patient case studies
and included information about the practicalities of the trial, including use of EASE Back trial case report forms
(CRFs); how to deliver the trial protocols, stressing the importance of patient blinding; and identification of
any adverse events or SAEs. Training included lectures, group discussion and use of patient case examples, as
well as practice of assessment and treatment skills. We trained 14 physiotherapists to deliver the treatments in
the EASE Back pilot trial, supported by a training team including an expert acupuncturist, a women’s health
specialist physiotherapist and a consultant obstetrician. Ongoing support to deliver the treatments in the
EASE Back trial was provided by an expert acupuncturist and a women’s health specialist physiotherapist; this
support took the form mostly of telephone and e-mail communications as well as some face-to-face visits
during which the acupuncturist observed participating physiotherapists’ treatment sessions with patients and
provided feedback and support. Physiotherapists completed a brief questionnaire before and immediately after
the training programme and at the end of the pilot RCT, in order to describe physiotherapists’ characteristics
and explore changes in their intended management of a patient with pregnancy-related low back pain and
in their confidence to assess and treat this population. The results from these questionnaires are summarised in
Chapter 3, Physiotherapists’ questionnaire results and feedback.
Conclusions
In conclusion, the pre-pilot work in phase 1 provided high-quality data on current UK SC and acupuncture
treatment for back pain in pregnancy. The survey and interviews results, particularly those from NHS-based
clinicians, were used to help develop the intervention protocols for all the treatment arms in the pilot
randomised trial in phase 2 of the EASE Back study. The interview findings from pregnant women, midwives
and physiotherapists informed the content of the patient information materials, the recruitment methods
and the clinician training programme for the pilot trial in phase 2, reported in Chapter 3.
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Chapter 3 Phase 2 pilot randomised controlled
trial
Objectives of phase 2 pilot randomised controlled trial
The specific objectives of phase 2 were to:
l test the trial procedures, training programme for health professionals, interventions and short-term
outcomes with pregnant women with back pain, and provide data on recruitment and follow-up rates,
treatment fidelity, outcome completion rates and an estimate of between-group difference on
key outcomes
l bring the above findings together, with experts in SC, acupuncture and trial design, in a consensus
conference to finalise the design, interventions, sample size, outcome measures and operational
aspects of a main EASE Back trial.
Design and setting
We conducted a single-centre pilot three-arm parallel RCT with data collection before randomisation and
at 8-week follow-up. The pilot trial included three treatment arms, randomising participants to receive SC,
SC plus true acupuncture or SC plus non-penetrating acupuncture. North Staffordshire, including UHNS
and associated antenatal clinics including community midwives, and physiotherapy clinics within the
North Division of Staffordshire and Stoke-on-Trent Partnership Trust, was the site for the pilot trial.
Ethical approval and research governance
Research ethical approval was sought in December 2012 from West Midlands Staffordshire Research Ethics
Committee (REC) and included the usual follow-up reminder procedures for clinical trials overseen by the
musculoskeletal CTU at Keele University [a follow-up questionnaire, followed by a postcard reminder if
no response, followed by a further full copy of the questionnaire if no response, followed by a minimum
data questionnaire if no response, followed by a minimum data collection (MDC) over the telephone if no
response]. The REC recommended using a maximum of two reminders, as they were concerned that the
planned follow-up processes would be seen as burdensome and one member of the committee felt strongly
that this was a vulnerable patient group, some of whom could be suffering with postnatal depression.
Despite our formal appeal (25 January 2013, see Appendix 8) in which we provided evidence from the CTU
from five previous trials about the importance of all of these follow-up reminders in achieving response rates
in excess of 80% and our reassurance to the committee that the follow-up time point of 8 weeks had been
chosen so that most women would not yet have given birth, the committee upheld their decision and we
had to remove two reminders from our usual follow-up processes. The postcard reminder and minimum
data questionnaire were removed and, therefore, the follow-up process in the EASE Back trial comprised
an 8-week questionnaire and a further full copy of the questionnaire if no response was obtained in 2 weeks
(at 10-week follow-up), followed by a telephone call for MDC if no response was obtained in 2 weeks
(at 12-week follow-up). Appendix 8 provides the evidence of the ethics committee appeal (which was
conducted with the knowledge of the NIHR HTA programme contact person for the EASE Back study), the
evidence from five of our previous trials about the importance of our usual follow-up processes in achieving
high response rates and the response from the REC. Following ethics approval on 28 February 2013, we
proceeded to apply for research and development approvals for all participating sites. Ethics and research and
development approvals were all gained by 22 April 2013 for the pilot trial.
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Given the known importance of patients’ expectations in analgesic responses and in particular in
acupuncture response, we obtained research ethics approval to explain in the participant information
documentation that all trial participants would receive SC and that, in addition, they might or might
not receive one of two forms of acupuncture, thus maximising non-specific effects. This approach has
previously been successful in acupuncture trials using validated sham Streitberger needles (blunted,
non-penetrating needles; Asia-med, Suhl, Germany),33,39 demonstrating both true and non-penetrating
acupuncture to be safe and credible to patients.
Amendments
There were no substantial amendments submitted to ethics for the pilot RCT. The following minor
amendments were made:
l 5 March 2013: this amendment related to the addition of a number of patient identification centre
sites (Stoke-on-Trent Primary Care Trust, North Staffordshire Primary Care Trust, South Staffordshire
Primary Care Trust) and a change of named study principal investigator (PI) for the UHNS.
l 9 April 2013: this amendment related to some minor changes to the wording of consent forms,
PILs and information relating to the treatment sites.
l 4 June 2013: this amendment related to a minor clarification to the eligibility screening questionnaire.
l 31 July 2013: this amendment related to a minor clarification to the eligibility screening questionnaire
and the covering letter for the 8-week follow-up questionnaire.
Participants
Participants were pregnant women with low back pain (with or without PGP) who contacted the research
team in response to information about the trial or who were identified from primary care, referrals to the
UHNS women’s health physiotherapy service, community midwives and antenatal clinics within UHNS
and the North Division of Staffordshire and Stoke-on-Trent Partnership Trust (SSOPT).
Inclusion criteria
Women were eligible to participate in the pilot trial if they were:
l women with pregnancy-related back pain [defined as self-reported pain in the lumbar area (between
the 12th rib and the gluteal fold)] with or without PGP
l under the care of participating NHS sites and GP practices
l aged 18 years or over
l at 13 to 31 weeks’ gestation (chosen in order to ensure that women could receive six to eight
treatment sessions within 6 weeks, if they were randomised to SC plus acupuncture, and yet still have
their 8-week follow-up questionnaire before they had given birth)
l naive to acupuncture treatment
l able to read and communicate in English (to provide full informed consent and to complete the
baseline and outcome assessments)
l willing to participate.
Women who had low back pain episodes before this pregnancy were suitable for inclusion as long as the
current episode of low back pain was either attributed to or made worse as a result of this pregnancy.
PHASE 2 PILOT RANDOMISED CONTROLLED TRIAL
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Exclusion criteria
Women were excluded from participation in the pilot trial if they:
l had ever had any form of acupuncture previously for any health problem
l were at high risk of miscarriage (previously had recurrent miscarriage, defined as three or more;
abnormalities in the cervix deemed to increase risk of miscarriage; antiphospholipid syndrome;
lupus anticoagulant)
l were at high risk of pre-term labour (previously giving birth before 37 weeks’ gestation), multiple
pregnancies, polyhydramnios (an excess of amniotic fluid in the amniotic sac, seen in about 1% of
pregnancies), pre-term ruptured membranes (the rupture of membranes prior to the onset of labour in
a woman who is at less than 37 weeks’ gestation, seen in 2% of all pregnancies) or had a history to
surgery to the uterine cervix (deemed to increase risk of pre-term labour)
l had diagnosed pre-eclampsia (a rapidly progressive condition characterised by high blood pressure and
the presence of protein in the urine, affecting 5–8% of pregnancies)
l had a history of surgery to the spine or the pelvis
l had contraindications to any of the treatments (coagulation problems, haemophilia or bleeding
disorders, were at increased risk of infection such as skin infections or loss of skin integrity from burns
or ulcerations at the site of needling) or had a high needle phobia
l had pain in the anterior pelvic region only (anterior PGP or pubic symphysis pain only)
l had a current urinary tract infection.
Recruitment methods and procedures
Building on the findings from phase 1, we tested several ways to identify and recruit women to the EASE
Back pilot RCT. Six methods were tested and participant flow through each is summarised in Appendix 9
and explained below.
Method 1: research midwives identified women in antenatal clinics and
determined eligibility
Research midwives identified potentially eligible women in usual antenatal clinics, discussed the trial
directly with them and provided a PIL. If both the woman and the research midwife had the time to do
so on the same day, a face-to-face appointment proceeded at which full eligibility was confirmed and
written informed consent gained.
Method 2: brief screen for back pain at the 20-week ultrasound
scan appointment
On arrival for their routine 20-week ultrasound scan, all pregnant women were to be given a study flyer
and a screening questionnaire to complete either before or after they had their scan, and were asked
to return the completed brief questionnaire to a dedicated box within the ultrasound scanning clinic.
Questions included the presence of pregnancy-related back pain and a consent form for further contact.
Questionnaires were collected on a weekly basis by research staff and screened by a research midwife. The
research midwife telephoned potentially eligible women to determine their eligibility and their interest in
the trial. If eligible, women were posted the PIL and a face-to-face appointment was booked to confirm
full eligibility and to gain informed consent. If no contact could be made, the trial information leaflet and
an EASE Back study card were posted to the woman, advising her to telephone the study administrator if
she was interested in participating.
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Method 3: women identified from the University Hospital of North
Staffordshire women’s health physiotherapy service referrals
Research midwives screened referrals from GPs, community midwives and antenatal clinic to the UHNS
women’s health physiotherapy service. A research midwife contacted all potentially eligible participants to
determine their interest in the study and their eligibility. If eligible and interested, they were sent the PIL by
post and a face-to-face appointment was booked to confirm full eligibility and to gain informed consent.
If no contact could be made, the trial information leaflet and the EASE Back study card were posted to the
woman, advising her to telephone the study administrator if she was interested in participating.
Method 4: research midwives identified women in antenatal clinics
Research midwives identified potentially eligible women in usual antenatal clinics. However, if either the
woman or the research midwife did not have time to complete a face-to-face visit there and then, or if
the woman wanted further time to think about participation, the research midwife provided the woman
with an EASE Back study card, which directed the woman to telephone the study administrator.
Method 5: clinicians gave pregnant women with back pain an EASE Back
study card
In the fifth method, we contacted participating GPs, obstetricians and community midwives to identify
potentially eligible women and give them an EASE Back study card, which directed women to telephone
the study administrator.
Method 6: self-referral from local awareness raising
Pregnant women with back pain who were made aware of the trial through our local media awareness
raising could directly telephone the EASE Back study administrator (termed ‘self-referring’ women). We used
several approaches to raise awareness about the pilot trial among local pregnant women and clinicians.
Study flyers were included in the standard information booking packs that all pregnant women received at
their first booking visit with a midwife, and were also to be given to women at their 20-week ultrasound
scan appointment. The study flyers included details of how women could find more information (providing
both a contact telephone number and a website address). We developed a study-specific website for the
EASE Back trial and a YouTube (YouTube, LLC, San Bruno, CA, USA) video clip that was linked to the
website; while we sought to include information about the trial on other internet sites including Facebook
(Facebook, Inc., Menlo Park, CA, USA), Twitter (Twitter, Inc., San Francisco, CA, USA), Mumsnet and Pelvic
Partnership, this was not possible in the end. In addition, study flyers and posters were distributed to, and
displayed in, local GP practices, children’s centres and the UHNS maternity centre and women’s health
department. We raised awareness of the trial through local radio (including one-off, free interviews about
the trial on Radio Stoke and Six Towns Radio as well as professionally produced radio infomercials running
frequently on 3 consecutive days on the local commercial radio station, Signal Radio), a free two-page
spread in a local newspaper with wide readership (The Sentinel) and paid advertisements about the study
on local buses. These awareness-raising methods were tested throughout the recruitment period and were
phased in over time. The need for such advertising and payment for advertising had not been originally
included in the grant application but the research team felt it was important to test out different methods in
order to estimate their likely value for a future large trial.
Eligibility screening and informed consent
Women identified through method 1 were screened for eligibility by research midwives on the same day as
their antenatal appointment. Those who appeared eligible were provided with a PIL. If time permitted, and
the woman wished to do so, she completed the full eligibility checks, consent process and baseline data
collection and was randomised on the same day. If time did not allow this, or if the woman wished to
have more time to consider participation, then a further face-to-face research appointment was booked
with a research midwife or research nurse or the woman was advised to telephone the study administrator
if she was subsequently interested in participating (method 4).
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In all other methods there was a brief initial eligibility check over the telephone (confirming intended clinical
site of birth as UHNS, presence of back pain related to this pregnancy, age of18 years or over, at gestational
weeks 13 to 31 and naive to acupuncture treatment). If women met these initial eligibility criteria, a study
letter and PIL were posted out to them and a research midwife or research nurse then contacted them by
telephone to complete further eligibility checking. If the woman was eligible and interested in participating,
a face-to-face appointment was booked for her with a research midwife or research nurse at a choice
of either an EASE Back study research clinic at UHNS or the woman’s own home for confirmation of final
eligibility, consent, baseline assessments and randomisation.
If the woman was eligible and willing to participate, written consent to participate was obtained. Full
baseline data collection took place, including completion of the baseline questionnaire and completion of
two self-administered pain provocation tests (see Baseline data collection). Women had a choice in location
and times of EASE Back study eligibility and consent appointments and in treatment location and times.
Ineligible women and those who declined to participate were signposted back to normal care pathways.
In order to explore generalisability, anonymised data were captured from women who were ineligible or
declined participation.
Audio-recordings of eligibility and consent meetings
The purposes of these audio-recordings were to explore how the trial was explained and presented to
women by those involved in obtaining informed consent, the potential usefulness and acceptability of the
information provided and any concerns on the part of the women, in particular about acupuncture in
pregnancy and/or the acceptability of randomisation to the different treatment groups. Previous research
has pointed to frequent difficulties in recruitment to randomised trials.57,62 Such difficulties pose major
threats to external validity, increase costs and reduce research staff productivity.63–65 Such research also
highlights the importance of a clear understanding among potentially eligible participants of the concept
of clinical equipoise, of threats to recruitment because of patient preferences66,67 and of tensions in the
process of informed consent.68 As part of testing the trial procedures in the light of these challenges, we
examined in detail a sample of the face-to-face meetings that took place between the research midwife or
research nurse and potentially eligible women.
Details on how to use the recorders, label the audio files to ensure anonymity, upload them to the secure
research e-mail address and delete once confirmation of their safe arrival had been received were including
in the training session for the research midwives and nurses. These recordings were transcribed in an
anonymised format. Data collection stopped after 30 audio recordings, when data saturation was clear.69
Analysis was carried out based on the constant comparative method60 with transcripts read and text segments
coded in order to identify themes which were then discussed within the research team.
Baseline data collection
The baseline data collection included a baseline questionnaire (see Appendix 10) and two objective
self-administered tests of pain provocation. The baseline questionnaire included sociodemographic
questions about age, education (highest qualification), marital status, social support (living alone), number
of children and pregnancies, job title, work status, physical demands of work, time taken off work because
of the back pain, performance at work and overall work satisfaction, as well as current body mass index
(BMI) and pre-pregnancy BMI. The baseline questionnaire also included questions about symptoms
including pain location using a body chart [in which responses were coded into low back pain only, low
back pain with anterior PGP, low pain back with pain in other bodily regions (such as the thoracic spine,
neck, shoulders and arms) or low back pain with anterior PGP and pain in other bodily regions], pain
duration of this episode, pain severity using a pain index [mean score of three Numeric Rating Scales (NRSs)
of least, usual and current pain70], pain intensity before going to bed,33 frequency of pain preventing being
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able to fall asleep, frequency of pain waking the woman up at night, impact of pain on everyday activities
[measured using both the Oswestry Disability Index (ODI)71 and the Pelvic Girdle Questionnaire (PGQ),
a recently validated tool that captures self-reported symptoms and impact on activities specifically for
pregnant and postpartum women72,73], overall quality of life [measured by the European Quality of Life-5
Dimensions (EQ-5D)74 and Short Form questionnaire-12 items (SF-12)75], use of both over-the-counter and
prescribed medications, treatments or appliances, treatment preferences and expectations for both SC and
SC plus acupuncture. In order to further assess the proportion of participants in the trial with low back pain
only or low back pain with PGP, the research midwife or research nurse instructed participants to conduct
two self-administered tests for PGP. These were the self-test P4, which is a participant-generated thigh
thrust, and the bridging test, where the woman performs a pelvic bridging manoeuvre with extension
of one leg (see Appendix 11). Both tests are conducted in a supine position, can be performed by pregnant
women and have been shown to have high sensitivity and specificity for posterior PGP compared with
reference standard tests.76 Compared with a reference standard, the sensitivity of the self-test P4 was
90% and for the bridging test 97%, with specificity being reported as 92% and 87% for the self-test P4
and bridging test respectively. Olsen et al.76 report a positive pain drawing as the most sensitive (96%)
and specific (85%) method of identifying anterior PGP (and we included a body chart in the baseline
questionnaire on which women were asked to shade the areas of pain). The research midwives instructed
the women to undertake the self-test P4 and the bridging test in a standardised way using a pre-prepared
script. A positive test was a reproduction of their familiar pain in the sacroiliac region.
Randomisation and allocation concealment
Participants were randomised using the musculoskeletal CTU (registered CTU), a process of third-party
remote randomisation. A random allocation sequence was used, based on computer-generated random
numbers. The research midwife or research nurse telephoned the CTU administrator on the same day
(whenever possible) or on the next working day following the face-to-face meeting at which written
consent was taken and a research administrator conducted the concealed randomisation process
and directly informed the participants about their treatment allocation, in writing, within 2–3 days of
randomisation (in the next available post). This ensured that the person involved in randomisation was
unaware of the baseline data of each trial participant. Given that back pain tends to worsen as pregnancy
progresses, we stratified randomisation based on gestation weeks (dichotomised into two groups, less
than or more than 24 weeks), in order to ensure that equal proportions of women at earlier and later
gestation were randomised to each of the three treatment groups. The randomisation was also blocked
(using randomly varying blocks of sizes 3 and 6) to ensure that the number of participants was equally
distributed among the three treatment arms. All participants continued with their usual care from their
midwife and other antenatal carers, and this was recorded in the follow-up questionnaire at 8 weeks.
Participants were posted written confirmation of their treatment allocation along with the EASE Back study
self-management booklet. Those randomised to SC alone also received information about how to access
physiotherapy should both they and their community midwife feel they needed it. Those randomised to
receive one of the acupuncture interventions also received, in the same postal package, information about
the next steps for them to start their treatment. We developed written service-level agreements with
participating physiotherapy services to facilitate the commencement of treatment within 2 weeks of
randomisation to one of the acupuncture treatments and agreed the process of communication between
trial participants and the physiotherapy service (through administrators in the existing physiotherapy hub
who arrange all physiotherapy appointments in the participating trust).
PHASE 2 PILOT RANDOMISED CONTROLLED TRIAL
NIHR Journals Library www.journalslibrary.nihr.ac.uk
32
Blinding
The women randomised to SC plus either true or non-penetrating acupuncture were blinded to whether
they were receiving true or non-penetrating acupuncture. Physiotherapists providing the treatments
were not involved in the baseline data collection or follow-up outcome assessment processes. The NIHR
Clinical Research Network West Midlands research midwives and nurses dealing with the baseline and
outcome data collection were blinded to the intervention assignments. Selection bias was avoided by the
system of remote allocation to treatments described earlier. Data about outcomes were collected using
self-completed questionnaires (and telephone follow-up for a minimum data set). These data were
collected and entered by staff without knowledge of the allocation of the individual concerned. In
addition, analyses of patient-reported outcomes at 8-weeks follow-up were conducted and verified by
blinded statisticians.
Training and auditing processes
Research midwives in the Childbirth And REproductive health (CARE) for Comprehensive Local Research
Network (CLRN) West Midlands North network and research nurses in the Clinical Research Network West
Midlands were key to identifying potentially eligible women for the pilot trial, to providing full information to
potentially eligible women, to determining eligibility for the trial and to gaining women’s written consent and
full baseline data. Following written consent, research midwives and research nurses were also responsible
for telephoning the randomisation service. In addition, our EASE Back study administrator conducted brief
initial eligibility screens during a telephone call initiated by interested women. Several training events led by
the study team for these key staff ensured the processes for identification, explanation, screening and
consent were feasible and clear (see Chapter 2, Training programme for research midwives and nurses, for
full details of the research midwife and nurse training programme). This was facilitated by a named lead
research midwife and a named lead research nurse, clear flow charts and a pro forma for completion during
the eligibility screening and checking meetings (see Appendix 12 for the full eligibility screening pro forma).
The research team conducted audits of these eligibility screening and consent meetings.
The processes for identifying potentially eligible women, completing screening and eligibility checks,
audio-recording face-to-face meetings, obtaining informed consent, collecting baseline data including
guiding women to complete the two objective tests for PGP and contacting the CTU for randomisation
were initially assessed as mock scenarios within the training session prior to commencing recruitment
(see Chapter 2, Training programme for research midwives and nurses). During the recruitment period,
any new members of the research nurse team who joined the study were also trained and assessed
by the lead research nurse to ensure they were competent in these processes. The lead research nurse
was audited by the trial co-ordinator. The lead research nurse then carried out audits on all other research
midwives and nurses. The audit found that all research midwives and nurses were competent in the
process of taking informed consent and guiding women to perform the objective tests, and that the pilot
trial procedures were being adhered to.
The lead research nurse ran a training session on MDC telephone calls after the 8-week questionnaire
with the research nurse team and listened to the telephone follow-up calls until she was happy that the
nurses were competent in collecting follow-up data. This was checked again halfway through the MDC
period by the lead research nurse, to ensure consistency across all the nurse team, and no problems
were identified.
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Physiotherapists’ questionnaire results and feedback
Questionnaire results
Fourteen physiotherapists (13 female) who delivered the EASE Back pilot trial interventions completed
three questionnaires (before and immediately after the training programme, and at the end of the EASE
Back pilot RCT). Their demographic and practice characteristics are summarised in Table 6. All had prior
experience (although mostly ‘infrequently’) of treating pregnancy-related back pain. The majority had
previously received postgraduate training in back pain, but only one in women’s health. Eleven currently
used acupuncture in the management of musculoskeletal pain, including back pain, but none currently
used acupuncture for back pain in pregnant women.
Physiotherapist questionnaires sought information about their self-confidence in managing pregnant
women with back pain and their clinical management of a typical patient with this problem (in a patient
case vignette), before and immediately after the training programme, and after delivering the EASE Back
study interventions to participants. The results are summarised in Table 7. Self-confidence in diagnosis and
management of back pain in pregnancy increased after the training and remained high at the end of the
pilot RCT. In terms of SC, the large majority of respondents reported that they would manage the patient
case in one-to-one treatment sessions, and the number of times the patient would typically be seen
increased after the EASE Back study training, with many preferring to see the patient more than twice.
TABLE 6 Characteristics of participating physiotherapists
Characteristics (denominatora)
Years of clinical experience, median (IQR) 8.5 (5.0–17.5)
Use acupuncture for musculoskeletal pain, n (%) 11 (78.6)
Work setting (13)
Exclusively NHS, n (%) 6 (42.9)
Combination of NHS and non-NHS, n (%) 7 (50.0)
Frequency of treating pregnant women with back pain (13)
Infrequent – at most one in last 6 months, n (%) 10 (71.4)
Somewhat frequent – between two and five in last 6 months, n (%) 2 (14.3)
Very frequent – at least one per week, n (%) 1 (7.7)
Circumstances under which pregnant women access physiotherapyb (13)
Referred from their midwife, n (%) 1 (7.7)
Referred from their GP, n (%) 12 (92.3)
Referred from their obstetrician, n (%) 1 (7.7)
Self-referred to physiotherapy, n (%) 1 (7.7)
Postgraduate training (14)
In women’s health, n (%) 1 (7.14)
In back pain in general, n (%) 13 (92.9)
In back pain in pregnancy, n (%) 2 (14.3)
IQR, interquartile range.
a Denominator varies, as some respondents did not answer all the questions.
b Multiple responses possible.
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The questionnaire sought information on physiotherapists’ reported advice to, and management of, the patient
case before and immediately after the training programme for the EASE Back study and at the end of the pilot
RCT. Figure 4 summarises the advice that therapists reported they would offer and Figure 5 the clinical
management approaches. We observed increases in the reported use of written advice on self-management,
advice to continue with everyday activities, advice about safe pharmacological treatment options and advice
about the use of home massage (see Figure 4), following the EASE Back study training programme. We also
observed increases in the use of various management approaches after the training programme including
exercises supervised by a physiotherapist, strengthening exercise, pelvic floor exercise and acupuncture
see Figure 5).
TABLE 7 Physiotherapists’ confidence and reported management
Physiotherapists’ questionnaire results Before training (n= 14) After training (n= 14) At trial end (n= 12)
Self-confidence in diagnosis and
management of back pain in pregnancy,a
median (IQR)
8.0 (6.0–11.0) 16.0 (16.0–17.0) 16.0 (16.0–17.0)
Patient would normally be seen in
individual, face-to-face sessions, n (%)
12 (85.7) 12 (85.7) 11 (91.7)
Patient would normally be seen as part of
group, but could access one-to-one
sessions, n (%)
1 (7.1) 1 (7.1) 1 (8.3)
Patient seen in up to two treatment
sessions, n (%)
9 (64.3) 5 (35.7) 4 (33.3)
Patient seen in more than two treatment
sessions, n (%)
5 (35.7) 8 (64.3) 8 (67.3)
Care episode would last 3–4 weeks, n (%) 10 (71.4) 4 (28.6) 6 (50.0)
Care episode would last > 4 weeks, n (%) 4 (28.6) 9 (71.4) 6 (50.0)
Typical length of session: up to 30 minutes,
n (%)
11 (78.6) 8 (57.1) 10 (83.3)
Care would finish after treatment,
re-referral required for further treatment,
n (%)
3 (21.4) 0 (0) 1 (8.3)
Care would be left open for duration of the
pregnancy, n (%)
7 (50.0) 9 (69.2) 6 (50.0)
Care would be left open for a defined
period of time after end of treatment, n (%)
3 (21.3) 4 (30.8) 5 (41.7)
IQR, interquartile range.
a Self-confidence measured using four items; responses from the four items were summed (after reverse coding the first
item) to give a self-confidence score (0–20); the higher the score the higher the confidence.
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A home exercise programme
Exercises supervised by a physiotherapist
Strengthening exercises
Postural control/stabilising exercises
Repeated directional exercises
Pelvic floor exercises
Exercise in water
Relaxation techniques
Prescribed periods of bed rest
Supportive belts
Supportive pillows
Heat therapy
Cold therapy
Manual therapy
Acupuncture
Massage
TENS
Number of physiotherapists
End of the study
After training
Pre training
FIGURE 5 The EASE Back study physiotherapists’ management of the typical patient case.
0 2 4 6 8 10 12 14
Temporary/self-limiting nature of the pain
Oral advice on self-management
Written advice on self-management
Pacing between activities and rest
Postural stresses occurring during pregnancy
Adaptations in posture to help the pain
Adaptation in lifting techniques
Continuing with everyday activities
Use of pelvic belts
Use of pillows
Rest as a form of treatment for the pain
Work
A home exercise programme
Safe pharmacological options
Home massage
Walking aids
Other
Number of physiotherapists
End of the study
After training
Pre training
FIGURE 4 The EASE Back study physiotherapists’ use of advice for the typical patient case.
PHASE 2 PILOT RANDOMISED CONTROLLED TRIAL
NIHR Journals Library www.journalslibrary.nihr.ac.uk
36
Physiotherapist feedback
Fourteen physiotherapists attended the EASE Back study training programme, 12 of whom provided
treatment to the pilot trial participants. Each physiotherapist treated a median [interquartile range (IQR)]
of five (two to nine) participants; six physiotherapists treated between two and four participants, three
treated between five and eight participants and three treated between 10 and 19 participants. These
differences were a result of women choosing some geographical treatment sites more frequently than
others. Following the end of all treatment in the pilot trial, we invited the physiotherapists to a half-day
feedback workshop (in April 2014) to gain their views of participation in the pilot trial, to explore what
worked well and less well from their perspectives, in order to inform the future main RCT and any future
training programme. Several key issues were highlighted including the following:
l Some women had not read the self-management study booklet prior to their first physiotherapy
appointment, which meant that much of the first treatment session was taken up with the therapist
needing to explain the self-management information before starting acupuncture,
l Uncontrolled epilepsy, allergy to metal and allergy to Tubigrip should be included in the list of exclusion
criteria for a future main RCT.
l Women should receive a full explanation of what participation in the trial means in terms of
commitment to attending treatment sessions.
l The course of physiotherapy treatment for each participant should be blocked out in physiotherapists’
diaries well in advance.
l The training programme for physiotherapists’ should include more content on management of pubic
symphysis pain (anterior PGP).
Feedback from participating physiotherapists highlighted that the following worked particularly well in the
pilot trial and should be continued for a future main RCT:
l the offer of evening treatment times to participants
l the block booking of participants’ whole treatment course into physiotherapists’ diaries
l ensuring flexibility in staff providing EASE Back study treatments to cover annual leave
l a minimum of two physiotherapists trained in the EASE Back study at each treatment site to provide
peer support and sufficient capacity to treat participants
l the mentoring support and supervision from the acupuncture trainer
l new patient appointment slots that lasted 1 hour to ensure that there was sufficient time to provide
advice, start the exercise programme and deliver acupuncture.
Interventions
The pilot trial included three treatment arms, randomising participants to receive SC, SC plus true
acupuncture or SC plus non-penetrating acupuncture.
Standard care
Full details and justification for the SC protocol were provided in Chapter 2, The development of a standard
care protocol. SC comprised a high-quality and comprehensive self-management booklet plus onward
referral, if necessary, for face-to-face physiotherapy. This was felt to be the most appropriate SC package, as it
mostly closely reflected current practice, according to which most pregnant women with back pain are not
referred to other health professionals for treatment for their back pain but, rather, are advised to self-manage,
with only those who are the most severely affected being referred to physiotherapists. This booklet (see
Appendix 5) was posted to women in the SC group along with a letter explaining which group they had been
randomised to. They were not instructed to avoid other treatments, but their use of other treatments was
monitored through self-report questions in the 8-week follow-up questionnaire. We provided information
in the SC information pack about how to access EASE Back study physiotherapy care should both the
woman and her midwife feel that this was needed and we developed an EASE Back study SC protocol for
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these women with participating physiotherapists, based on the results of phase 1 surveys and interviews
(see Chapter 2, The development of a standard care protocol, for details). Physiotherapists assessing and
managing these women completed EASE Back study CRFs (see Appendix 13) to describe the care provided.
Standard care plus true acupuncture
The same advice and education package was posted to women randomised to SC plus a course of true
acupuncture, along with a letter explaining how to arrange the first physiotherapy appointment and that the
first treatment should be within 2 weeks. Physiotherapists provided a course of SC plus true acupuncture
informed by findings from the phase 1 surveys and interviews. In addition to SC, participants randomised to
also receive true acupuncture were to receive treatment as follows: a patient assessment to ascertain the
quality, location and intensity of the presenting back pain (with or without PGP) followed by acupuncture
treatment, using acupuncture points from selected from the agreed list of points summarised in Table 8. The
list of points was informed by the survey of current practice in phase 1, texts about acupuncture for back pain
and PGP in pregnancy and previous RCTs. Point location and depth of insertion were as described in Table 8.
TABLE 8 Acupuncture points and depth of needling in the true acupuncture arm
Local points
Point Description Depth of insertion/needle
BL23 1.5 cun lateral to the spinous process of L2 30–40mm/50mm
BL24 1.5 cun lateral to the spinous process of L3 30–40mm/50mm
BL25 1.5 cun lateral to the spinous process of L4 30–40mm/50mm
BL26 1.5 cun lateral to the spinous process of L5 30–40mm/50mm
BL27 1.5 cun lateral to the spinous process of S1 30–40mm/50mm
BL28 1.5 cun lateral to the spinous process of S2 20–30mm/40mm
BL54 3 cun lateral to the spinous process of S4 50–70mm/75mm
BL31 Over the first sacral foramen 20–30mm/40mm
BL32 Over the second sacral foramen 20–30mm/40mm
BL33 Over the third sacral foramen 20–30mm/40mm
GB30 Over the piriformis muscle, at junction of lateral third and medial two-thirds of line
joining sacral hiatus and greater trochanter of the femur
50–70mm/75mm
HJJ L4 One finger-breadth lateral to the spinous process of L4 30–40mm/50mm
HJJL5 One finger-breadth lateral to the spinous process of L5 30–40mm/50mm
All of the above points can be needled bilaterally. Tender points over the gluteus minimus and the pelvic rim can also
be included.
Distal points
GB34 One finger-breadth anterior and one inferior to the fibular head 25–30mm/40mm
ST36 3 cun below the joint line of the knee and a finger-breadth lateral to the
tibial crest
25–30mm/40mm
LR3 Just distal to the junction of the bases of the first and second metatarsal bones 25–30mm/40mm
LI4 On the highest point of the first dorsal interosseous muscle of the hand 20–30mm/30–40mm
BL60 Midway between the lateral malleolus and the Achilles tendon 15–25mm/30mm
BL62 1 cun below the tip of the lateral malleolus 10–20mm/30mm
BL, bladder; GB, gall bladder; HJJ, Huato Jia Ji; LI, large intestine; LR, liver; ST, stomach.
One or two of the above points are to be included in the treatment. It is not necessary to needle bilaterally, unless the
clinician judges it to be needed.
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The patient was suitably positioned (side-lying wherever possible or prone) and the therapist chose a
minimum of six and a maximum of 10 bilateral points in total, thus needling between 12 and 20
acupuncture points. The choice of these points was made using the principles of Western acupuncture
and trigger point acupuncture. Acupuncture points were to be in the general location of the patient’s
pain (local points) with the addition of distal points. The therapists identified and needled the relevant
points at the appropriate depth and rotated the needle to elicit the de-qi sensation. It was intended that
all needles be inserted into muscle. Traditional acupuncture needles were used in sizes 50mm× 30mm,
40mm× 30mm, 70mm× 30mm and 30mm× 30mm. Therapists could change the points at each
treatment session, should they feel this was appropriate, as long as all points used were those from the
agreed list in Table 8. All needles were of the disposable, sterile, stainless steel variety. Acupuncture
treatment was to last from 20 to 30 minutes, during which time the therapist was to stimulate the needles
again, ensuring that the needling sensation (de-qi) was maintained. On completion of the treatment all
needles were to be safely removed, any sensations felt by the participant during treatment and any
adverse reactions were recorded on the CRF and the patient booked for the next appointment. Between
six and eight treatment sessions were to be offered to participants over a period of 6 weeks, and efforts to
engage women in treatment after failure to attend were agreed with participating physiotherapy services.
Standard care plus non-penetrating acupuncture
In order to control for time and attention with physiotherapists, we included a SC plus sham acupuncture arm
using non-penetrating needles (the devices look exactly like real needles but the tip is blunted and the shaft of
the needle is allowed to slide in the handle, giving an illusion of penetration). This trial arm consisted of the
same advice and education booklet posted to women randomised to SC plus a course of non-penetrating
acupuncture, along with a letter explaining how to arrange the first physiotherapy treatment session and that
the first treatment should be within 2 weeks. The same NHS physiotherapists provided the non-penetrating
acupuncture treatment, and the participants’ letters explained that they had been randomised to receive SC
plus one of two forms of acupuncture treatment. The non-penetrating Streitberger needle has been validated
in several studies and used successfully in two previous trials of acupuncture.33,39 The device looks exactly like a
real needle but has a blunted tip, and is tapped onto the skin, held in place by an O-ring, and gives the illusion
of needle insertion. Women were treated in a side-lying or prone position, which permitted both comfortable
positioning for the participant and adequate blinding to the non-penetrating acupuncture needles.
In addition to SC, participants randomised to also receive non-penetrating acupuncture received the treatment
as follows: the patient was assessed to ascertain the quality, location and intensity of the presenting back pain
(with or without PGP), the patient was suitably positioned and the therapist applied the non-penetrating
needles bilaterally over the four points detailed in Table 9. After the non-penetrating needles were positioned,
no further attempt to stimulate the needles was made. The treatment lasted for 20–30 minutes. On completion
of the treatment all needles were safely removed, any sensations felt by participants during treatment and
any adverse reactions were recorded on CRFs and the patient was booked for the next appointment. Between
six and eight treatment sessions were offered by physiotherapists over a period of 6 weeks.
TABLE 9 Acupuncture points in the non-penetrating acupuncture arm
Local points
Point Description
Depth of insertion of
the needles
BL26 1.5 cun lateral to the spinous process of L5 n/a
BL27 1.5 cun lateral to the spinous process of S1 n/a
BL54 3 cun lateral to the spinous process of S4 n/a
GB30 Over the piriformis muscle, at junction of lateral third and medial two-thirds
of line joining the sacral hiatus and the greater trochanter of the femur
n/a
BL, bladder; GB, gall bladder; n/a, not applicable.
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Fidelity of treatments
For each participant, physiotherapists recorded full details of the advice and treatments, number and mode
of treatment sessions, any non-attendance, acupuncture points used, any sensations during acupuncture
treatments and any adverse events on specifically designed CRFs (see Appendix 13). The CRFs also included
one NRS to capture pain severity after treatment at each session. These CRFs were audited against the
physiotherapists’ clinical notes to ensure accuracy and to determine protocol adherence by participating
physiotherapists before collation by the research team in order to fully describe the interventions delivered.
Where protocol deviations were noted, these were discussed with the physiotherapists involved in order,
whenever possible, to enhance adherence to the agreed intervention protocol. Protocol deviations were mostly
related to challenges in getting women to attend for all of their arranged treatment sessions. Where
participants did not attend for treatment, physiotherapists attempted to contact them to re-engage them in
treatment whenever possible.
Outcome measures and follow-up
Process outcomes
Process outcomes from the pilot trial included recruitment rates (both overall and from each separate
recruitment method), follow-up rates at 8 weeks (both overall and in each treatment arm), attendance at
treatment sessions, treatment protocol adherence, completion rates on key outcome measures, and floor
and ceiling effects of key outcome measures.
Clinical outcomes
Patient-reported outcomes were assessed at the 8-week follow-up (i.e. 8 weeks after randomisation).
The decision about the most appropriate follow-up time point for the pilot trial was taken in order
to maximise the chances of most participants having received their full course of treatment, but not yet
having given birth. We expected that women recruited to the trial at 30 and 31 weeks’ gestation would
wait a maximum of 2 weeks for the start of their acupuncture treatment and would have a course of
treatment over 6 weeks. Therefore, they should have completed their acupuncture treatment and received
their follow-up questionnaire just before the birth of their baby. Studies of low back pain and PGP in
pregnant women have previously followed up participants 1 week after the end of treatment33 and at
12 weeks (3 months) post partum.15,17 We did not plan longer-term follow-ups in this pilot trial but, rather,
we provide data on baseline and one follow-up time point only (at 8 weeks), in order to ensure that we
delivered the feasibility and pilot study within a period of 24 months.
Outcomes at the 8-week follow-up were collected by postal questionnaire (see Appendix 14) and included
the same measures of pain, everyday function and general health as at baseline, overall global rating of
change since baseline, whether or not the woman was still pregnant (and, if yes, number of weeks’
gestation), a series of questions about treatment credibility, satisfaction with the treatment package
received, satisfaction with the results from treatment and side effects from treatment in the EASE Back
study. In addition, we included an open question on the 8-week follow-up questionnaire about the
participant’s experience of treatment in the trial. We developed a minimum outcome data set from these
wider set of outcomes which was collected over the telephone for those participants who did not respond
to the postal reminder.
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Cost outcomes
Data collection was undertaken to obtain patient-level cost and outcome data for all women participating
in the trial in order to conduct a preliminary economic evaluation and inform the design of a cost–utility
analysis alongside a future main trial. The SC plus non-penetrating acupuncture arm of the trial was not
included in the economic analysis; therefore, data were analysed for only the SC and SC plus true
acupuncture arms.
Resource use associated with SC and acupuncture treatment was based on primary data collected using
information from the trial and self-completed questionnaires at 8 weeks. Cost data collection was undertaken
on all women and from a broad perspective, taking into account health-care, patient and societal costs. NHS
resource use data included GP consultations, visits to health-care professionals, outpatient appointments,
investigations or treatments and inpatient stays related to their back pain during pregnancy. Information on
costs borne by the patient with regard to over-the-counter medicines and devices was requested in the
8-week questionnaire. In order to assess broader societal economic consequences, productivity costs relating
to both absenteeism (absence from work) and presenteeism (working with reduced productivity) were
considered. Self-reported data on employment status, occupation and time off work and reduced productivity
at work (presenteeism) owing to their back pain over the 8-week study period were collected. As it was
assumed that some of the women attending the acupuncture treatment sessions might be in work or have
other children, data were also collected regarding the travel costs, time off work and child care costs
associated with attending a treatment sessions during the trial. As part of the pilot, the methods of collecting
cost data from patient questionnaires and completeness of the data were assessed, in order to inform cost
data collection in a future large trial.
Details of the number of treatment sessions attended by each participant were collected as part of the
trial. The costs required to deliver the treatments included the acupuncture sessions, other aspects of SC,
duration of each session and consumables needed.
For the purpose of costing staff time associated with the treatments, we estimated the average time of a
treatment session with a physiotherapist during the study. Both the acupuncture intervention and SC
involved, on average, a standard 60-minute initial consultation and follow-up consultations of 40 minutes
per session.
In order to enable the calculation of quality-adjusted life-years (QALYs), all patients were asked to
complete the five-level version of the EQ-5D questionnaire (i.e. EQ-5D-5L) at baseline and 8 weeks in order
to assess quality of life.77
Maternal/neonatal outcomes
We collected the following additional obstetric birth/neonatal outcomes from maternity records for all
participants in order to inform a future main trial: gestation week at time of delivery, live births, length of
labour (and second stage of labour), whether or not the woman needed to be induced, mode of delivery,
whether or not the woman had an episiotomy or a perineal tear, estimated blood loss at birth, antenatal
and postnatal haemoglobin count, pain relief during labour, baby’s sex and weight, Apgar scores at
1 minute and 5 minutes after birth and whether or not the baby was admitted to the neonatal unit.
Adverse events
We collected adverse event data through CRFs completed after each physiotherapy treatment, through
self-report of participants in the 8-week follow-up questionnaire and through maternity record reviews.
Expected adverse events from the acupuncture interventions include drowsiness/light-headedness, nausea/
vomiting, fainting, bruising at needle sites, feeling hot/burning, headaches and transient pain at needle
sites. We defined SAEs as death, hospitalisation, significant disability or incapacity, any life-threatening
circumstance (to the woman or developing child) or any other medically significant occurrence that were
potentially attributable to any of the trial procedures or treatments. Potential SAEs were identified via
treating physiotherapists.
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Sample size
In line with pilot trial recommendations,45 the EASE Back pilot trial did not have a primary outcome or the
usual sort of power calculation that one would expect in a main RCT. The sample size was based on
the number of births overseen by the participating maternity centre (UHNS) per year at the time of the
funding application and estimates about the proportion of women likely to be eligible and consent
to participate. The UNHS maternity service oversaw approximately 6100 births per year and we estimated
that between 50% and 66% would self-report back pain at some point in their pregnancy and at least
30% would self-report back pain in gestational weeks 13–31. Thus, we estimated that approximately
1800 women would be potentially eligible over the course of 1 year, equivalent to approximately 600 over
a recruitment period of 4–5 months. We estimated that we would need to raise awareness of the EASE
Back pilot trial among these 600 pregnant women with back pain and that approximately one in four
might agree to participate. To allow for some withdrawal and loss to follow-up, we anticipated needing to
approach about 720 women in order to recruit 180 women and provide follow-up data on 150 women.
In reality, we recruited 125 women in 6 months. The research team and the TSC felt that 125 women
provided an adequate number to estimate critical parameters in the pilot trial (e.g. recruitment rates,
variation in key patient-reported outcome measures, treatment fidelity), using the rule of thumb of
30 patients or greater per group.78
Analysis
To ensure transparency in analyses, a statistical analysis plan (SAP) was developed by the study statistician
(RO), together with the PI (NF), trial co-ordinator (AL), senior CTU statistician (ML), health economists
(SJ and JK) and other study team members. The SAP, including all the mock-up tables and figures, was
presented to the TSC for review and discussion. All agreed amendments were implemented and the
revised SAP was approved and signed off by the TSC.
The analysis of the pilot focused on (1) evaluation of the physiotherapy training programme through
analysis of physiotherapy questionnaire data; (2) baseline description of the study population, including
pain location and a summary of gestation weeks; (3) assessment of process measures including recruitment
rate and methods of recruitment uptake and response to follow-up; (4) exploratory analysis of clinical
outcomes; (5) descriptive summaries of treatment received (in relation to adherence with randomised
intervention), satisfaction with care and evaluation of the adherence to treatment protocols through
analysis of CRF data; (6) extent of missing data and data accuracy; (7) summary of birth and neonatal
outcomes; (8) reports of adverse events in any of the treatment arms; and (9) summary of parameters to
aid the choice of primary outcome measure and sample size calculation for a full RCT.
In the absence of standard practice regarding the type of economic evaluation to conduct alongside
feasibility and pilot studies, a cost–consequence analysis was chosen. This allowed an exploration of the
feasibility of conducting an economic evaluation as part of a future RCT testing acupuncture compared with
SC in women with pregnancy-related back pain, rather than demonstrating cost-effectiveness at this stage.
The SC plus non-penetrating acupuncture arm of the trial was not included in the economic analysis. The
main purpose of including a non-penetrating acupuncture treatment was to explore the merits of this
for a future main trial, in order to explore the importance of needle penetration in explaining acupuncture
effects. The SC plus non-penetrating acupuncture intervention would not be commissioned in actual NHS
practice. Therefore, health economic data were analysed for only the SC and SC plus true acupuncture
arms. The cost–consequence analysis describes all the important results relating to costs and consequences
of the treatments for the management of back pain in pregnant women in the SC and the SC plus true
acupuncture arms of the pilot trial. The base case analysis for the evaluation adopted a NHS and Personal
Social Services (PSS) perspective, with additional analysis considering a broader societal perspective taking
into account patient-incurred costs and productivity losses. Costs are presented for each broad cost category
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(health-care costs, patient-incurred costs, productivity costs) and in a disaggregated form within each of these
cost categories. Unit costs were obtained from various sources including the British National Formulary
(BNF),79 NHS reference costs and Unit Costs of Health and Social Care80,81 and multiplied by resource use
items from the trial. Unit costs are presented in Table 10. Discounting was not necessary as the follow-up
period was 8 weeks. Owing to the lack of nationally representative unit cost estimates for private health-care
visits, any private care was costed as the NHS equivalent. Patient-reported costs for over-the-counter
treatments and patient-incurred time, travel and child care costs were used to estimate patient-related costs.
Productivity losses were assessed using the human capital approach; self-reported days of work absence and
reduced productivity at work due to back pain during the 8 weeks were multiplied by the average sex-specific
wage estimates identified from annual earnings data and UK Standard Occupational Classification coding.82,83
Reduced productivity time loss was generated by translating the self-reported scores obtained using a
0–10 scale into work loss based on the actual number of days worked during this period. In addition, time
off work and reduced time spent on unpaid activities in order to attend physiotherapy appointments was
estimated using a similar approach. Responses to the EQ-5D questionnaire were converted to index scores
using the interim crosswalk UK value set. The area-under-the-curve approach that links each patient’s utility
scores at different time points was applied to calculate QALYs for each study participant over the 8-week
time period. Regression-based adjustment was used to account for baseline differences in EQ-5D score.
TABLE 10 Unit costs used in the economic analysis
Health-care resource Unit cost (£)
Primary carea
GP consultation (11.7 minutes) 34
Practice nurse consultation (per hour) 44
Health visitor (per hour) 43
Nurse home visit (per hour) 60
Community physiotherapist (per hour) 30
Secondary care contactsb
Midwife: first attendance 96
Midwife: follow-up 54
Obstetrician: first attendance 165
Obstetrician: follow-up 112
Acupuncturist: first attendance 49
Acupuncturist: follow-up 44
Physiotherapist: first attendance 49
Physiotherapist: follow-up 44
Study treatment sessions
First session: 60 minutes 30
Follow-up session: 40 minutes 23
Prescribed medication Patient specificc
Medical investigations/interventions Patient specificb
Day of sickness absence from work One-fifth of average weekly earning wages
a Unit Costs of Health and Social Care.80
b NHS Reference Costs Schedule 2012/13.81
c BNF.79
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A complete case analysis was undertaken and all costs and outcomes were summarised using means,
SDs and 95% confidence intervals (CIs). Cost and QALY data alongside RCTs are invariably skewed;
therefore, bias-corrected accelerated bootstrapping with 1000 replications was used to generate 95% CIs
around differences in mean costs and QALYs. All statistical analysis was performed using Stata version 13.
The CHEERS (Consolidated Health Economic Evaluation Reporting Standards) statement and checklist were
consulted for reporting the economic evaluation. Owing to a cost–consequence analysis being undertaken,
some items of the checklist were not appropriate for this study.
Patient involvement
Prior to funding application, the study plans were discussed in detail with women attending the antenatal
back pain class at the participating hospital (UHNS). The women felt that it was important to be able to offer a
number of alternative treatments, as their perspective was that currently few options exist. They considered
acupuncture a potentially attractive option but stressed that information had to be clear and particularly
needed an explanation of safety issues. They felt that this information had to be given both verbally through
health-care professionals, and in a written format which allowed women to reflect on it at home. In addition,
two women who had attended the back class and were receiving one-to-one physiotherapy reviewed a draft
of the PIL for the pilot RCT and commented on its content, style and readability.
We had two patient representatives on the TSC who:
l identified the limitations of the Disability Rating Index (included in the original funding application to
be used as a second measure of back pain-related disability) for the pregnant population, which led
to the inclusion instead of the PGQ, a newly developed outcome assessment tool specifically for those
with back and PGP in pregnancy,72 reviewed and fed back on the PIL and the baseline and follow-up
questionnaires in the pilot RCT
l fed back on the visibility of EASE Back study posters and banners when attending
antenatal appointments
l reviewed and fed back on the draft self-management booklet EASE Back: Managing Your Back and
Pelvic Girdle Pain in Pregnancy
l helped with the media advertising by appearing in a newspaper article in The Sentinel about the
pilot trial and being the voice of a woman with pregnancy-related low back pain in the Signal
Radio infomercials.
Results of the pilot randomised controlled trial
Participant flow
Of 388 women assessed for eligibility in 6 months, 280 were potentially eligible and 125 women (45%) were
recruited into the EASE Back pilot trial and randomly allocated to one of the three treatment arms (Figure 6).
One participant, in the SC plus non-penetrating acupuncture arm, was randomised in error (she fulfilled
criteria for a high-risk pregnancy) and was subsequently withdrawn prior to treatment. Overall, the 8-week
follow-up rate was 74% (n= 91).
Baseline comparability
Participants’ baseline characteristics (Table 11) were largely similar among the three treatment arms. The mean
(SD) age of the 124 participants was 28 (5.3) years; 54 (44%) were married, 87 (70%) were in full/part-time
employment and 53 (42%) were ≥ 24 weeks pregnant at the time of inclusion. More than half (68 out of
124) had experienced back pain for more than 6 weeks and the mean (SD) pain severity score (mean score
of three Pain NRSs on 0–10 scales) was 4.6 (SD 1.7). About one-third of participants (38 out of 144) had low
back pain with anterior PGP and pain in other parts of the body. More than half of the participants (67 out of
124, 54%) had moderate back pain-related disability measured by the ODI.
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Assessed for eligibility (n = 388)
Not randomised (n = 263) 
• Not meeting eligibility criteria, n = 108; 
   280 potentially eligible
• Declined to participate, n = 50
• Unable to contact for full eligibility screening, n = 38
• Did not attend face-to-face meeting and no further
   contact, n = 67
Analysed for key clinical outcome
measures (n = 32 for pain intensity,
n = 31 for PGQ and ODI)
Allocated to SC alone (n = 41) 
• Received allocated intervention,
   n = 41
Randomised (n = 125; 45% of potentially eligible)
Allocated to SC plus true
acupuncture (n = 42) 
• Received allocated
   intervention, n = 33
• Did not attend treatment
   sessions, n = 8
• Attended but did not receive
   acupuncture treatment, n = 1
Allocated to SC plus
non-penetrating acupuncture
(n = 42) 
• Received allocated intervention,
   n = 36
• Randomised in error, n = 1
• Did not attend treatment
   sessions, n = 3
• Attended but did not receive
   acupuncture treatment, n = 2 
Completed 8-week follow-up
(n = 32) 
• Lost to follow-up, n = 9
• Withdrew consent, n = 1
   (declined to continue to
   participate)
Completed 8-week follow-up
(n = 32) 
• Lost to follow-up, n = 10
• Withdrew consent, n = 0
Completed 8-week follow-up 
(n = 27) 
• Lost to follow-up, n = 17
• Withdrew consent, n = 2
   (declined to continue to
   participate, randomised in error)
Analysed for key clinical outcome
measures (n = 32 for all
key outcomes)
Analysed for key clinical outcome
measures (n = 27 for all
key outcomes)
FIGURE 6 The CONSORT (Consolidated Standards of Reporting Trials) diagram for the EASE Back pilot trial.
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TABLE 11 Baseline characteristics of pilot trial participants
Baseline characteristic SC (n= 41)
SC+ true acupuncture
(n= 42)
SC+non-penetrating
acupuncture (n= 41)
Age (years), mean (SD) 27.8 (5.4) 28.1 (5.1) 29.0 (5.3)
Highest qualification: degree/postgraduate, n (%) 13 (31.7) 14 (33.3) 18 (43.9)
Gestation weeks at inclusion: > 24, n (%) 17 (41.5) 18 (42.9) 18 (42.9)
Married, n (%) 16 (39.0) 19 (45.2) 19 (46.3)
No. of children, n (%)
0 16 (39.0) 20 (47.6) 14 (34.2)
1 17 (41.5) 13 (31.0) 17 (41.5)
2 or more 8 (19.5) 9 (21.4) 10 (24.4)
Working, n (%) 28 (68.3) 27 (64.3) 32 (78.1)
Physical demands of current/most recent paid job:
heavy/very heavy, n (%)
12 (29.3) 13 (32.5) 11 (26.8)
Taken time off during the current pregnancy
because of back pain,a n (%)
8 (28.6) 9 (33.3) 15 (46.9)
Back pain interference with performance at work
(0–10 NRS),a,b mean (SD)
5.0 (2.5) 4.9 (2.6) 5.0 (3.1)
Work satisfaction (0–10 NRS),a,c mean (SD) 6.6 (2.7) 5.4 (1.9) 6.6 (2.3)
Pain location (manikin), n (%)
Low back pain only 7 (17.1) 9 (21.4) 7 (17.1)
Low back pain with anterior PGP 8 (19.5) 6 (14.3) 4 (9.8)
Low back pain with anterior PGP and
pain elsewhere
10 (24.4) 14 (33.3) 12 (29.3)
Low back pain and pain elsewhere 16 (39.0) 13 (31.0) 18 (43.9)
Duration of pain episode: > 6 weeks, n (%) 23 (56.1) 20 (47.2) 25 (61.0)
Pain severity (mean score of three NRSs),
mean (SD)
4.5 (1.6) 4.5 (1.5) 4.6 (1.8)
Pain intensity before going to bed, mean (SD) 6.8 (1.9) 6.8 (1.8) 7.0 (2.2)
Woken up most/every night by pain, n (%) 16 (39.0) 15 (35.7) 17 (41.5)
ODI score (0–100),d mean (SD) 34.8 (11.2) 32.9 (13.7) 35.7 (13.6)
ODI score (categorised), n (%)
Minimal disability (0–20%) 5 (12.2) 8 (19.0) 4 (9.8)
Moderate disability (21–40%) 24 (58.5) 20 (47.6) 23 (56.1)
Severe disability (40–60%) 12 (29.3) 13 (31.0) 11 (26.8)
Crippled (61–80%) 0 (0.0) 1 (2.4) 3 (7.3)
PGQ score (0–100),e mean (SD)
Total 56.9 (16.0) 48.7 (17.2) 54.2 (17.3)
Activity subscale 54.6 (17.0) 46.7 (18.1) 52.7 (18.1)
Symptom subscale 65.4 (17.1) 56.1 (17.2) 59.3 (19.9)
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Process outcomes (recruitment, retention, blinding)
Recruitment
Methods of raising local awareness of the trial
Multiple approaches of raising awareness about the EASE Back pilot trial among potentially eligible women
in the local area were pilot tested. Women contacting the research office about the trial were asked how
they had come to know about the study. Recruitment lasted for 6 months (27 weeks) from April to
October 2013. Flyers and posters were used throughout the entire recruitment period, while the bus
advertising campaign ran for 8 weeks (from week 19 to week 25 of the recruitment period). The internet
website was available for the entire recruitment period with the addition of a YouTube video about the
study from week 9. The radio and newspaper advertising campaign varied; some were one-off short radio
advertisements and interviews with the trial PI (NF) and others were in the form of radio infomercials
(running many times per day on a local commercial radio station, for 3 consecutive days, in week 25 of
recruitment). We also published articles in a local newspaper on two occasions in weeks 7 and 12 of the
recruitment period. These articles were linked to the newspaper’s website, where interested women
could obtain further information. There was also an advertisement in a local magazine in week 11 of the
recruitment period. Table 12 summarises these methods, the number of women identified through them
and the number subsequently recruited into the pilot trial. Almost half of the women identified from
the local awareness-raising campaign came to know about the study through flyers and posters, and the
next most successful method was the advertisements on local radio or in local newspapers.
TABLE 11 Baseline characteristics of pilot trial participants (continued )
Baseline characteristic SC (n= 41)
SC+ true acupuncture
(n= 42)
SC+non-penetrating
acupuncture (n= 41)
Pre-pregnancy BMI, n (%)
Normal/underweight 16 (40.0) 19 (47.5) 12 (31.6)
Overweight 8 (20.0) 11 (27.5) 17 (44.7)
Obese/morbidly obese 16 (40.0) 10 (25.0) 9 (23.7)
Taking prescribed medication, n (%) 7 (17.1) 5 (11.9) 5 (12.2)
Treatment preferences: yes, n (%) 10 (24.4) 8 (19.1) 10 (24.4)
SF-12 – Physical Component Scale score,
mean (SD)f
36.4 (7.6) 38.2 (8.0) 37.0 (9.7)
SF-12 – Mental Component Scale score,
mean (SD)f
46.6 (10.1) 44.7 (12.1) 48.1 (11.7)
Self-assessed P4 test: familiar pain produced or
increased in lumbosacroiliac area,
g n (%)
25 (75.8) 26 (81.3) 22 (66.7)
Bridging with extension of leg: familiar pain
produced or increased in lumbosacroiliac area,
g
n (%)
25 (89.3) 24 (80) 23 (82.1)
Positive on both P4 test and bridging test, n (%) 17 (41.5) 21 (50.0) 16 (39.0)
a Applies only to those in a paid job.
b Higher mean score implies more interference.
c Higher mean score implies more satisfaction.
d The ODI has 10 sections with scores ranging from 0 to 5 in each section. Item scores are summed and transformed to
yield a score of 0 to 100, where 100 is the worst possible score.
e The PGQ items are scored on a 4-point scale and item scores are summed and transformed to yield a score of 0 to 100,
where a score of 100 is the worst possible score
f The SF-12 scales are based on a normalised general population average score of 50 with a SD of 10.
g Percentage applies to those who were able to perform the test.
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Success of six methods of identification and recruitment
The number and proportion of women identified and recruited through the six methods described in
Recruitment methods and procedures are presented in Table 13. The brief screening questionnaire for
back pain given to women as they attended their routine 20-week ultrasound scan appointment was the
most successful method, followed by community midwives providing women with an EASE Back study
card and women self-referring following the local awareness-raising efforts.
Recruitment figures over time
Recruitment is summarised in Table 14. The average weekly recruitment was five women per week
(range 0–12). The lowest recruitment (no participants) was in the week of the height of the summer
holiday period and highest recruitment (12 participants) was in the week following the radio infomercials
on Signal Radio. Estimated (180 women over 5 months) compared with observed recruitment (125 women
over 6 months) is presented in Figure 7.
Reasons for ineligibility
From 388 women we contacted, 280 were potentially eligible at initial screens and 108 ineligible. The
reasons for ineligibility are presented in Table 15. The most common were previous acupuncture (26 out of
105, 25%), previous pre-term delivery (12%) and the woman being registered at a GP practice outside the
included list of practices (11%). The number and proportion of eligible women who declined to participate
are presented in Table 13.
Generalisability of the sample
Table 16 compares key baseline characteristics [age and index of multiple deprivations (from postcodes)]
captured from the anonymised data on women who were ineligible or declined participation with the
EASE Back trial participants. There was reasonable overall comparability in these key baseline characteristics.
Retention
The 8-week follow-up rate was 74%. Table 17 presents the details of the follow-up responses (including
number of responses after initial mailing, reminder mailing and MDC over the telephone) both overall and
for each of the three treatment arms. There was a slight imbalance in the follow-up rates among the
treatment arms, with the SC plus non-penetrating acupuncture arm having the lowest response rate at
8 weeks (66%). Only 14% of the women had given birth by the time they returned the 8-week follow-up
questionnaire. Three participants withdrew from the trial: one in the SC arm (declined to continue to
participate) and two in the SC plus non-penetrating acupuncture arm (one was subsequently ineligible as
she had been consented in error; one declined to continue to participate).
TABLE 12 Summary of methods of local awareness raising
Awareness-raising method Identified, n (%)a Recruited, n (%)b
Flyers or posters 25 (48.1) 12 (48.0)
Advertisements on local radio/newspapers 18 (34.6) 5 (27.8)
Internet websitec 2 (3.9) 1 (50.0)
Advertisements on local buses 3 (5.8) 3 (100.0)
Word of mouth 4 (7.7) 3 (75.0)
Total 52 24
a Column percentage with the overall total as the denominator.
b Row percentage with the number identified as the denominator.
c Includes study-specific website and YouTube video posted on local media websites.
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TABLE 14 Summary of weekly recruitment
Week starting Number recruited Participant accrual
22 April 1 1
29 April 2 3
6 May 6 9
13 May 2 11
20 May 3 14
27 May 4 18
3 June 3 21
10 June 4 25
17 June 7 32
24 June 6 38
1 July 7 45
8 July 3 48
15 July 6 54
22 July 5 59
29 July 5 64
5 August 6 70
12 August 4 74
19 August 3 77
26 August 0 77
2 September 6 83
9 September 6 89
16 September 5 94
23 September 5 99
30 September 5 104
7 October 6 110
14 October 12 122
21 October 3 125
0
25
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Recruitment period (months)
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FIGURE 7 Expected vs. observed recruitment.
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TABLE 15 Reasons for ineligibility
Reason Frequencya % of responsesb % of casesc
Previous acupuncture 26 20.2 24.8
Previously given birth before 37 weeks 13 10.1 12.4
GP practice not in eligible list for the trial 11 8.5 10.5
No current back pain 9 7.0 8.6
Recurrent previous miscarriage 9 7.0 8.6
Pregnancy classified as high risk 9 7.0 8.6
High risk of pre-term delivery 7 5.4 6.7
Previous surgery to uterine cervix 6 4.7 5.7
Not between 13 and 31 completed weeks of gestation 5 3.9 4.8
Unusually high fear or needles 5 3.9 4.8
Pregnant with more than one baby 4 3.1 3.8
Not planning to give birth at UHNS 4 3.1 3.8
Already under care of a physiotherapist 4 3.1 3.8
Back pain not caused/worsened by pregnancy 3 2.3 2.9
Previous surgery to spine or pelvis 3 2.3 2.9
Communication problems 3 2.3 2.9
Aged under 18 years 2 1.6 1.9
Has ruptured membranes 2 1.6 1.9
Not eligible pain location 1 0.8 1.0
Abnormalities with uterus 1 0.8 1.0
Antiphospholipid syndrome or lupus anticoagulant 1 0.8 1.0
Problem with blood clotting 1 0.8 1.0
Total 129 – –
a Multiple responses possible as some women were ineligible for more than one reason.
b For ‘% of responses’, the denominator is 129 (total number of all responses).
c For ‘% of cases’, the denominator is 105 (total number of ineligible women).
TABLE 16 Baseline characteristics of trial participants and non-participants
Key characteristic Consent (n= 125)
Potentially eligible but did
not consent (n= 157) Non-participantsa (n= 263)
Age (years), mean (SD) 28.3 (5.3) 27.1 (6.5) 27.9 (6.2)
Deprivation tertile, n (%)
Least deprived third 48 (40.3) 60 (39.5) 76 (29.6)
Medium 38 (31.9) 49 (32.2) 88 (34.2)
Most deprived third 33 (27.7) 43 (28.3) 93 (36.2)
a Includes all women who were assessed for eligibility but were not recruited into the trial because either they were not
eligible or they were eligible but declined to participate.
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Blinding
During MDC via the telephone, three cases of unblinding out of the 70 MDC calls conducted were recorded
between the participant and the research nurse collecting data. All three had been randomised to receive
SC plus true acupuncture.
Results from audio-recordings of screening/consent meetings
The face-to-face meeting with a research midwife or nurse comprised a full eligibility screen and informed
consent (followed by baseline data collection and randomisation), and we audio-recorded a sample of
30 of these meetings. The section Audio-recordings of eligibility and consent meetings previously described
the methods. The average length of the recordings covering the discussion about the trial between the
participant and midwife/nurse was 12 minutes. All audio files were transcribed and fully anonymised.
Given the brevity of the recordings and early data saturation, it was not possible to apply the same
analysis framework as in phase 1 (i.e. an iterative, constructionist grounded theory framework60). Instead,
a simplified constant comparative approach within and across cases was undertaken,84 with relevant data
for comparison identified as those that were pertinent to the research objectives.
The research midwives and nurses adhered well to the processes of information giving and eligibility
screening; they could clearly be heard reading through the PIL and the eligibility criteria in line with the
protocol, and from the earliest interviews it was clear that women had very few questions about the trial
and those that were asked were consistent with those identified through the qualitative work in phase 1
(i.e. questions around positioning for treatment, whether or not the needles would be painful, the
geographical location of treatment centres and the length of time needed for treatment). However, given
the brevity of the recordings, it was decided to continue data collection (from the 10 originally foreseen)
to 30 to ensure saturation had indeed been reached.
Treatment delivery and adherence
Case report forms were analysed to describe the interventions delivered (Table 18). In total, 4 of the
41 participants (10%) randomised to SC accessed face-to-face physiotherapy. Eight participants
randomised to SC plus true acupuncture and four in the SC plus non-penetrating acupuncture arm
failed to attend for any treatment and therefore received no acupuncture, and 21 (62%) and 29 (76%)
received the number of treatment sessions specified in the protocol (between six and eight treatment
sessions) for the arms respectively.
TABLE 17 Response rates at 8-week follow-up
Mailing
Responded, n (%)
SC (n= 40)a SC+ TA (n= 42) SC+NPA (n= 41) Total (n= 123)a
Initial mailing 14 (35.0) 9 (21.4) 12 (29.3) 35 (28.5)
Reminder mailing 10 (11.5) 18 (54.5) 10 (34.5) 38 (20.5)
MDCb 8 (34.8) 5 (20.0) 5 (22.7) 18 (25.7)
Response rate 32/40 (80.0) 32/42 (76.2) 27/41 (65.9) 91/123 (74.0)
Number who had given birth by time
of response
7 (21.9) 4 (12.5) 2 (7.4) 13 (14.3)
NPA, non-penetrating acupuncture; TA, true acupuncture.
a Two women had withdrawn from the trial by the time of their 8-week follow-up and so were not mailed the
follow-up questionnaire.
b A number of women who were phoned for MDC then returned full questionnaires.
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TABLE 18 Summary of treatments delivered
Treatment delivered
Treatment arm
SC (n= 41) SC+ TA (n= 42) SC+NPA (n= 42)
Participants
Number of participants who booked appointment to see
a physiotherapist
4 37 41
Total number of participants who attended at least one treatment
session with a physiotherapist
4 34 38
Total number of participants who received acupuncture treatment 0 33 36
Number of treatment sessions provided (per participant),
median (IQR)
2 (1–4) 6 (3–7) 6 (6–7)
Number of treatment sessions per participant (categorised), n (% of number of participants seen)
1–5 4 (100) 13 (38.2) 9 (23.7)
6–8 0 (0.0) 17 (50.0) 27 (71.1)
9–11 0 (0.0) 4 (11.8) 2 (5.3)
Number of treatments per participant in line with protocols,a
n (% of number of participants)
2 (50.0) 17 (50.4) 27 (71.1)
Treatment sessions: total number planned 13 240 273
Total number of treatment sessions provided, n (% of
total planned)
9 (69.2) 189 (78.8) 224 (82.1)
Total number of sessions that were not attended – DNAs/UTAs,
n (% of total planned)
4 (30.8) 51 (21.3) 49 (17.9)
Total number of sessions attended where acupuncture was
provided, n (% of attended)
0 (0.0) 163 (86.2) 197 (87.9)
Treatment content across all sessions, % (SD)
Assessment/reassessment 100 (0) 91.8 (17.7) 80.6 (25.4)
Education and advice 100 (0) 81.4 (23.4) 73.2 (25.7)
Tubigrip provided with instruction 54.2 (41.7) 15.2 (25.5) 9.6 (11.6)
Pelvic support belt provided with instruction 50.0 (57.7) 4.5 (8.1) 5.4 (17.1)
Heat therapy used in clinic 0 (0.0) 5.4 (11.6) 3.9 (8.1)
Massage therapy used in clinic 0 (0.0) 5.4 (12.0) 3.9 (8.1)
Manual therapy used in clinic 0 (0.0) 0 (0.0) 2.1 (9.2)
Supervised exercises in clinic 6.3 (12.5) 24.1 (26.1) 18.1 (24.7)
Home exercises given/reviewed 83.3 (33.3) 39.7 (29.9) 35.2 (29.9)
Issued walking aids 31.3 (47.3) 1.9 (8.8) 2.4 (6.6)
continued
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The number of treatments that participants received was lower than expected, mainly as a result of the
challenges that prevented women attending for their allocated treatment. The did-not-attend rates ranged
from 18% to 31%. While the average number of treatment sessions in both arms receiving acupuncture
was six (in line with the specified protocols), 13 (38%) in the SC plus true acupuncture arm and nine
(23.7%) in the SC plus non-penetrating acupuncture arm attended fewer than six sessions.
In terms of content of treatment, assessment/re-assessment and advice were provided at the majority of
treatment sessions. The very small number of participants accessing face-to-face physiotherapy in the SC arm
was expected but makes comparisons across the treatment arms difficult. The use of pelvic supports (belts or
Tubigrip) and walking aids appears to have been more frequent in the SC arm. Exercise approaches were
commonly used across all treatment arms, mostly a home exercise programme that focused on muscle
strengthening of core trunk muscles and pelvic floor muscles as well as pelvic tilting exercises. Overall, the
contents of treatment were delivered broadly in line with the specified protocols.
A pain severity NRS score recorded at the end of each treatment session indicated that, on average, those
randomised to either of the acupuncture arms reported much lower pain after treatment than those in
the SC only arm.
Table 19 shows the acupuncture points used in both the true acupuncture and non-penetrating
acupuncture treatment arms. Both of the acupuncture protocols were delivered as intended. In the
true acupuncture treatment arm, BL25, BL26, BL31 and BL54 (all points in the area of the lower back)
were the most frequently used local points. Distal points were used much less commonly. In the
non-penetrating acupuncture arm, the local points specified in the protocol were used in the large
majority of sessions.
TABLE 18 Summary of treatments delivered (continued )
Treatment delivered
Treatment arm
SC (n= 41) SC+ TA (n= 42) SC+NPA (n= 42)
Exercise approaches across all sessions, % (SD)
Transversus abdominus muscle strengthening 43.8 (51.5) 23.4 (28.1) 19.7 (25.0)
Pelvic floor muscle strengthening 43.8 (51.5) 23.4 (28.1) 19.7 (25.0)
Pelvic tilt exercise 52.1 (44.3) 21.5 (16.9) 15.8 (17.5)
Gluteal muscle strengthening 27.1 (35.6) 27.6 (25.1) 20.9 (21.1)
Lower back/pelvic stretching 12.5 (25.0) 12.9 (18.2) 6.0 (11.0)
Advice/signposting to general physical activity opportunities 50 (57.7) 6.1 (17.9) 10.3 (20.9)
Other exercisesb 12.5 (25.0) 13.7 (24.8) 12.9 (21.4)
Pain severity score after treatment (0–10), mean (SD) 6.0 (0.8) 1.9 (2.0) 2.3 (2.3)
DNA, did not attend; NPA, non-penetrating acupuncture; TA, true acupuncture; UTA, unable to attend.
a Two to four sessions for SC, six to eight for SC+ acupuncture.
b Other exercises included advice on aquanatal classes, increase repetitions, correcting standing posture, gym ball, thoracic
rotation, lumbar spine extension, obliques exercises and reviewing exercises in the EASE Back study booklet.
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TABLE 19 Acupuncture points used
Acupuncture point
Treatment sessions Participantsa
SC+ TA (Na,b= 163) SC+NPA (Na,b= 197)
SC+ TA
(N= 33)c
SC+NPA
(N= 36)c
Left, n (%)c Right, n (%) Left, n (%) Right, n (%) n (%) n (%)
Local points
BL23 50 (30.7) 51 (31.3.0) – – 19 (57.6) –
BL24 89 (45.4) 91 (55.8) – – 23 (69.7) –
BL25 155 (95.1) 155 (95.1) – – 33 (100) –
BL26 155 (95.1) 156 (95.7) 197 (100) 196 (99.5) 33 (100) 36 (100)
BL27 93 (42.9) 92 (56.4) 196 (99.5) 195 (99.0) 22 (66.7) 36 (100)
BL28 38 (23.3) 38 (23.3) – – 9 (27.3) –
BL54 128 (78.5) 134 (82.2) 195 (99.0) 196 (99.5) 28 (84.9) 36 (100)
BL31 100 (61.4) 100 (61.4) – – 25 (75.7) –
BL32 46 (28.2) 46 (28.2) – – 13 (39.4) –
BL33 20 (12.3) 20 (12.3) – – 4 (12.1) –
GB30 67 (41.1) 78 (47.9) 173 (87.2) 192 (97.7) 26 (78.8) 36 (100)
HJJ L4 35 (21.5) 35 (21.5) – – 11 (33.3) –
HJJ L5 33 (20.3) 33 (20.3) – – 10 (30.3) –
Distal points
GB34 5 (3.1) 37 (22.7) – – 8 (24.2) –
ST36 0 (0.0) 7 (4.3) – – 1 (3.0) –
LR3 9 (5.5) 19 (11.7) – – 8 (24.2) –
LI4 15 (9.2) 21 (12.9) – – 8 (24.2) –
BL60 42 (25.8) 43 (26.9) – – 21 (63.6) –
BL62 1 (0.6) 19 (11.7) – – 5 (15.2) –
BL, bladder; GB, gall bladder; HJJ, Huato Jia Ji; LI, large intestine; LR, liver; ST, stomach.
a Points which were used when patients had treatments; points (left or right) per participant in any of the sessions;
b The denominator is the total number of treatment sessions attended where acupuncture treatment was provided;
c The denominator is the total number of participants who received acupuncture treatment; a dash (–) means not
applicable for that treatment arm.
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Needle or de-qi sensations
Participants were asked about needling (de-qi) sensations experienced at each treatment session. de-qi
sensations such as an ache, a warmth, tingling and pressure were reported in the large majority (94%) of
true acupuncture treatment sessions and also in 31% of the non-penetrating acupuncture treatment
sessions (Table 20).
TABLE 20 Reported needling sensations
Needling sensation
Treatment arm
SC+ TA (number of treatment
sessions with acupuncture= 163)
SC+NPA (number of treatment
sessions with acupuncture= 197)
Number of sessions in which de-qi
sensations were reported, n (%)
153 (93.9) 61 (31.0)
Sensations described during acupuncture n (% of number of sessions in which de-qi sensation was achieved)
Ache 66 (43.1) 14 (23.0)
Aching in the back 35 (22.9) 7 (11.5)
Warmth 29 (19.0) 13 (21.3)
Tingle 26 (17.0) 12 (19.7)
Sharpness 23 (15.0) 7 (11.5)
Tickle 11 (7.2) 0 (0.0)
Pressure 11 (7.2) 0 (0.0)
Numbness 4 (2.6) 9 (14.8)
Heaviness 4 (2.6) 3 (4.9)
Soreness 3 (2.0) 2 (2.8)
Sweaty palms 2 (1.3) 1 (1.6)
An ‘awareness’ 0 (0.0) 1 (1.6)
Twinge 0 (0.0) 0 (0.0)
Othera 35 (22.9) 10 (16.4)
a Other de-qi sensations included dullness, relaxed, tenderness, tightness, stinging, feeling strange and bruising pain.
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Patient-reported outcomes
Exploratory analysis of key clinical outcomes
The descriptive statistics (mean and SD) of the key clinical outcomes (pain and disability outcomes) at
baseline and the 8-week follow-up are presented in Table 21. Table 22 shows the differences in the mean
scores from baseline. Overall, there was a reduction in pain and disability scores from baseline to the
8-week follow-up. A greater reduction in score was observed in the two arms randomised to receive SC
plus acupuncture than in the arm receiving SC alone.
Table 23 summarises the differences in mean scores among the treatment arms (with 95% CI) adjusted
for baseline scores and other baseline covariates obtained from multiple linear regression. We do not
place undue significance on these results since a formal sample size calculation was not carried out;
rather we focus on CI estimation. As expected, the CIs are quite imprecise. Several comparisons have been
made: SC alone versus SC plus true acupuncture; SC alone versus SC plus non-penetrating acupuncture;
and SC plus true acupuncture versus SC plus non-penetrating acupuncture. These comparisons indicated
some between-group differences in physical function (mean PGQ) and pain severity between SC alone
and SC plus true acupuncture and between SC alone and SC plus non-penetrating acupuncture but not
between SC plus true acupuncture and SC plus non-penetrating acupuncture.
TABLE 21 Descriptive analysis of key clinical outcomes
Key outcome
Baseline (n= 124) 8-week follow-up (n= 91)
SC SC+ TA SC+NPA SC SC+ TA SC+NPA
ODI score (0–100), mean (SD) 34.8 (11.2) 32.9 (13.7) 35.7 (13.6) 32.2 (18.8) 21.3 (17.7) 26.2 (14.4)
PGQ score (0–100), mean (SD)
Total 56.9 (16.0) 48.7 (17.2) 54.2 (17.3) 52.2 (28.4) 31.9 (21.8) 40.3 (21.8)
Activity subscale 54.6 (17.0) 46.7 (18.1) 52.7 (18.1) 51.5 (29.4) 31.3 (22.1) 40.0 (23.4)
Symptom subscale 65.4 (17.1) 56.1 (17.2) 59.3 (19.9) 54.4 (26.5) 33.8 (22.4) 40.2 (20.2)
Pain severity (mean score of
three NRSs)
4.5 (1.6) 4.5 (1.5) 4.6 (1.8) 4.2 (2.2) 2.4 (2.2) 2.2 (1.5)
NPA, non-penetrating acupuncture; TA, true acupuncture.
TABLE 22 Differences in mean scores from baseline
Key outcome SC (n= 32) SC+ TA (n= 32) SC+NPA (n= 27)
ODI score, mean difference (95% CI) 1.9 (–5.1 to 8.8) 7.8 (1.6 to 14.0) 7.7 (2.9 to 12.5)
PGQ score, mean difference (95% CI)
Total 5.1 (–5.1 to 15.2) 14.0 (6.9 to 21.2) 11.6 (5.2 to 18.0)
Activity subscale 4.1 (–6.4 to 14.6) 12.8 (5.4 to 20.3) 10.1 (3.5 to 16.8)
Symptom subscale 8.6 (–1.9 to 19.0) 18.8 (11.1 to 26.5) 17.8 (9.7 to 25.8)
Pain severity (mean score of three NRSs) 0.2 (–0.8 to 1.2) 1.8 (1.1 to 2.5) 2.1 (1.4 to 2.9)
NPA, non-penetrating acupuncture; TA, true acupuncture.
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TABLE 23 Estimates of treatment effect
Outcome
Adjusted for baseline scores only
Adjusted for baseline scores and
baseline covariatesa
Marginal mean Adjusted mean difference (95% CI)
Marginal
mean
Adjusted mean
difference (95% CI)
Marginal
mean
Adjusted mean
difference (95% CI)
SC vs. SC plus acupuncture arms
ODI score (0–100) – 31.2 – –
SC (reference) 23.2 –8.0 (–16.1 to 0.1) 31.3 –
SC+ TA 25.2 –5.9 (–14.2 to 2.4) 23.3 –8.0 (–16.2 to 0.2)
SC+NPA – – 25.0 –6.3 (–14.7 to 2.3)
PGQ total score (0–100) – 48.3 – –
SC (reference) 35.8 –12.6 (–23.8 to –1.3) 48.3 –
SC+ TA 40.1 –8.2 (–19.6 to 3.1) 36.7 –11.6 (–22.9 to –0.4)
SC+NPA – – 39.0 –9.3 (–20.7 to 2.0)
PGQ activity subscale score – 47.6 – –
SC (reference) 35.3 –12.3 (–23.9 to –0.8) 47.7 –
SC+ TA 39.9 –7.7 (–19.4 to 4.0) 36.2 –11.5 (–22.9 to –0.4)
SC+NPA – – 38.6 –9.1 (–20.9 to 2.6)
PGQ symptom subscale score – 52.0 – –
SC (reference) 36.2 –15.8 (–27.2 to –4.5) 52.4 –
SC+ TA 40.1 –11.9 (–23.4 to –0.3) 36.0 –16.4 (–27.8 to –5.0)
SC+NPA – – 40.0 –12.4 (–24.1 to –0.7)
Pain severity (mean score of
three NRSs)
– – 4.2 –
SC (reference) 2.5 –1.8 (–2.7 to –0.8) 4.1 –
SC+ TA 2.2 –2.0 (–3.0 to –1.0) 2.6 –1.6 (–2.5 to –0.6)
SC+NPA – – 2.2 –2.0 (–3.0 to –1.0)
TA vs. NPA arms
ODI score (0–100) – 23.2 – –
SC+ TA (reference) 25.2 2.1 (–6.3 to 10.5) 23.3 –
SC+NPA – – 25.0 1.8 (–6.8 to 10.3)
PGQ total score (0–100) – 35.8 – –
SC+ TA (reference) 40.1 4.3 (–7.0 to 15.6) 36.7 –
SC+NPA – – 39.0 2.6 (–8.9 to 14.2)
PGQ activity subscale score 35.3 – – –
SC+ TA (reference) 39.9 4.6 (–7.1 to 16.3) 36.2 –
SC+NPA – – 38.6 2.3 (–9.4 to 14.1)
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Estimates of other health outcomes
Table 24 summarises participants’ global assessment of change at follow-up compared with baseline.
About half (45 out of 91) reported complete recovery or much improvement. However, this proportion
was much lower in the SC arm (6 out of 32, 19%) the SC plus true acupuncture (21 out of 32, 66%) or
SC plus non-penetrating acupuncture (18 out of 27, 67%) arm.
Table 25 summarises other participants’ outcomes at the 8-week follow-up. Overall, the majority (78 out
of 91, 86%) of women were still pregnant by response to follow-up, with most more than 33 weeks
pregnant, and this was fairly balanced across the treatment arms. There was substantial reduction in pain
intensity before going to bed and in the proportion of women woken up every/most nights at 8 weeks
compared with baseline in those randomised to SC plus acupuncture but not in the SC alone arm. Overall,
quality of life did not improve substantially at 8 weeks but there was marked improvement in physical
health (measured using the physical component scale of the SF-12) in the SC plus non-penetrating
acupuncture arm (–5.7, 95% CI –10.7 to –0.7).
TABLE 23 Estimates of treatment effect (continued )
Outcome
Adjusted for baseline scores only
Adjusted for baseline scores and
baseline covariatesa
Marginal mean Adjusted mean difference (95% CI)
Marginal
mean
Adjusted mean
difference (95% CI)
Marginal
mean
Adjusted mean
difference (95% CI)
PGQ symptom subscale score – 36.2 – –
SC+ TA (reference) 40.1 3.9 (–7.5 to 15.5) 36.0 –
SC+NPA – – 40.0 4.0 (–7.6 to 15.6)
Pain severity (mean score of
three NRSs)
– – 2.4 –
SC+ TA (reference) 2.2 –0.2 (–1.3 to 0.78) 2.6 –
SC+NPA 2.2 –0.2 (–1.3 to 0.78) 2.2 –0.4 (–1.4 to 0.6)
NPA, non-penetrating acupuncture; TA, true acupuncture.
TABLE 24 Participants’ global assessment of overall change from baseline (n= 91)
Change since baseline
Overall SC SC+ TA SC+NPA
n % n % n % n %
Completely recovered 6 6.6 1 3.1 4 12.5 1 3.7
Much improved 39 42.9 5 15.6 17 53.1 17 63.0
Somewhat improved 17 18.7 8 25.0 5 15.6 4 14.8
Same 7 7.7 2 6.3 1 3.1 4 14.8
Somewhat worse 11 12.1 8 25.0 2 6.3 1 3.7
Much worse now 11 12.1 8 25.0 3 9.4 0 0.0
Total 91 – 32 – 32 – 27 –
Completely recovered or much improved 45 49.5 6 18.8 21 65.6 18 66.7
NPA, non-penetrating acupuncture; TA, true acupuncture.
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Health-care use, treatment credibility and satisfaction with care
Table 26 presents use of other health-care services and self-reported satisfaction with care for the
73 participants who completed the full 8-week follow-up questionnaire. Overall, fewer than half of the
participants (31 out of 73) had used any over-the-counter medicines, treatments or appliances (e.g. TENS
machine, maternity belt), and this number was slightly lower (8 out of 22) among women in the SC plus
non-penetrating acupuncture arm. Use of prescribed medicines, treatments or appliances and any
other NHS or private health care (e.g. inpatient stays, physiotherapy) was generally low, and was lowest
in the SC plus non-penetrating acupuncture treatment arm (see Table 26). No participants had attended
either the NHS or private health-care services for investigation or treatments (e.g. radiography, surgery,
injection) for back pain within the 8-week follow-up period.
In terms of treatment credibility, 60% (43 out of 71) of participants were very or quite confident that the
information or treatment they received helped their back problem. In total, 69% (49 out of 71) reported
they would be very or quite confident in recommending the information/treatment to a friend who
suffered from a similar problem; however, the proportions rating treatment credibility as high were much
lower in the SC alone arm (7 out of 24, 29%). Levels of satisfaction with the treatment package received
and the results from treatment were high overall (65%) but lower in the SC arm (17%) than in the SC plus
true acupuncture (85%) and SC plus non-penetrating acupuncture (96%) arms.
TABLE 25 Results of other health outcomes
Key characteristics SC (n= 32) SC+ TA (n= 32) SC+NPA (n= 27)
Taken at both baseline and
follow-up, n
24 27 22
Pain intensity before going
to bed, mean (SD)
6.5 (2.8) 3.7 (2.8) 3.5 (2.3)
Woken up most/every night by
back pain, n (%)
9 (37.5) 4 (14.8) 1 (4.6)
SF-12 – Physical Component
Scale, mean score(SD)a
36.5 (10.6) 41.4 (11.5) 43.3 (9.5)
SF-12 – Mental Component
Scale, mean score (SD)a
49.1 (8.1) 48.4 (13.8) 50.2 (12.3)
Change from baseline
(baseline to 8-week score)
Pain intensity before going to
bed, mean (95% CI)
0.04 (–1.5 to 1.6) 2.7 (1.4 to 4.0) 3.2 (1.8 to 4.5)
Woken up most/every night by
back pain, percentage difference
(95% CI)
1.5% (–22.9% to 25.9%) 20.9% (1.2% to 40.6%) 36.9% (19.5% to 54.3%)
SF-12 – Physical Component
Scale, mean score difference
(95% CI)a
–0.3 (–5.5 to 4.9) –2.8 (–6.2 to 0.6) –5.7 (–10.7 to –0.7)
SF-12 – Mental Component
Scale, mean score difference
(95% CI)a
0.03 (–4.1 to 4.1) –0.2 (–4.2 to 3.9) 1.2 (–5.3 to 7.7)
a SF-12 scales are based on a ‘normalised’ general population average of score of 50 with a SD of 10.
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Responses to open question on follow-up questionnaire
In total, 14 women allocated to SC alone, 18 allocated to SC plus true acupuncture and 12 allocated to SC
plus non-penetrating acupuncture provided responses to the open question on the follow-up questionnaire
about their overall experience. A summary of the responses with examples is given.
Of those in SC alone, eight women expressed negative views of the value of the SC package they received
in the trial, while others took the opportunity to explain the impact of back pain on their pregnancy and
labour. Examples of comments include:
I don’t feel I benefited at all from the standard care plan and the booklet showed me nothing that
I wasn’t already aware of. I do feel the acupuncture would have been better.
The EASE Back study did not help with my back pain at all, and I ended up finishing work sooner than
I wanted to.
and
The back pain experienced during labour was unbearable and worse than my contractions, so resulted
in me having an epidural for my back pain.
TABLE 26 Health-care use, treatment credibility and satisfaction with care
Treatment arm
SC (n= 24) SC+ TA (n= 27) SC+NPA (n= 22)
Health-care use, n (%)
Over-the-counter medicines, treatments or appliances for back
pain (n= 73)
12 (50.0) 11 (40.7) 8 (36.4)
Prescription of medicines or appliances for back pain (n= 72) 6 (26.1) 5 (18.5) 1 (4.6)
Attended any other NHS or private health care because of back
problem (n= 73)
7 (29.2) 7 (25.9) 2 (9.1)
Attended NHS or private health care for investigation or
treatments for back pain (n= 72)
0 (0.0) 0 (0.0) 0 (0.0)
Treatment credibility, n (%)
Confidence with the information/treatment received: very/quite
confident (n= 71)
3 (13.0) 22 (81.5) 18 (85.7)
Confidence in recommending the information/treatment:
very/quite confident (n= 71)
7 (29.2) 22 (88.0) 20 (90.9)
How logical the information/treatment seemed: very/quite
logical (n= 71)
13 (54.2) 21 (84.0) 20 (90.9)
Success of information/treatment in alleviating other complaints:
very/quite successful (n= 71)
3 (12.5) 19 (76.0) 16 (72.3)
Satisfaction with care, n (%)
Satisfaction with the treatment package received: very/quite
satisfied (n= 72)
4 (16.7) 22 (84.6) 21 (95.5)
Satisfaction with results from treatment: very/quite
satisfied (n= 72)
4 (16.7) 22 (84.6) 21(95.5)
NPA, non-penetrating acupuncture; TA, true acupuncture.
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From those receiving SC plus true acupuncture, the comments were overwhelmingly positive (13 of the
18 comments suggested positive experiences). Examples include:
I feel that I have received excellent treatment during this study. I do believe that the acupuncture has
really aided my back pain and am certainly in a lot less discomfort at this stage in my pregnancy.
The acupuncture has allowed me to carry on with daily activities (especially those at night time) with
less pain. I would recommend this treatment to others and would consider it again to treat any
other conditions.
I have really benefited from taking part in this study. The treatment and advice given by the
physiotherapist have dramatically improved my pain during my pregnancy and I will continue to use
some of the techniques afterwards. I really hope this study continues and that more women are
offered such treatment. Thank you!
The care received has been excellent despite my initial doubts, it eased my pain an awful lot.
Two comments suggested that participants wanted more acupuncture treatment than they were offered in
the study; for example:
I think the course length can be extended to 12 weeks as the more acupuncture done, the pain
reduces a lot.
In addition, several participants shared the reasons why they struggled to attend for treatment:
I was unable to attend physiotherapy appointments due to lack of childcare. I proceeded to continue
to exercise caution in my daily movements.
I won’t be able to get to any hospitals for acupuncture because of money problems, but the only thing
I have for my back pain is paracetamol and my water bottle. Sometimes it works, sometimes it
doesn’t, it depends how bad my back pain is.
Finally, the comments made by women allocated to SC plus non-penetrating acupuncture were a little
more varied. One felt that the acupuncture had not been helpful:
I didn’t feel that the acupuncture helped at all, but the booklet contained some useful information.
Thank you.
Several others particularly emphasised the benefits of the exercise component of treatment, for example:
I found the exercises I was given to do at home helped a lot, when I felt pain starting I would do the
exercises and I could keep it under control. I feel the acupuncture also helped but you would need to
keep up the exercises.
I have been very pleased with the impact of doing the exercises from the booklet. It was particularly
useful having the physio show me exactly how to do the ones I wasn’t sure about. Thank you!
PHASE 2 PILOT RANDOMISED CONTROLLED TRIAL
NIHR Journals Library www.journalslibrary.nihr.ac.uk
62
In addition, several women clearly felt they had benefited from the treatment, including:
Fantastic care. I loved the acupuncture and felt more relaxed and comfortable at these sessions than I
had in a while. I would often nod off to sleep I felt so relaxed. Although I am now wearing a support
belt and walking with elbow crutches I am much more confident dealing with my back pain
The physio was very supportive and provided very good advice and support. The acupuncture was a
first time experience and I am very surprised (positively) at the good results. Would recommend this
treatment to all pregnant women! Thank you!
Missing data and data accuracy
Missing data levels on key disability outcomes
The Oswestry Disability Index
Missing data on the ODI at baseline were very minimal. Of the 1240 individual ODI items (10 items each
for 124 participants), there were only 35 items with missing data (2.8%). The two most frequently missing
items were activities reported as ‘not applicable’ by participants with pregnancy-related low back pain (with
and without PGP): ‘lifting’ (7.3% missing) and ‘sex life’ (8.9% missing). More than 80% (103 out of 124)
of participants completed all the questionnaire items. Missing ODI data at the 8-week follow-up were
similarly very low but slightly higher than at baseline. Of the 910 individual ODI items (10 items each for
91 participants), there were 71 items with missing data (7.8%), 62 of which were on questions about
lifting and sex life. About half of the participants (43 out of 91) completed all the ODI follow-up
questionnaire items.
The Pelvic Girdle Questionnaire
Missing data for the PGQ were very low but slightly higher than for the ODI. Out of 3100 PGQ items at
baseline (25 items for each for 124 participants), there were only 191 items with missing data (6.2%).
Again missing data on individual items were very minimal except for a few questions frequently reported
as not applicable (e.g. running, sporting activities). Forty-six per cent (57 out of 124) completed all the
items of the PGQ at baseline. At the 8-week follow-up, the overall rate of missing data was 8.7% [197 out
of 2275 items (25 items for each of the 91 participants)]. Forty-one per cent (37 out of 91) completed all
the items of the PGQ at 8-week follow-up.
Data accuracy
A random check of 10% of the data entered into the trial database was carried out to verify the data
entry accuracy before data cleaning and analysis. Overall, the data entry accuracy was very high, with more
than 99.5% accuracy across all the questionnaires.
Health economic evaluation
Baseline and 8-week economic data were available for 73 participants (24 in the SC arm, 27 in the SC plus
true acupuncture arm and 22 in the SC plus non-penetrating acupuncture arm); this represented 59% of
the sample. The health economic analysis focused on the 51 participants receiving SC versus SC plus true
acupuncture that informed the base case analysis. Details of NHS and broader health-care resource use
are reported in Table 27. Primary care NHS resource use was similar between the two trial arms (SC vs.
SC plus true acupuncture). Participants in the SC plus true acupuncture arm reported more visits to NHS
physiotherapists and NHS acupuncturists, although this could be a problem with double-reporting. Despite
the question asking for health-care use outside of the EASE Back study, it is possible that participants
misunderstood this question.
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Table 28 shows the EQ-5D scores at baseline and at 8 weeks, and the total QALYs in the two arms. At
8 weeks, we observed a lower EQ-5D score in participants in the SC arm and a higher score for the SC
plus true acupuncture arm. The mean difference in QALYs was 0.010 (95% CI –0.001 to 0.024). Receiving
the acupuncture intervention was, therefore, associated with incremental QALYs over the 8 weeks.
Table 29 shows the disaggregated mean (SD) costs for each treatment arm. The cost of treatment was reported
as part of the total cost of each trial arm. The principal aim of the cost–consequence analysis was to look at
all the costs of the two interventions (SC alone vs. SC plus true acupuncture) and compare these with the
corresponding outcomes in terms of QALYs gained.
TABLE 27 Mean health-care resource use
Resource use category SC (n= 24) SC+ TA (n= 27)
Study back pain visits, mean (SD) 0.29 (0.9) 6.03 (2.76)
GP visits, mean (SD) 0.38 (0.9) 0.52 (1.2)
NHS midwife visits, mean (SD) 0.08 (0.4) 0.22 (0.6)
Private midwife visits, mean (SD) 0.00 (–) 0.04 (0.2)
‘NHS acupuncture’ visits, mean (SD) 0.00 (–) 0.22 (1.2)
NHS physiotherapist visits, mean (SD) 0.04 (0.2) 0.37 (1.5)
NHS ‘other’ health care professional visits, mean (SD) 0.25 (1.2) 0.11 (0.6)
‘Over-the-counter’a treatments, n (%) 12 (50) 11 (41)
Prescribed medication,a n (%) 6 (25) 5 (19)
Visited NHS or private practice,a n (%) 7 (29) 7 (26)
TA, true acupuncture.
Values are mean (SD) number of consultations unless stated otherwise.
a The number (percentage) of participants reporting usage within over-the-counter treatments and prescribed medication
categories are given.
TABLE 28 European Quality of Life-5 Dimensions scores by treatment arm (mean and SD)
Complete case analysis SC SC+ TA
Baseline (n = 41) (n = 42)
Mean (SD) 0.649 (0.12) 0.651 (0.16)
8 weeks (n = 24) (n = 27)
Mean (SD) 0.570 (0.23) 0.698 (0.22)
Total QALYs, mean (SD) 0.096 (0.02) 0.106 (0.02)
Mean difference (95% CI) 0.010 (–0.001 to 0.024)
Adjusteda 0.096 0.106
Mean difference (95% CI) 0.009 (0.000 to 0.019)
TA, true acupuncture.
a Incremental QALY estimates following multiple regression-based adjustment for baseline scores on the EQ-5D.
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The results show that, although the SC plus true acupuncture intervention has a higher total NHS cost and
health-care than SC alone, it is the intervention that also achieves higher QALY gains. From a NHS/PSS
perspective, the difference in costs between SC plus true acupuncture and SC alone was £174.67
(95% CI £102.35 to £271.20). The differences in cost can be attributed to the additional acupuncture
sessions and the relatively small reported increase in utilisation of acupuncture, midwifery and physiotherapy
in a few participants in that treatment arm. On the basis of the NHS and health-care perspective, there is
no intervention that is dominant (i.e. has lower costs and better outcomes). Acupuncture provided alongside
SC, however, appears more effective in treating pregnant women with low back pain, but this increased
effectiveness comes at an increased cost.
Work-related outcomes and out-of-pocket costs
Information on time off work and out-of-pocket costs related to treatment is reported in Table 30. Only
two (9.5%) participants in the SC alone arm reported taking time off as a result of their back pain,
compared with nine (33.3%) women in the SC plus true acupuncture group. The percentage of
participants taking time off work as a result of back pain and to attend physiotherapy sessions was slightly
higher in the SC plus true acupuncture arm for those in full-time employment and slightly lower for those
in part-time employment than SC alone. The associated productivity-related costs showed higher costs
TABLE 29 Mean per participant costs by treatment arm over 8 weeks
Complete case analysis
Mean (£) (SD)
SC (n= 24) SC+ TA (n= 27)
Intervention cost 11.52 (43.2) 149.43 (71.14)
GP 12.75 (29.8) 17.62 (39.3)
NHS midwife 6.25 (30.6) 16.66 (48.03)
Private midwife 0.00 (–) 3.55 (18.4)
‘NHS acupuncture’ 0.00 (–) 9.96 (51.76)
NHS physiotherapist 2.04 (10.0) 16.85 (69.2)
‘Other’ professionals in NHS 5.83 (28.6) 3.74 (19.43)
Prescriptions 1.76 (8.6) 0.54 (2.8)
‘Over-the-counter’ treatments 8.67 (14.3) 7.38 (21.7)
Back pain-related work absencea 98.36 (330.3) 258.86 (517.8)
Back pain-related reduced productivity 806.55 (769.58) 783.45 (762.7)
NHS/PSS cost 40.15 (90.78) 214.82 (191.92)
Adjusted mean differenceb (95% CI) 174.67 (102.35 to 271.20)
Incorporation of back pain-related health-care resource use (n = 42)
Health-care costc 48.82 (94.18) 225.77 (205.65)
Adjusted mean differenceb (95% CI) 176.94 (100.73 to 265.50)
Incorporation of back pain-related wider societal resource use (n = 42)
Societal costd 953.74 (921.14) 1268.08 (1207.24)
Adjusted mean differenceb (95% CI) 314.34 (–256.84 to 887.86)
TA, true acupuncture.
a Includes both work absence due to back pain and work absence to attend treatment sessions.
b Difference= intervention–control group. Reported CIs were generated using conventional parametric methods.
c Includes costs to the NHS, private health-care costs and over-the-counter medication costs.
d Includes health-care costs and productivity-related costs.
Values are mean (SD) number of consultations/investigations unless stated otherwise.
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among patients in the acupuncture treatment arm attending physiotherapy sessions (£0.81 vs. £16.87).
Reduced productivity during paid work was reported by six (22%) women in the SC plus true acupuncture
arm. Overall, slightly higher productivity costs were observed in the SC plus true acupuncture intervention
arm than in the SC alone arm.
Taking a broader societal perspective, the cost of time lost from work during the trial follow-up period of
8 weeks, reduced productivity at work and time taken off work to attend physiotherapy sessions is also
reported. From these perspectives, the SC alone treatment arm was the least costly, although it was
also associated with higher presenteeism costs.
Maternity record review results
Obstetric birth/neonatal outcomes
Table 31 summarises the birth outcomes obtained from the maternity records of trial participants, overall
and by treatment arm. All women who participated in the pilot trial had live births, at a mean gestation
week of 40 (SD 1.5 week). Labour duration was similar across all three treatment arms, as were the need
to be induced, the mode of delivery, the proportion of women who had either an episiotomy or a perineal
TABLE 30 Work outcomes for participants in paid and unpaid employment
Work outcome SC SC+ TA
Employed at baseline 28 of 41 27 of 42
Employed at 8 weeks 21 of 24 23 of 27
Working full-time in paid job, n (%) 3 (12.5) 9 (33.3)
Working part-time in paid job, n (%) 7 (29.2) 2 (7.4)
Employed, but currently off sick as a result of back pain, n (%) 1 (4.2) 2 (7.4)
Employed, but currently on maternity leave, n (%) 10 (41.7) 10 (37.0)
Reported taking time off work as a result of back pain, n (%) 2 (9.5) 9 (33.3)
Mean (SD) number of days lost from work 1.4 (4.5) 3.4 (6.9)
Mean (SD) cost (£) of days lost from work 111.48 (352.1) 284.08 (554.8)
Mean (SD) number of days of reduced productivity at work 15.6 (10.1) 11.1 (9.0)
Mean (SD) cost (£) reduced productivity at work 921.77 (754.7) 919.70 (745.9)
Reported taking time off work to attend appointments, n (%) 1 (4.2) 14 (51.9)
Mean (SD) cost (£) of work absence to attend physiotherapy appointments 0.81 (3.98) 16.87 (24.34)
Reported reduced time in unpaid activities, n (%) 0 (–) 6 (22.2)
Reported paying someone to look after children, n (%) 0 (–) 1 (3.7)
Mean (SD) cost (£) of looking after children 0 (–) 5 (–)
Mode of transport to sessions, n (%)
Car/van 2 (8.3) 18 (66.7)
Taxi/train/bus 0 (–) 2 (7.4)
Foot 0 (–) 1 (3.7)
Mean (SD) cost (£) of parking 1 (1.4) 1.6 (1.1)
Mean (SD) cost (£) of bus/taxi/train fare 0 (–) 5.5 (0.7)
TA, true acupuncture.
Work estimates based on sample of participants in paid employment at 8 weeks (39 out of 73).
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TABLE 31 Birth outcomes by treatment arms
Birth outcomes Overall (n= 122)
Treatment arm
SC (n= 40) SC+ TA (n= 42) SC+NPA (n= 40)
Gestation week at delivery, mean (SD) 39.7 (1.5) 39.5 (1.6) 39.6 (1.6) 40.1 (1.3)
Live birth, n (%) 122 (100) 40 (100) 42 (100) 40 (100)
Labour durationa (hours), mean (SD) 4.1 (4.5) 3.2 (2.8) 3.8 (3.7) 5.2 (6.1)
Second-stage labour durationa (minutes),
mean (SD)
45 (57.4) 41.0 (57.0) 49.6 (54.1) 44.3 (62.9)
Needed to be induced,a n (%) 40 (35.7) 14 (36.8) 14 (35.9) 12 (34.3)
Mode of delivery, n (%)
Spontaneous vaginal delivery 80 (66.1) 26 (65.0) 30 (73.2) 24 (60.0)
Instrumental delivery 14 (11.6) 4 (10.0) 4 (9.8) 6 (15.0)
Elective caesarean section 18 (14.4) 9 (22.5) 4 (9.8) 5 (12.5)
Emergency caesarean section 9 (7.4) 1 (2.5) 3 (7.3) 5 (12.5)
Had an episiotomyb 17 (18.1) 5 (16.7) 6 (17.7) 6 (20.0)
Perineal tear, n (%)
No tear 56 (47.9) 17 (46.0) 20 (47.6) 19 (50.0)
First-degree tear 9 (7.7) 1 (2.7) 4 (9.5) 4 (10.5)
Second-degree tear 35 (29.9) 13 (35.1) 10 (23.8) 12 (31.6)
Third-degree tear 7 (6.0) 2 (5.4) 3 (7.1) 2 (5.3)
Information not available 10 (8.6) 4 (10.8) 5 (11.9) 1 (2.6)
Estimated blood loss at birth (ml),
median (IQR)
300 (200–450) 300 (250–400) 300 (200–400) 350 (300–500)
Blood loss of 500ml or more, n (%) 28 (24.1) 8 (20.5) 7 (18.0) 13 (34.2)
Last antenatal haemoglobin count (g/l), n (%)
< 115 33 (27.3) 9 (23.1) 14 (33.3) 10 (25.0)
115–165 (normal range) 87 (719.9) 30 (76.9) 27 (64.3) 30 (75.0)
> 165 1 (0.8) 0 (0.0) 1 (2.4) 0 (0.0)
Woman’s postnatal haemoglobin count (g/l),c n (%)
< 115 19 (70.4) 7 (77.8) 7 (77.8) 5 (55.6)
115–165 8 (29.6) 2 (22.2) 2 (22.2) 4 (44.4)
continued
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tear and the mean estimated blood loss at birth. The majority of women (66.4%) used Entonox® (BOC Ltd,
Manchester, UK; gas and air) as pain relief during labour, 32% used pethidine and 21% had an epidural.
Pattern of pain relief used during labour was the same across all three treatment arms.
Neonatal outcomes were also very similar across all three treatment arms (Table 32). Approximately 50%
of all babies were male and the majority had a birthweight of 3000–4000 g. In total, only three babies
(2.5%) were admitted to the neonatal unit and 95% or more of all babies had an Apgar score of 7–10 at
5 minutes after birth.
Adverse events
No SAEs attributable to the trial interventions or trial processes were reported. There were four SAEs
reported by treating physiotherapists to the trial team (one in SC, two in SC plus true acupuncture and
one in SC plus non-penetrating acupuncture), all examples of brief periods of hospitalisation or admission
to the maternity assessment unit at UHNS, for reasons other than those related to the trial or treatments.
All women were discharged after monitoring and all resumed treatment.
Self-reported side effects
Ten women (five in SC plus true acupuncture and five in SC plus non-penetrating acupuncture) reported
some side effects from treatment in response to this question on the 8-week questionnaire, summarised
in Table 33.
Minor adverse reactions following treatment
Minor adverse reactions reported by physiotherapists on CRFs are summarised in Table 34. All were
expected minor adverse effects. The most common was slight bleeding at the needle sites in 35 (21%)
treatment sessions in the SC plus true acupuncture arms and in one (0.5%) treatment session in the
SC plus non-penetrating acupuncture arm.
TABLE 31 Birth outcomes by treatment arms (continued )
Birth outcomes Overall (n= 122)
Treatment arm
SC (n= 40) SC+ TA (n= 42) SC+NPA (n= 40)
Pain relief used during labour,d n (%)
TENS machine 5 (4.1) 3 (7.5) 1 (2.4) 1 (2.5)
Water birth 2 (1.6) 0 (0.0) 1 (2.4) 1 (2.5)
Entonox® (gas and air) 81 (66.4) 27 (67.5) 27 (64.3) 27 (67.5)
Pethidine 40 (32.8) 14 (35.0) 17 (40.5) 9 (22.5)
Morphine 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Epidural 26 (21.3) 5 (12.5) 12 (28.6) 9 (22.5)
Spinal 19 (15.6) 9 (22.5) 5 (11.9) 5 (12.5)
General anaesthetic 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Patient-controlled analgesia 1 (0.8) 0 (0.0) 1 (2.4) 0 (0.0)
Information not available 9 (7.4) 1 (2.5) 3 (7.1) 5 (12.5)
NPA, non-penetrating acupuncture; TA, true acupuncture.
a Excludes elective caesarean section.
b Applies only to spontaneous vaginal/instrumental delivery.
c Data available for 27 women only (nine in each arm).
d Possible multiple responses.
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TABLE 33 Self-reported side effects in 8-week questionnaire
Side effect
Number
SC+ TA SC+NPA
Nausea 1 1
Vomiting 1 0
Drowsiness/light-headedness 4 4
Fainting 1 0
Headaches 1 0
Pain or soreness 2 3
TABLE 32 Neonatal outcomes by treatment arms
Neonatal outcomes Overall (n= 122)
Treatment arm
SC (n= 40) SC+ TA (n= 42) SC+NPA (n= 40)
Baby’s sex (female), n (%) 62 (51.2) 19 (48.7) 23 (54.8) 20 (50.0)
Birthweight of baby (g), n (%)
< 2500 1 (0.8) 0 (0.0) 1 (2.4) 0 (0.0)
2500–3000 21 (17.2) 8 (20.0) 9 (21.4) 4 (10.0)
3000–3500 41 (33.6) 12 (30.0) 16 (38.1) 13 (32.5)
3500–4000 48 (39.3) 17 (42.5) 13 (31.0) 18 (45.0)
> 4000 11 (9.0) 3 (7.5) 3 (7.1) 5 (12.5)
Apgar scorea at 1 minute after birth, n (%)
0–3 1 (0.8) 1 (2.5) 0 (0.0) 0 (0.0)
4–6 6 (4.9) 2 (5.0) 3 (7.1) 1 (2.5)
7–10 115 (94.3) 37 (92.5) 39 (92.9) 39 (97.5)
Apgar score at 5 minutes after birth, n (%)
4–6 1 (0.8) 1 (2.5) 0 (0.0) 0 (0.0)
7–10 121 (99.2) 39 (95.5) 42 (100) 40 (100)
Baby admitted to the neonatal unit,b n (%) 3 (2.5) 2 (5.0) 0 (0.0) 1 (2.5)
NPA, non-penetrating acupuncture; TA, true acupuncture.
a Apgar score has five components – appearance (skin colouration), pulse (heart rate), grimace response (reflex irritability),
activity (muscle tone) and respiration (heart rate) – each given a score of 0–2, with a total score of 0–10, 10 being the
perfect score.
b Reasons for admissions included low Apgar score (no muscle tone) at 30 minutes, respiratory distress syndrome and
suspected sepsis, and breathing difficulty.
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Primary outcome measure and sample size for a full
randomised controlled trial
Choice of primary outcome for future main trial
We included two outcomes measures capturing data on physical function (the ODI and the PGQ) and
one measure of pain severity in the pilot trial, in order to help inform the decision about a primary
outcome measure for a future main trial. Several factors were taken into consideration in examining the
performance of these measures. These included the number of missing data at the item and scale levels;
any evidence of floor or ceiling effects; the precision of the outcome measures based on the 95% CI;
and their responsiveness to change.
The number of missing data was minimal for both these measures (reported in Missing data and data
accuracy). No floor or ceiling effects were shown in the total score of either the ODI (minimum score= 10%,
scored by n= 1; maximum score= 66%, scored by n= 1) or the PGQ (minimum score= 13.6, scored by
n= 1; maximum score= 85.3, scored by n= 1). The standard errors for the estimated treatment effect were
large in both the ODI and the PGQ measures, leading to wider CIs (which could partly be a result of the small
sample size). However, the PGQ total score had a slightly larger margin of error than the ODI.
A number of statistical indices were used to assess the relative responsiveness of the key outcome measures.
These included standardised effect size (SES), the mean change score divided by the SD of the measure at
baseline; standardised response mean (SRM), the mean change score divided by the SD of the change scores;
responsiveness statistic (RS), based on the mean change score divided by the SD of change of stable patients;
TABLE 34 Treatment adverse events reported on physiotherapy CRFs
Adverse events
Treatment arm
SC (total number of
treatment sessions= 9)
SC+ TA (number of sessions
of acupuncture= 164)
SC+NPA (number of sessions
of acupuncture= 197)
Standard care, n (%)
Pain while
exercising
0 (0.0) 5 (3.0) 1 (0.5)
Muscle soreness 0 (0.0) 1 (0.6) 0 (0.0)
Discomfort as a
result of exercise
0 (0.0) 0 (0.0) 1 (0.5)
Acupuncture, n (%)
Slight bleed at
needle site
– 35 (21.3) 1 (0.5)
Pain on needle
insertion
– 6 (3.7) 0 (0.0)
Slight bruising – 6 (3.7) 0 (0.0)
Slight soreness – 2 (1.2) 1 (0.5)
Muscle spasm – 2 (1.2) 0 (0.0)
Numbness – 1 (0.6) 0 (0.0)
Feeling slight
sharpness
– 1 (0.6) 0 (0.0)
Feeling
uncomfortable
– 1 (0.6) 0 (0.0)
Slight drowsiness – 0 (0.0) 4 (2.0)
NPA, non-penetrating acupuncture; TA, true acupuncture.
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and the paired t-test statistic, overall and in improved patients. The global assessment of improvement used as
the anchor was the participant’s self-reported global rating of change in her back pain problem at the 8-week
follow-up measured using a 6-point ordinal scale dichotomised into ‘improved’ (combining options ‘completely
recovered’, ‘much improved’, ‘somewhat improved’) and ‘not improved’ (combining options ‘same’, ‘somewhat
worse’, ‘much worse’). A SES/SRM/RS greater than 0.8 can be considered large, moderate values range from
0.5 to 0.8, and values below 0.5 are small.85 A higher value of the above indices indicates greater sensitivity to
clinical change. For a better comparison of the scores we present standardised pain intensity scores of 0–100
by multiplying each score by 10. All the three outcome measures showed moderate or large SES, SRM and RS;
the PGQ symptoms scale particularly outperformed the other outcomes on most of these indices (Table 35).
Responsiveness was also quantified through a receiver operating characteristic (ROC) curve analysis by
plotting the true positive (sensitivity) versus the false positive (1 - specificity) for multiple cut-off points of the
outcome measures against the patient’s global assessment of change. Patients were grouped into improved
(‘completely recovered’/’much improved’/’somewhat improved’) or no change and worse (‘same’/’somewhat
worse’/’much worse’). The best discrimination occurs with a curve that reaches most to the upper left; a
sharp initial rise (high true-positive rate and low false-positive rate), then flattens while the false-positive rate
is still small. For each outcome measure (Figure 8) the curve was to the left above the diagonal, showing
some discriminative ability, and the areas under the curve were all above 0.85 showing good discrimination.
Based on all of the above parameters, we feel that the PGQ (total score measuring both symptoms and
impact of everyday activities) is the best choice of primary outcome measure for a future main RCT.
TABLE 35 Tests of responsiveness for the pain and disability outcome measures
Key outcomes n
Responsiveness measures
Paired t-test statistic
(improved)SES SRM RS
Paired t-test
statistic (overall)
ODI score (0–100), mean (SD) 90 0.494 0.345 0.370 3.274 8.099
PGQ score (0–100), mean (SD)
Total 90 0.598 0.461 0.474 4.378 8.893
Activity subscale 90 0.498 0.395 0.393 3.748 7.933
Symptom subscale 90 0.829 0.625 0.712 5.930 9.794
Pain severity (mean score of three NRSs)a 91 0.814 0.549 0.656 5.236 13.088
a 0–10 scale transformed to 0–100.
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FIGURE 8 The ROC curves of key outcomes against self-rated change. AUC, area under the curve.
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Sample size estimate for a future main EASE Back trial
A future main trial is likely to be best powered to detect small to moderate differences between SC and SC
plus true acupuncture (testing effectiveness) but given the results of this pilot trial we feel it will also be helpful
for a future main trial to compare a package of SC plus true acupuncture with SC plus non-penetrating
acupuncture (specifically testing the added efficacy of needle penetration and manipulation).
The sample size calculation is therefore based on a three-arm, parallel-group RCT with the PGQ total score
as the primary outcome measure and follow-up at 8 weeks as the primary time point. As there are no previous
studies reporting a minimum clinically important difference (MCID) for the PGQ in this population, our
parameters for the sample size calculation are based on the pilot data. The point estimate for the comparison
of true acupuncture with SC was 12.6 (95% CI 1.3 to 23.8) and for true acupuncture with sham acupuncture
was 4.3 (95% CI –7.0 to 15.6) with a SD of 17.0 for the PGQ total score at baseline. The best cut-off point
that maximises sensitivity and specificity from the ROC curve analysis was found to be approximately a 4-point
difference in the total score. At this difference in score, the sensitivity was 0.87 and specificity was 0.79. Since
the estimated optimum cut-off sits within the CIs for both the two point estimates, this provides sufficient
justification that the MCID would be achievable for testing for superiority in treatment effect in a main trial.
We have, therefore, chosen a mean difference of 4 points in the PGQ total score as the minimum important
difference for this population of women, and a SD of 18 (one-sided 80% upper limit of the baseline SD) –
translating to a small effect size of 0.22. We have adopted a conservative approach of using an 80% upper
one-sided confidence limit of the SD rather than the estimate itself, in line with the conservative approach
recommended by Browne78 when using pilot data.
Given that the primary analysis will use analysis of covariance to compare the mean score between the
two groups 8 weeks after randomisation adjusting for baseline scores, a sample size of 160 participants
in each arm will be required to detect a 4-point difference in the mean scores between SC plus true
acupuncture and SC plus non-penetrating acupuncture and between SC and SC plus true acupuncture
with a power of 80% at a 5% two-sided significance level, assuming an autocorrelation of 0.5. The
pilot data showed a correlation of 0.52 between the baseline and 8-week PGQ total scores; thus, an
autocorrelation of 0.5 seems reasonable. Therefore, a total of 480 participants will be required. It is
expected that no more than 20% of the participants will be lost to follow-up (as we have identified ways
to increase the response rate to at least 80% from 74% from pilot data); thus, a future main trial would
need to recruit 600 participants in total (200 per arm). Our pilot data have shown that it is possible to
recruit an average of five women per week from one maternity centre using six recruitment methods.
Therefore, for a main trial we estimate that three maternity centres will need to recruit participants for
approximately 12–15 months using the three most successful recruitment methods.
The above suggestions for a primary outcome measure and estimated sample size for a future main EASE
Back trial were presented to stakeholders at the EASE Back study dissemination event in May 2014 for
discussion (see Chapter 4).
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Conclusions
In conclusion, phase 2 of the EASE Back study was a pilot RCT in which participants were recruited over
6 months, randomised to one of three treatment arms (SC alone, SC plus true acupuncture and SC plus
non-penetrating acupuncture), and followed up at 8 weeks following randomisation. Through this pilot
RCT, we tested six recruitment methods, and randomised 45% of potentially eligible women. Our linked
audio-recordings highlighted that women expressed no new concerns about acupuncture treatment
that had not been identified in phase 1 interviews. Treatments were delivered in line with intervention
protocols, although some women did not attend for treatment. The follow-up rate was 74% at 8 weeks,
lower than the usual follow-up rates observed in our previous trials. We believe this resulted from the REC
decision to reduce the number of follow-up reminders from our usual procedure. While all analyses of
patient-reported clinical outcomes (pain, function, quality of life), health economic outcomes and safety
outcomes can be considered only exploratory in this pilot RCT, the results overall tended to favour the
addition of acupuncture to SC for pregnancy-related back pain. We used the results from the pilot trial to
determine which outcome should be the primary outcome for a future main RCT and to estimate the
sample size required for such a trial. All of the findings from the pilot RCT were presented and discussed
at an end of study dissemination event in May 2014, summarised in Chapter 4.
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Chapter 4 End of study dissemination event
A t the end of the pilot trial (May 2014), we hosted a dissemination event to share the key findings ofthe EASE Back study with a range of stakeholders.
Participants and programme
We shared the results with a wide range of key stakeholders including national experts in the care of
pregnant women, international experts from Sweden (Elden and Stener-Victorin) who had conducted
the previous high-quality RCTs testing acupuncture for pregnancy-related PGP, representatives from the
community and research midwives, physiotherapists, physiotherapy managers and research managers that
we had worked with in the study, as well as trial methodologists. Women who had participated in the
pilot trial were also invited but were unable to attend because of time and family commitments. In total,
35 people attended the event.
The programme for the day is provided in Appendix 15 and included an overview of the EASE Back study
aims and objectives, summaries of the methods and findings of both phase 1 (the pre-pilot work) and
phase 2 (the pilot RCT) and a short presentation on the potential aims, design and plans for a future main
EASE Back trial. They listened to examples of the radio advertising used to raise local awareness about the
pilot trial and reviewed the self-management booklet used in the pilot trial. The key focus of the day was
to consider the key findings of the pilot RCT (the process outcomes, and the exploratory safety, clinical and
cost outcomes) and their implications, in order to agree whether or not the findings provided sufficient
evidence that a future main RCT might be desirable and feasible.
Discussion points
After hearing a summary of all of the results of the EASE Back study, participants worked in three separate
multidisciplinary groups to discuss six key questions. The questions and a summary of the feedback from
participants are provided:
Is a main trial desirable and feasible? If so, which trial design is best?
All felt that a future main trial was desirable but would benefit from modifications. The rationales for
deciding a main trial would be desirable included the need to reduce the negative impact of back pain in
pregnancy, the need to improve the quality of life during pregnancy of this group of women, the need for
a better evidence base to underpin NHS practice, and the need to test additional treatment options for this
population given that referral rates to NHS women’s health specialists were perceived to be rising.
The group felt that a future main trial was also feasible, and that the pilot RCT had provided the evidence
needed to inform a larger and multicentre RCT. This group of women were considered to be a challenging
group to recruit to RCTs and to commit to a course of treatment. Some modifications were suggested in
order to ensure high rates of recruitment, follow-up and treatment attendance in a future main trial
(these are described in the following section).
Several options for the design of a future main trial were discussed. These included a two-arm parallel RCT,
randomising participants to either SC or a combination of SC and true acupuncture, powered to detect
superiority of the addition of acupuncture to SC. Some participants felt that the SC treatment should be further
standardised for a future main trial, so that either all women receive the self-management booklet only or all
women receive the booklet and at least one session with a physiotherapist who would go through the booklet
advice and demonstrate helpful exercises and self-management tips. A second option discussed was a three-arm
parallel RCT randomising participants to the same three treatment arms as the pilot RCT, powered to also detect
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superiority of the SC plus true acupuncture arm in comparison with the SC plus non-penetrating acupuncture
arm. Some concerns were raised by acupuncture experts among the stakeholders about the non-penetrating
needles still being ‘active’ treatment (and not a true inert or sham treatment). This led to recommendations
about using fewer needles and placing them outside the pain area in the sham acupuncture arm of a future
main trial. We also discussed the merits of a three-arm parallel RCT with unequal randomisation (1 : 2 : 2 to SC,
SC plus true acupuncture and SC plus non-penetrating acupuncture, respectively) and an adaptive trial design
that starts with these three arms but is informed by an interim analysis to continue as either a three-arm trial
or a two-arm trial (should the interim analysis shown futility in attempting to continue as a three-arm trial that
could demonstrate superiority of SC plus true acupuncture over SC plus non-penetrating acupuncture). Some
stakeholders felt that the question of most relevance to the NHSwould be the one answered by a simple
two-arm RCT (thus dropping the idea of a sham acupuncture comparison group altogether) while several others
recommended a four-arm design adding in a treatment armwhere women all receive one-to-one SC treatment
offered by physiotherapists but not acupuncture of any sort. However, the preferred design was the adaptive
trial design starting with three arms, as it appeared to offer benefits in terms of greater efficiency for a future
large trial; if an interim analysis revealed futility (i.e. even if recruitment to all three arms continued, there
would be no differences in patient outcome between the true and non-penetrating acupuncture arms) then
recruitment, treatment and follow-up efforts could be directed to two trial arms (SC alone and SC plus true
acupuncture). Using the PGQ as the primary outcomemeasure and an 8-week time point as the primary time
point (with longer-term follow-ups at 3 and 6 months) would mean needing to recruit 600 women to a full EASE
Back trial. We estimate that this would require three maternity centres with linked community midwifery and
physiotherapy services, recruiting for a maximum of 15 months.
How could recruitment be maximised in a future main trial?
Although overall the recruitment rate in the EASE Back pilot trial was high (we recruited 45% of those
women who were eligible), it was clear that we did not reach all the pregnant women likely to have back
pain in the locality during the 6 months of recruitment (we had contact with 366 women out of the 720 we
estimated might be suitable for screening for the pilot trial). The six recruitment methods tested in the pilot
RCT had varied success, but the three most successful methods were a brief questionnaire screening for
back pain given to women as they attend their routine 20-week ultrasound scan appointment, community
midwives giving women under their care the EASE Back study card and self-referral of women in response
to local awareness raising, particularly the regular radio infomercials. Overall, the stakeholders at the
dissemination event felt that all three of these successful methods should be used in a future main trial but
that efforts were needed to ensure, as far as possible, that all women attending their 20-week ultrasound
scan appointment were given a screening questionnaire and were also given an EASE Back study flyer to take
home with them (in case they currently did not have back pain but developed it later in the pregnancy).
Research midwives suggested the use of small voucher incentives for staff within the ultrasound scan
clinics to reward those getting most questionnaires completed and returned (based on examples of similar
incentives used in other trials with pregnant women). They recommended that there was regular and
extensive use of radio advertising to raise awareness of local women about a full trial (and it was ensured that
the costs of these were included in any main trial application). Other recommendations included a model in
which research midwives dedicate more sessions per week to supporting recruitment in a full trial and a slight
change to several exclusion criteria for the trial (to exclude only women with previous acupuncture treatment
in the last 2 years, to exclude women who had previously delivered a baby prior to 37 weeks and to include
women with anterior pelvic pain only and include acupuncture points in that area such as KI11 and SP12).
How could follow-up rates be improved in a future main trial?
The overall follow-up rate in the pilot trial was 74%, and this is lower than previous RCTs led by our team
at Keele. We believe that the decision of the REC which reviewed the pilot RCT to allow us to use only
two reminders contributed to this low follow-up rate and that a future full RCT using the usual processes
of reminders for RCT follow-up in the CTU at Keele would result in approximately 10% higher retention
at the 8-week follow-up (see Appendix 8 for evidence from our previous trials). A future main trial would
also collect longer-term follow-up data (at 3 and 6 postnatal months) and, therefore, additional efforts
were felt to be needed to ensure high longer-term follow-up rates. Therefore, in addition to making a
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stronger case (with evidence from the pilot RCT) for the need for the usual follow-up reminder process
to any future REC reviewing the main RCT, stakeholders at the end of study event also recommended
offering women the option of online questionnaire completion prompted through emails and/or reminders
by Short Message Service text messaging. Many of those attending also felt that the use of low-value
shopping voucher incentives (such as £10 for each returned questionnaire or a total of £20 after return of
the last questionnaire) should also be considered, based on the recent systematic review evidence that
monetary incentives and offers of monetary incentives increase postal and electronic questionnaire
response in randomised trials.86 Stakeholders felt it important to provide trial participants with the option
of declining the vouchers. Home visits to collect outcome data were discussed but felt by the group not
to be feasible in a large future trial.
How could participant attendance at treatment be maximised?
Interventions in the EASE Back pilot trial were delivered in line with protocols, in terms of the content
of treatment. However, the challenge we observed was in women attending for the full course of
treatment (between six and eight treatment sessions in those participants allocated to receive acupuncture).
Recommendations from the dissemination event included ensuring that the consent process very clearly
describes the commitment needed on the part of included women to engage in the full course of treatment
as well as making sure treatment appointments are as flexible as possible (to include evening appointments
and to consider the possibility of weekend appointments for those women struggling to attend for
treatment owing to work commitments). Additional suggestions included working with a greater number
of physiotherapists to deliver EASE Back study interventions (thus offering great flexibility of treatment slots)
and using Short Message Service text reminders to participants the day before their appointment to prompt
them to attend for treatment.
How should physiotherapists be supported?
All felt that any future main trial should include a similar training and mentoring programme for
participating physiotherapists, and that building in plans for peer support and pair-working (with at least
two EASE Back-trained physiotherapists per treatment site) would be beneficial. The group of stakeholders
recommended regular refresher workshops throughout the recruitment and treatment period of a future
main trial, to offer the opportunity to discuss problems, patient case examples and obtain support from
those leading the training. They wanted easy telephone contact to community midwives to address
questions they might have about normal (and abnormal) features of pregnancy. They suggested that
the group of 14 physiotherapists trained in EASE Back study interventions could proceed to support the
wider group of therapists who might deliver treatment in a future multicentre trial. Some also suggested
using community midwives to offer treatment in a future main trial, where those midwives might already
be trained in using acupuncture for pain problems.
Should qualitative research be included in a future main trial?
There was mixed opinion about the value of linked qualitative research within a future main EASE Back
trial. Those that felt it would be valuable recommended seeking REC approval to conduct qualitative
interviews with those women who are eligible for a main trial but who decline to take part, in order to
better understand the reasons for decline, and to interview a sample of women receiving treatment in
order to fully understand their experiences of treatment, perceived treatment benefits, challenges faced in
committing to a course of treatment and the impact particularly on work, time off work and the start of
maternity leave. Such in-depth qualitative data could also help to explain the reasons for the results of a
future main trial. A further purpose to qualitative research in the future main trial would be to explore the
role of the therapeutic relationship between the women and the physiotherapists. This appeared to be
important in the open responses women gave on their 8-week questionnaires.
DOI: 10.3310/hta20330 HEALTH TECHNOLOGY ASSESSMENT 2016 VOL. 20 NO. 33
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Foster et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
77
Key conclusions and recommendations
In summary, a multidisciplinary group attending the end of study dissemination event at which the aims,
design, methods and results of the EASE Back feasibility and pilot trial were presented reached the
conclusion that a future main RCT testing the additional benefit of acupuncture to SC for women with
pregnancy-related back pain (with and without PGP) is desirable and feasible. Recommendations included
an adaptive trial design for the main trial with a pre-planned interim futility analysis in order to decide
whether to continue with a three-arm full RCT or to stop recruiting to the SC plus non-penetrating
acupuncture arm. Other recommendations included ways to maximise recruitment, follow-up rates,
attendance at treatment sessions, support of participating physiotherapists and the potential role of linked
qualitative research in a future main EASE Back trial.
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Chapter 5 Discussion and conclusions
We have shown that that a RCT testing the addition of acupuncture to SC for pregnancy-related backpain is feasible.
Over 24 months, the EASE Back feasibility and pilot trial included (1) a pre-pilot phase comprising a
national survey of physiotherapists and qualitative focus group and individual interviews with pregnant
women, midwives and physiotherapists; (2) development of SC, true acupuncture and non-penetrating
acupuncture treatment protocols; (3) development and delivery of a brief training programme to support
physiotherapists to deliver treatment; (4) development of six methods with which to identify and recruit
potentially eligible pregnant women; (5) a pilot RCT to assess recruitment rate, treatment fidelity and
follow-up rate; (6) several patient-reported outcome measures of pain and function in order to select the
most suitable one for use in a future main trial; and (7) a consensus conference with multiple stakeholders
to reach agreement on the merits of, and procedures for, a future main trial.
The feasibility and pilot trial specifically:
l Provided data on current UK SC and acupuncture treatment for low back pain in pregnant women.
We described current practice for pregnant women with low back pain and used these data in
the development of treatment protocols for SC, SC plus true acupuncture and SC plus non-penetrating
acupuncture. Features of the treatment protocols including the number of treatment sessions, the
types of advice and exercises, the acupuncture points and the overall course of treatment are,
therefore, in line with what the NHS currently provides or would be reasonably expected to provide.
l Explored the views of pregnant women with back pain about the acceptability of the proposed
interventions, the content and delivery of participant information, the outcomes most important to
them and the most appropriate timing of outcome measurement. We found that pregnant women and
midwives welcome the idea of a trial as they want more treatment options for this clinical problem.
Other than minor questions about positioning for treatment, the location of the needles and the time
needed to attend for treatment, women expressed very few concerns. The participant information for
the pilot trial ensured that these details were explained, including the information about the known
risks of minor side effects of acupuncture such as feeling drowsy or light-headed. Women wanted help
with the pain but particularly the impact of the pain on their everyday activities, including work. We
tested several outcome measures of pain and function in the pilot trial, including a recently developed
instrument specifically for this patient population (the PGQ). In order to ensure that most women
would not yet have given birth at the time of their follow-up data collection, we selected a follow-up
time point of 8 weeks after randomisation. Only 14% of participants had given birth by the time of
their follow-up.
l Optimised trial information, recruitment and consent procedures by learning what works best from the
perspectives of pregnant women with low back pain, midwives and physiotherapists. The results of
the pre-pilot work highlighted that this patient group are young, busy working women trying to
continue to look after other small children and stay in work despite their pain, and these challenges
mean they find it difficult to get to NHS appointments and to engage with research. We therefore
developed six methods of identifying potentially eligible women for the pilot trial, as we needed
to find out which might work best. The methods included a brief screen for back pain when women
attend their routine 20-week ultrasound scan appointment, the development of small EASE Back
study business cards that midwives could simply give women they look after and a local media
awareness-raising campaign to get the message about the pilot trial directly to local women (using
YouTube, a website, radio, newspaper and local bus advertisements). We used brief telephone
screens to assess initial eligibility before asking women to attend for a full eligibility and information
meeting with a research midwife or nurse. We audio-recorded 30 of these meetings and again found
that women expressed few concerns other than positioning for treatment and the time commitment
required for treatment.
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l Investigated the views of NHS health professionals regarding (1) the acceptability and feasibility of
referring women with back pain in pregnancy to physiotherapists for acupuncture, (2) the proposed trial
design and interventions and (3) ways in which to maximise recruitment and retention to a trial. The
pre-pilot work highlighted that both midwives and physiotherapists felt that there are currently very few
effective treatment options for pregnant women with low back pain and that acupuncture has merit
and should be researched. Midwives welcomed the trial, felt acupuncture would be very acceptable to
women and were keen to ensure that the women they looked after could access care in the trial.
Physiotherapists were keen to participate in the trial but had concerns about the safety of acupuncture
in pregnancy, mostly related to their original acupuncture training, through which at least some had
been told that pregnancy was a contraindication for acupuncture. These concerns informed the
development of a training programme for the 14 physiotherapists that took part, led by the research
team, including an experienced acupuncturist, a women’s health physiotherapist and a consultant
obstetrician. Physiotherapists’ confidence in the diagnosis and management of pregnancy-related back
pain increased after the training and remained high to the end of the trial. The findings of the interviews
with physiotherapists and midwives highlighted the need to offer women choice about geographical
treatment sites, flexibility in the timing of treatment sessions (including evening appointments) and the
provision of cover for annual leave periods for participating physiotherapists. Within the constraints of a
pilot trial we offered some choice to women in line with these suggestions (of up to four treatment
sites, one of which could offer evening appointments) and trained more physiotherapists than needed
in order to specifically provide reasonable cover for annual leave and part-time working patterns
of physiotherapists.
l Tested the trial procedures, training programme for health professionals, the interventions and short-term
outcomes with pregnant women with back pain, providing data on recruitment and follow-up rates,
treatment fidelity, outcome completion rates and an estimate of between-group difference on key
outcomes. We recruited 125 women over 6 months (45% of those who were eligible) and randomised
them to one of the three treatment arms. Three of the six methods of identifying and recruiting women
were more successful. We designed protocols, eligibility criteria, patient information material and
CRFs and found that they performed well in the pilot RCT. We trained 14 physiotherapists to deliver
the EASE Back study interventions and provided mentoring support during the pilot trial. They delivered
the treatments in line with specified protocols, although some women did not attend for their allocated
treatments despite efforts to contact them and re-engage them in treatment. Our usual follow-up
processes for RCTs were reduced based on the decision of the REC reviewing the pilot trial (despite our
appeal and evidence from five previous trials). The follow-up rate at 8 weeks was 74%, lower than
we had hoped, but in our view unsurprising given the decision of the REC about using fewer reminders
than we have previously used in RCTs. Outcome completion rates on key measures were high, with
few missing data. Exploratory analysis of patient-reported clinical outcomes highlighted benefits from
acupuncture over SC alone for pain and function and potential benefits of true acupuncture over
non-penetrating acupuncture for function. The pilot data allowed us to estimate between-group
differences on outcomes of symptoms and impact on activities using the PGQ; we determined the
MCID for this measure and concluded that this would be a suitable primary outcome measure for a
future main trial. In the pilot trial, the baseline SD for the PGQ total score was 17 (one-sided 80% upper
confidence limit= 18) and we determined that the MCID is 4 points; therefore, a future RCT using
this measure should be able to demonstrate a SES as low as 0.22. We also tested out ways to collect
health economic data and conducted an exploratory health economic analysis. Overall, the preliminary
results suggest that adding acupuncture to SC shows potential for providing a cost-effective alternative
to SC alone. The results of both the clinical outcomes and health economic analyses presented in this
report are exploratory and can inform a future main trial.
DISCUSSION AND CONCLUSIONS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
80
l Brought the above findings together, with experts in SC, acupuncture and trial design, in a consensus
conference to finalise the design, interventions, sample size, outcome measures and operational
aspects of a main EASE Back trial. We presented all the results at an end of study dissemination event
and consensus meeting, and discussed the feasibility and desirability of a future main trial. We estimate
that 160 women per arm (480 in total) with pregnancy-related low back pain (with and without PGP)
would be required for a full trial to have 80% power, at 5% significance, to detect an effect difference
equal to or more than the MCID at the 8-week follow-up between treatment arms. Assuming a 80%
follow-up rate (using our CTU standard follow-up processes and adding options for follow-up data
collection and the offer of small shopping voucher incentives for response), we estimate a total sample
size of 600 women need to be recruited. Being conservative, we estimate this could be achieved from
three centres (three maternity centres and linked community services) over 15 months’ recruitment.
A full trial would benefit from longer-term follow-up (most likely at 3 and 6 months postpartum)
and an adaptive trial design using a pre-specified interim analysis to decide whether the trial should
continue with all three treatment arms.
In conclusion, based on the learning from this feasibility and pilot RCT, a future main RCT testing the
additional benefit of acupuncture over SC is feasible. The design and structure of the main RCT was
developed and tested in this pilot RCT. Recruitment and follow-up were challenging, largely because this
patient population comprises young, busy women often with other small children at home and demanding
jobs to continue with, despite pain. We have shown that three recruitment methods are successful and
these could be made more successful if the changes recommended at the consensus conference are
implemented. We also believe that our usual RCT follow-up processes need to be followed in a future trial
and we need to work with the REC reviewing the main trial, to help them see the need for all of the
reminders. We believe there is a good window of opportunity to proceed to a large, multicentre RCT and
have had requests from several sites in the UK interested in working with us on a future large trial.
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Appendix 2 Focus group participant brief
questionnaire
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Appendix 3 Topic guides for interviews and
focus groups
EASE Back study interview topic guide: acupuncturist
1. Introduction.
i. Explain usual arrangements for completion of brief profile, consent, recording, anonymity, focus
group rules, etc.
ii. NB: signing of consent form to be at termination of discussion as check that consent still in place.
2. Experience of back pain among patients.
i. Just to check: what are your qualifications and when did you qualify?
ii. Tell me a little about your experience of back pain among your pregnant patients . . .
iii. Probe for symptoms, effects on daily life, work, sleep, partner/family relationships, physical activities,
mood, etc.
iv. Have you received any specific postgraduate training around the area of back pain in pregnancy?
3. Views on complementary therapies generally.
i. What are your views on complementary therapies generally other than acupuncture?
ii. Have you any experience of using them?
iii. If so, which and in what ways?
iv. NHS or private?
v. Reasons for use?
vi. Outcomes?
4. Managing symptoms.
i. Do you feel you can offer any help with managing symptoms other than acupuncture?
ii. What would be the usual type of approach you would take with these patients?
iii. Probe – how effective, anything else that might be done, does it depend on the severity of the back
pain or other symptoms?
iv. Are there any ‘standard’ self-management resources that you use?
5. Managing patients using acupuncture.
i. Do you provide acupuncture within a private or a NHS setting? Say more . . .
ii. Are there particular aspects of a patient’s symptoms that influence your approach?
iii. Is acupuncture your first line approach?
iv. If yes, are there circumstances in which it might not be?
v. If no, what is? Say more . . .
vi. Are there particular points that you would not use? Say more . . .
vii. Any particular needles?
viii. Any variation on depth?
ix. Is there any particular aspect of managing these patients you find difficult? Say more . . .
x. Any adverse effects?
xi. What do you feel are patients’ expectations about what you have to offer them?
xii. What kinds of explanations about the problem do you use with these women?
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xiii. Do you have any procedures for informed consent?
xiv. Is there any particular information, and in what format, that you give patients?
6. Views on acupuncture in pregnancy – depending on above responses.
i. What sorts of expectations do you think patients have around acupuncture?
ii. When do you consider acupuncture most helpful in the course of the pregnancy?
iii. What sorts of outcomes are be important to you? To women? Prompts RE: employment,
childcare, etc.
iv. When would it be most appropriate to assess those outcomes, e.g. directly after a course of
treatment, a month of so after the end of treatment but before the birth, after the birth?
7. Views on taking part in the trial.
Women:
i. How would you think women might feel about taking part? Reasons and any specific concerns they
anticipate women having . . .
ii. Any particular groups of women that might/not be willing?
iii. What might support/encourage women to take part?
iv. What might discourage/inhibit/prevent them?
8. Professionals:
i. How would you think professionals might feel about inviting women to take part? Reasons. . .
ii. Any particular groups of women that they might/not be willing to invite?
iii. What might support/encourage them in inviting women to take part?
iv. What might discourage/inhibit/prevent them?
9. Close of interview.
i. Any other final remarks/additional views.
ii. Signing of consent form as a check that consent is still in place.
iii. Reimbursement of travel expenses (where appropriate).
EASE Back study interview topic guide: midwives
and physiotherapists
1. Introduction.
i. Explain usual arrangements for completion of brief profile, consent, recording, anonymity, focus
group rules, etc.
ii. NB: signing of consent form to be at termination of discussion as check that consent still in place.
2. Experience of back pain among patients.
i. Tell me a little about your experience of back pain among your pregnant patients . . .
ii. Probe for symptoms, effects on daily life, work, sleep, partner/family relationships, physical
activities, mood, etc.
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3. Managing symptoms.
i. Do you feel you can offer any help with managing symptoms?
ii. What would be the usual type of approach you would take with these patients?
iii. Probe – how effective, anything else that might be done, does it depend on the severity of the
back pain or other symptoms?
iv. Are there any ‘standard’ self-management resources that you use?
4. Managing patients.
i. Is there any particular aspect of managing these patients you find difficult? Say more . . .
ii. What do you feel are patients’ expectations about what you have to offer them?
iii. What kinds of explanations about the problem do you use with these women?
iv. How do you usually manage these patients?
5. Views on complementary therapies generally and acupuncture specifically.
i. What are your views on complementary therapies generally?
ii. Have you any experience of using them?
iii. If so, which and in what ways?
iv. NHS or private?
v. Reasons for use?
vi. Outcomes?
vii. Repeat for acupuncture specifically.
6. Views on acupuncture in pregnancy – depending on above responses.
i. Have used in pregnancy?
ii. Reasons for doing so?
iii. If not used, probe for reasons, including specifically any concerns about adverse effects.
iv. What sorts of expectations do you think patients have around acupuncture?
v. If acupuncture was to be provided, when would be most helpful in the course of the pregnancy?
vi. What sort of outcomes would be important to you?
vii. When would it be most appropriate to assess those outcomes, e.g. directly after a course of
treatment, a month of so after the end of treatment but before the birth, after the birth?
7. Views on taking part in the trial.
Explain the trial.
Women:
i. How would you think women might feel about taking part? Reasons and any specific concerns
they anticipate women having . . .
ii. Any particular groups of women that might/not be willing?
iii. What might support/encourage women to take part?
iv. What might discourage/inhibit/prevent them?
8. Professionals:
i. How would you think professionals might feel about inviting women to take part? Reasons . . .
ii. Any particular groups of women that they might/not be willing to invite?
iii. What might support/encourage them in inviting women to take part?
iv. What might discourage/inhibit/prevent them?
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9. Midwives:
i. Which women with back pain do you refer on to physiotherapists? Probe for details.
ii. Explain the plan for audio-recording in pilot trial of consent meeting and explore their views of
these plans.
10. Close of interview.
i. Any other final remarks/additional views.
ii. Signing of consent form as a check that consent is still in place.
iii. Reimbursement of travel expenses (where appropriate).
EASE Back study interview topic guide: women
1. Introduction.
i. Explain usual arrangements for completion of brief profile, consent, recording, anonymity, focus
group rules, etc.
ii. NB: signing of consent form to be at termination of discussion as check that consent still in place.
2. Experience of back pain in pregnancy.
i. Tell me a little about your experience of back pain in your pregnancy . . .
ii. Probe for symptoms, effects on daily life, work, sleep, partner/family relationships, physical activities,
mood, etc.
3. Help received with managing symptoms.
i. Do you feel you have received any help with managing symptoms?
ii. If yes, probe who from, what sorts of help, how effective, anything else that might be done?
iii. If no, has help been sought?
iv. If yes, from whom, what sort of responses received?
v. If no, reasons for not seeking help.
vi. Anything else that you have done to help with the pain, including self-help strategies and accessing
information, and if so, from where? How effective?
4. Expectations after pregnancy.
i. How do you expect the situation to be after the baby is born?
ii. Reasons?
5. Views on complementary therapies generally and acupuncture specifically.
i. Have you any experience of complementary therapies?
ii. If so, which types? (Probes as follows.)
iii. NHS or private?
iv. Reasons for use?
v. Financial cost?
vi. Outcomes?
vii. Repeat for acupuncture as appropriate.
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6. Views on acupuncture in pregnancy – depending on above responses.
i. Willingness to consider acupuncture for back pain in pregnancy – initial ideas about this and any
specific concerns.
ii. Have you used acupuncture in pregnancy?
iii. If used, probe for reasons.
iv. How did you decide which acupuncturist to use?
v. NHS or private?
vi. Practitioner background?
vii. Outcomes?
viii. If not used, probe for reasons.
ix. If acupuncture was to be provided, when would be most helpful in the course of the pregnancy?
x. What sort of outcomes would be important to you?
xi. When would it be most important to you to assess those outcomes, e.g. directly after a course of
treatment, a month of so after the end of treatment but before the birth, after the birth?
7. Views on taking part in research.
Explain about the trial.
i. How would you feel about taking part? Reasons . . .
ii. How do you think women generally might feel? Reasons . . .
iii. Any particular concerns about being invited to take part in this type of trial?
iv. What might support/encourage women to take part? Specifically what information would they want
before deciding to take part?
v. What might discourage/inhibit/prevent them?
8. Closing the interview.
i. Any other final remarks/additional views.
ii. Signing of consent form as a check that consent is still in place.
iii. Reimbursement of travel expenses (where appropriate).
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Appendix 4 Participant information leaflet
EASE BACK Study 
Evaluating Acupuncture and Standard care for pregnant womEn with BACK 
pain
www.keele.ac.uk/easeback    
Participant Information Leaflet
REC ref: 13/WM/0021 
Version 2.2. Date: 02/04/13
You are being asked to take part in a research study. The study will test ways of 
managing back pain during pregnancy. It is being carried out by the University 
Hospital of North Staffordshire (UHNS), local community midwives, and 
physiotherapy services working with a research team at Keele University. This leaflet 
explains why the research is being done and what it will involve. Please take time to 
read the information carefully, before you decide whether or not to take part, and 
discuss it with others if you wish. 
Why is the research being carried out?
We are trying to find out how best to help women with back pain during pregnancy. 
Back pain during pregnancy is common and can affect daily activities, work and 
sleep. Usual care for pregnant women with back pain typically involves advice about 
things that they can do to help ease their pain, for example, changes in posture and 
simple exercises to do at home. Acupuncture may also be a treatment that could 
help. It is already recommended in UK guidelines for treating back pain in the 
general population. Some midwives and physiotherapists also use it to treat 
pregnant women with back pain. However, we do not know if it is better than usual 
care. In order to understand whether acupuncture can really help pregnant women 
with back pain, we want to offer some women ‘usual care’ and other women ‘usual 
care plus acupuncture’ in what is called a ‘randomised trial’. This is what the EASE
BACK study is all about. 
Why have I been invited to take part?
You have been invited to take part because you are pregnant and experiencing back 
pain. We are asking 180 pregnant women in total to take part in the study.
Do I have to take part?
It is up to you to decide whether or not to take part. Your involvement is purely 
voluntary. Whether or not you decide to take part in this study, your midwife or 
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obstetrician will still give you the best care they can. If you do decide to take part, 
you will still be free to withdraw from the study at any time, without giving a reason 
and withdrawing will not affect your current or future health care in any way. 
What are the treatment packages?
The treatment packages on offer are usual care, or usual care in combination with 
one of two types of acupuncture, which are described in more detail below. This 
means that all women in the EASE BACK study will receive usual care, and some 
will also receive acupuncture. 
· Usual care
Across the UK usual care for pregnant women with back pain involves advice, education and 
guidance about things that women can do to help themselves, as well as postural changes 
and exercises to try at home. A detailed booklet containing this guidance will be posted to all
women that take part in the study, explaining how to reduce and prevent your back pain. In 
addition, as would be the case normally, those with the most severe problems may also be 
referred to physiotherapy for additional treatment. 
· Usual care and one of two different forms of acupuncture
In addition to usual care, some participants in the EASE BACK study will also receive 
one of two different forms of acupuncture. This will help us see whether the type of 
acupuncture makes a difference to your pain. Acupuncture will be delivered by fully 
trained physiotherapists, and you have a choice of four locations at where to receive 
your treatment: the University Hospital of North Staffordshire, Bradwell Hospital 
(Chesterton), Cobridge Community Health Centre and Bentilee Health Centre. 
Acupuncture originated from the Far East nearly 4000 years ago, and involves the 
stimulation of certain parts of your body, using very fine needles at particular points. 
The needles do not bear any resemblance to those used for taking blood or giving 
injections. You may experience a mild discomfort when they are inserted but, in 
general, acupuncture is considered painless. Your physiotherapist will explain the 
procedure fully.
If you are allocated to receive usual care plus acupuncture you will receive between 6 to 
8 treatments over approximately 6 weeks. Each treatment session will last 30 to 40 
minutes. To receive acupuncture the physiotherapist will work out the most comfortable 
position with you, but this is likely to involve lying on your side, or being propped up on 
your back. Your physiotherapist will make sure you are comfortable before starting 
treatment. As you need to keep still and be as relaxed as possible when the 
acupuncture needles are in place it would be better if you do not bring young children 
into the treatment room with you. If you have to bring your children along, it would be 
helpful if you could also bring along a family member or friend to help look after them in 
the waiting area.     
What will happen to me if I decide to take part?
First, a Research Midwife or Nurse will contact you over the telephone to talk to you 
about the study, and to answer any questions that you may have after reading this 
information leaflet. She will ask you about your general health, your pregnancy and 
your back pain to see if you are eligible to take part. The phone call should take 
approximately 15 minutes.
Second, if you are eligible and are interested in taking part, you will be invited to a 
face to face meeting at the University Hospital of North Staffordshire. If you cannot 
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make it to the hospital, the Research Midwife or Nurse can visit you in your own 
home. The visit should take approximately 45 minutes.
Because we are interested in knowing the sorts of questions that you might ask, and 
the sorts of concerns you might have, we would like to audio-record some of these 
meetings. If your meeting is going to be recorded you will be asked to agree to this 
before it starts. As with all parts of the research, you do not have to agree and if you 
decide you do not want the meeting recorded, you can still take part in the rest of the 
research.  If you are happy for it to be recorded, you will be asked to sign a consent 
form.
At the face to face meeting the Research Midwife or Nurse will answer any questions 
you may have and will explain the study to you in detail. They will also be able to tell 
you more about each of the centres where treatment is offered, for example information
about car parking and the availability of child friendly facilities. Please do not hesitate to 
ask about anything that is not clear. It is very important you fully understand what taking 
part in the study means. If you agree to take part you will be asked to sign a second 
consent form. Once you have agreed to take part, you will be asked to complete a 
questionnaire about you, your circumstances, your back pain and how it is affecting 
you. The Research Midwife or Nurse will also ask you to do two simple tasks so they 
can understand your back pain in more detail. 
It is important to realise that the Research Midwife or Nurse will not know which treatment 
package you will get. The study treatment given to you will be chosen at random, which is 
done using a computer so it is purely by chance. This means that you will have an equal 
chance of getting any one of the treatment packages.  If you are still happy to take part in the 
study after your visit, you will receive a letter in the post telling you which treatment package 
you are going to receive.
What else do I have to do?
Eight weeks after the meeting with the Research Midwife or Nurse, you will be sent 
another questionnaire by post. We would like you to complete the questionnaire and 
post it back to us (we pay the postage). The questionnaire should take approximately 
20 minutes to complete. A researcher may contact you by phone if we do not 
receive your completed questionnaire to find out how you are doing. We will also 
look at your maternity records after you have had your baby to collect information on 
your birth. If you want to take part in the study but do not want us to look at 
your maternity records you are still able to do so – just let us know.    
Who will see the information collected from me?
All information that is collected about you will be kept strictly confidential. Research 
data will be sent from the Research Midwives and Research Nurses at the University 
Hospital of North Staffordshire to the research team at Keele University. This will 
include your name and address in order that research staff can stay in touch with 
you over the course of the study and send you the follow up questionnaire. These 
details will be sent securely and kept in locked filing cabinets or in password 
protected computer databases accessible only to essential research staff within the 
EASE BACK study team. All other information about you will have your name and 
address removed so that you cannot be recognised from it. If you agree, your GP will 
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be notified that you are taking part in this study. Again, just let us know if you do not 
want them informed.
What are the possible benefits of taking part?
We hope the treatment packages will help you, however this cannot be guaranteed. 
If you feel that your treatment has not worked, you are free to go back to your 
midwife or obstetrician to see what else they can offer you. The information that we 
get from this study may help us to treat pregnant women with back pain in the future.
What might be the risks?
Serious risks are extremely unlikely and the Research Midwife or Nurse will check 
that there is no reason why you should not receive any of the treatment packages 
before you are able to take part. In a previous study of acupuncture in pregnancy, 
there were no serious side effects for women, their babies or the birth. Minor side 
effects were common but women felt that acupuncture helped their back problems 
despite this. Overall, about 5% of women are expected to experience minor side 
effects with acupuncture. The most frequent side effects are: 
· Momentary discomfort where the needles are inserted (happens in about 1 in 
5 women) 
· Drowsiness after treatment (happens in about 1 in 10 women) 
· Nausea with feeling faint (happens in about 3 in 100 women)  
· Headache (happens in about 2 in 100 women)
Other possible minor side effects include mild bruising where the needles are 
inserted and temporary worsening of your symptoms. There are no specific risks with 
usual care, other than the temporary soreness that can follow starting a new 
exercise programme. 
What if something goes wrong?
If you are harmed whilst taking part in this research as a result of negligence on the 
part of a member of the study team, then you may have grounds for legal action 
against the NHS organisation which is hosting this research and to seek 
compensation via the NHS indemnity scheme, but you may have to pay for any legal 
costs. There are no arrangements to cover non-negligent harm. Regardless of this, if 
you wish to complain about any aspect of the way you have been approached or 
treated during the course of this study, the normal National Health Service 
complaints mechanism will be available to you.  
Will you pay me any expenses?
We will provide you with £10 to cover any travel and car parking costs that you may 
have to pay for attending the research visit with the Research Midwife or Nurse. 
What will happen to the results of the research study?
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As well as helping with the development of a future larger trial in the NHS, the 
findings from this study will be published in medical journals and presented at 
conferences for healthcare professionals. You will not be identified in any reports or 
publications resulting from the study. The results will be made available for you to 
see on the study website once the study has been completed.    
Who is organising and funding the research?
The research team is led by Professor Nadine Foster from the Primary Care Centre 
at Keele University and includes physiotherapists, midwives and obstetricians. The 
study is funded by the National Institute for Health Research (NIHR) Health 
Technology Assessment programme, the UK’s largest funder for NHS-based trials. 
Who has reviewed the study?
To protect your interests, all research in the NHS is looked at by an independent 
group of people, called a Research Ethics Committee. This study has been reviewed 
and given favourable opinion by the National Research Ethics Service Committee 
West Midlands - Staffordshire. The study has also been reviewed by scientific 
experts on behalf of the National Institute of Health Research (NIHR), who assessed 
it before awarding funding.
Who can I talk to if I have any questions?
You will have the chance to talk to the Research Midwife or Nurse both on the 
telephone and during your face to face meeting. However, if in the meantime you 
have any questions, or would like further information about this study, please contact 
the study co-ordinator            Mel Holden on 01782 733921 during office 
hours. 
What if I need to speak to someone outside of the study team, about this 
study?
If you have any questions or concerns about taking part in this research you can also 
contact the Patient Advice and Liaison Service (PALS). The phone number for the 
PALS office at the University Hospital of North Staffordshire is 01782 676450. The 
phone number for the PALS office for the Staffordshire and Stoke-on-Trent 
Partnership NHS Trust is Free Phone 0800 783 2865.
Thank you for taking the time to read this information leaflet.
This project was funded by the National Institute for Health Research Health Technology Assessment 
(NIHR HTA) Programme (project number 10/69/05) and will be published in full in Health Technology 
Assessment”.
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Appendix 6 Training programme for research
midwives and nurses
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Appendix 7 Training programme for
physiotherapists
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Appendix 8 Correspondence with Research
Ethics Committee
Professor Nadine Foster
Chief Investigator 
Arthritis Research UK Primary Care Centre
Primary Care Sciences,
Keele University,
Staffordshire, ST5 5BG
F.A.O Dr Kathryn Kinmond
West Midlands – Staffordshire REC
Barlow House 3rd Floor
4 Minshull Street
Manchester, M1 3DZ
25th January 2013
Dear Chair,
Ethics application:- The EASE BACK study: Pilot Randomised Controlled 
Trial
REC Reference Number:- 13/WM/0021
Please find below our responses to your requests for further information following ethical review 
of the above study at the meeting held on the 9th January 2013. Based on the feedback we 
received from ethics, we have also included a revised participant information leaflet, pilot trial 
consent form, advertisement materials, study protocol and study flow chart for your review. In 
addition we have also included a letter that we would like to send to women participating in the 
pilot trial and randomised to receive usual care plus acupuncture if the physiotherapy service is 
unable to contact them over the telephone to arrange an initial appointment. 
Summary of included documentation for review
· Participant information leaflet for pilot RCT, v2.0, 24/1/13
· Pilot trial consent form, v2.0, 24/1/13
· Advertisement materials (EASE BACK study card, flyers/ posters, v2.0, 24/1/13) 
· Study protocol, v2.0, 24/1/13
· Study flow chart, v2.0, 24/1/13
· Letter if physiotherapy service unable to contact woman, v1.0, 24/1/13
Responses to your requests for information are as follows:
1. Follow-up reminders
The Committee have asked for a maximum of two reminders to participants to return the follow-
up questionnaire. At the meeting we clarified with the Committee that the procedure for 
reminders that was included in the original protocol was in line with the Keele University Clinical 
Trial Unit’s Standard Operating Procedures, developed through experience with multiple 
previous randomised trials. We also stressed the importance of high follow-up rates in 
randomised trials, in order to ensure a robust and trustworthy analysis. We have gathered 
examples of the reminder processes that we have recently used within trials approved under the 
NRES system and their response rates (where available), and would like to share them with you 
as follows:
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SWAP trial (REC ref: 12/WM/0020), n=360 (recruitment currently ongoing), approval granted for 
4 reminders following initial questionnaire
• Questionnaire
• Reminder postcard at 2 weeks if no response
• Reminder questionnaire at 4 weeks if no response
• Postal brief questionnaire at 6 weeks if no response
• Minimal data collection via telephone at 8 weeks if no response
PhysioDirect trial (REC ref: 08/H0102/95), n=2250 randomised patients, total response rate at 
6 weeks following 3 reminders after initial questionnaire = 89%
• Response to questionnaire (without reminders): 40%
• Response after first reminder + questionnaire: a further 22%
• Response after second reminder + questionnaire: a further 9%
• Response to minimum data collection via telephone: a further 18% 
SMOOTH trial (REC ref: 07/H1008/235), n=257 randomised patients, total response rate at 3 
months following 3 reminders after initial questionnaire = 88%
• Response to questionnaire (without reminders): 49%
• Response after reminder postcard at 2 weeks: a further 22%
• Response after second questionnaire (at 4 weeks): a further 15%
• Response to minimum data collection (at 6 weeks): a further 2% 
STarTBack trial (REC ref: 07/Q2604/5), n=851 randomised patients, total response rate at 4 
months following 3 reminders after initial questionnaire = 81%
• Response to questionnaire (without reminders): 32%
• Response after reminder postcard at 2 weeks: a further 25% 
• Response after second questionnaire (at 4 weeks): a further 16%
• Response to minimum data collection (at 6 weeks): a further 8%
APEX trial (REC ref: 02/07/114), n=352 randomised patients, total response rate at 6 weeks 
following 3 reminders after initial questionnaire = 95%
• Response to questionnaire (without reminders): 52%
• Response after first reminder + questionnaire at 2 weeks: a further 31%
• Response after second reminder + questionnaire (at 4 weeks): a further 7%
• Response to minimum data collection (at 6 weeks): a further 5%
From the above, it is clear that the reminder process is critically important to achieving high 
response rates in randomised trials, and we would ideally prefer to continue to follow our usual 
processes, in order to achieve more than 80% response at the follow-up time point in the EASE 
BACK pilot trial. Women will have provided their consent to this study as part of a face-to-face 
informed consent process, where the reminder process can be explained, and the need to 
provide follow-up data can be made clear, so women will be aware of the importance of providing 
follow-up information. Given evidence from the above examples, combined with the feedback 
from the ethics committee, we propose that removing one planned reminder from the EASE 
BACK trial process (the minimum data questionnaire) will deliver the level of follow-up rates 
needed for the study in a way that has proven to be acceptable to participants in previous recent 
trials approved under the NRES system, and takes into account the concerns to achieve an 
acceptable level of burden to participants in this trial.  Our revised plan would therefore be to 
carry out the following:
EASE BACK pilot trial, n=180 randomised patients, aiming for a total response rate at 8 weeks 
of 80% or more 
• The 8 week questionnaire 
• A reminder postcard at 2 weeks if no response
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• A second questionnaire at 4 weeks if no response 
• Minimum brief data collection via telephone at 6 weeks if no response 
In order to reflect this change we have modified the study protocol and study flow chart, and 
enclose the updated versions of these documents for your review.
2. Health economics should be added to the secondary research objectives
Within the study protocol the study objectives are listed in section 3.2, on page 15: 
• Test the trial procedures, training programme for health care professionals, interventions and 
outcomes with 180 women with pregnancy-related back pain.
• Provide data on likely recruitment and follow-up rates for the main trial plus completion rates 
on key outcomes and an estimate of likely effect size difference between the intervention (usual 
care plus acupuncture) and control (usual care) arms.
The health economic outcomes are encompassed in each of the above objectives, along with all 
the other outcome measures being used in the study. Specific detail about the health economic 
data that is being collected is provided in full within section 3.11.4 (page 26) of the protocol. 
3. Specific consent for the collection of socio-economic data should be included in the 
consent form.
This has now been included in the consent form, and more information about this has also been 
included within the participant information leaflet (revised versions included for your review).
4. Appendix 2 should be removed from study documentation.
This has been removed.
5. The wording “we may be able to help” on the study advertisement is coercive and 
should be removed. 
The wording has been changed and the revised versions included for your review.
6. Collecting women’s full date of birth means women are more identifiable. Is the full 
date of birth needed?
To allow us to check for duplicates within the study (i.e. to ensure that we do not contact the 
same woman more than once) we do need every women’s full date of birth. However, we do 
have clear policies and procedures in place for use of personal data, and how to ensure the 
confidentiality of such data, which are outlined in our responses to questions A36 and A38 of the 
REC form.  
7. Change the wording on the participant information leaflet under ‘what if something 
goes wrong’. 
The wording has been changed and the revised version is included for your review. 
Should you require any further information, please do not hesitate to contact me, on telephone 
number 01782 734705, or Melanie Holden, the EASE BACK study co-ordinator on telephone 
number 01782 734720. I look forward to hearing from you in due course. 
Yours sincerely,
Professor Nadine Foster
Chief Investigator 
Tel: 01782 734705
Email: n.foster@keele.ac.uk
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Appendix 9 Participant recruitment methods
and flow
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Appendix 10 Baseline questionnaire
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Appendix 11 Self-tests for pelvic girdle pain
Self-assessed P4 test
Bridging with extension of the leg
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Appendix 12 Eligibility screening proforma
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Appendix 13 Physiotherapy case report forms
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Appendix 14 Follow-up questionnaire
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Appendix 15 Evaluating Acupuncture and
Standard carE for pregnant women with Back pain
study dissemination event
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